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ABSTRACT 
Background: Approximately one out of five adults in Sweden suffer from longstanding 
pain and many experience pain-related disability and reduced quality of life. Long-
standing pain is also associated with substantial societal costs and psychological factors 
are central to its development and maintenance. Studies imply the efficacy of cognitive 
behavior therapy (CBT) and Acceptance and Commitment Therapy (ACT) for long-
standing pain in adults, but there is a need for: (1) Randomized controlled trials evaluating 
the efficacy of ACT compared to established treatments; (2) adequate measures for use in 
treatment-evaluations that assess the impact of pain on behavior; (3) further evaluations of 
processes of change in ACT, and specifically for studies that more adequately model 
change over time and investigate the temporal precedence of change in the mediator in 
relation to the outcome; and (4) studies evaluating the cost-effectiveness of ACT. 
 
Aims: The overarching aims of the doctoral thesis were to evaluate the efficacy and 
processes of change in ACT for longstanding pain. Specifically, the aims were to 
evaluate: (1) The efficacy of ACT delivered in a group setting (Study I and Study II); (2) 
the cost-effectiveness of ACT (Study II); (3) the psychometric properties of a brief 
measure assessing pain interference, the Pain Interference Index (PII) (Study III); and (4) 
if changes in psychological inflexibility mediated changes in pain disability (Study I) and 
pain interference (Study IV). 
 
Methods: The efficacy of ACT was tested in two randomized controlled trials. The first 
trial utilized a wait-list control condition and included women with fibromyalgia (Study 
I). Assessments were done pre- and post-treatment and at 3-month follow-up. In Study II 
adults with non-specific longstanding pain were randomized to ACT or applied relaxation 
(AR). Data was collected pre-, mid- and post-treatment, and at 3- and 6-month follow-up. 
Pain disability was the primary outcome measure in both studies. Data was analyzed 
using hierarchical linear modeling and latent growth curve modeling. Cost-effectiveness 
was evaluated by calculating the quotient of the difference in average changes in costs and 
pain disability in ACT and AR (Study II). 
The psychometric properties of the PII were evaluated using cross-sectional data 
from adults with non-specific longstanding pain (Study III). Analyses comprised a 
principal component analysis, analysis of item statistics, corrected item-total correlations 
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and inter-item correlations. Concurrent criteria validity was evaluated using zero-order 
correlations and ordinary least squares regression analyses including pain intensity, pain 
disability, health-related quality of life and depression. In Study I mediation analyses 
were based on change scores in psychological inflexibility during treatment and change 
scores between pre- to follow-up assessment in outcomes (e.g. pain disability). Study IV 
incorporated the specified timeline between mediator (e.g. psychological inflexibility) 
and outcome (pain interference) based on session-to-session assessments from 
participants in Study II and used multilevel regression analyses to model change. 
 
Results: In Study I results showed significant improvements in the ACT-condition, in 
pain disability, fibromyalgia impact, mental health-related quality of life, self-efficacy, 
depression, anxiety and psychological inflexibility. Results in Study II illustrated 
significant improvements across conditions from pre-treatment to follow-up in pain 
disability, physical health-related quality of life, pain intensity, depression and anxiety. 
Also, ACT improved significantly relative to AR in pain disability during treatment, but 
AR improved in pain disability compared to ACT between post-assessment and 6-month 
follow-up. Pain acceptance increased significantly only in ACT. This increase was 
maintained at 6-month follow-up. In addition, results indicated that ACT was more cost-
effective than AR at post-treatment and 3-month follow-up, but these results had leveled 
out at 6-month follow-up. The psychometric evaluation of PII (Study III) indicated the 
reliability and validity of the measure in assessing pain interference in adults. In Study I 
treatment changes in psychological inflexibility mediated pre- to follow-up 
improvements in pain disability and secondary outcome measures in ACT. Similarly, 
change in psychological inflexibility mediated change in pain interference in ACT 
during treatment in Study IV. 
 
Discussion and conclusions: Results correspond with previous studies on ACT for 
longstanding pain and suggest the utility of ACT for fibromyalgia and non-specific 
longstanding pain (Study I and Study II). Also, psychological inflexibility is further 
established as a central treatment target and mediator of improvement in ACT (Study I 
and Study IV). Health economic analyses illustrated that ACT was associated with 
significant cost reductions and cost-effectiveness compared to AR up to 3-month follow-
up (Study II). In sum, the studies add to the support for ACT for longstanding pain and 
specifically contribute in areas that were found to be lacking in the empirical literature.  
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1 INTRODUCTION 
This doctoral thesis evaluated the efficacy of a contextual behavioral therapy, Acceptance 
and Commitment Therapy (ACT), in improving pain-related disability, pain interference 
and health-related quality of life (HRQL) in persons suffering from longstanding pain and 
related distress. Notably, the objective was not to attain improvements in pain disability 
and pain interference by means of reductions in pain following treatment. Rather, we 
hypothesized that ACT would facilitate disengagement from, and a willingness to 
experience, distressing pain, related cognitions and emotions. Furthermore, we anticipated 
that this would create more flexible psychological or behavioral repertoires and in turn 
improve pain disability and pain interference. In line with these hypotheses, we evaluated 
if improvements in psychological flexibility were functionally related to improvements in 
pain disability and pain interference. 
In addition, the effect of treatment on health-related costs and the cost-effectiveness 
of treatment were evaluated. Lastly, we evaluated the psychometric properties of a brief 
pain interference questionnaire that was also used as an outcome measure in the afore-
mentioned analyses of processes of change. Before I present and discuss the details of the 
specific studies I will give a background to longstanding to pain, its prevalence, 
consequences and treatment challenges, and to the theoretical, clinical and empirical 
underpinnings of cognitive behavior therapy (CBT), and ACT in particular. 
2 BACKGROUND 
The ability to experience pain is of major evolutionary importance and the pain system 
serves facilitation of tissue integrity and tissue repair when integrity has been 
compromised. Pain is transmitted from nociceptive neurons via large (Aδ-fibers) and 
small diameter fibers (C-fibers) conveying brief sharp pain and blunt throbbing pain 
respectively. These fibers project to the dorsal horn of the spinal cord where nociceptive 
signaling is further projected to higher cortical areas (Willis and Westlund, 1997). 
Melzack and Wall (1965) changed the view of the spinal cord as a passive transmission 
station for pain, to a (metaphorical) gate where potential modulation of nociceptive input 
can take place. This modulation occurs by way of interaction between pain-transmitting 
and non-pain-transmitting neurons in the spinal cord dorsal horns, in such a way that the 
influence of non-pain transmitting neurons can inhibit the perception of pain (Melzack 
and Wall, 1965). 
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2.1 PAIN CLASSIFICATION 
Pain is referred to as acute when it arises in direct temporal relation to e.g. tissue damage 
and subsides when healing has occurred (Turk and Melzack, 2011). When pain persists 
and exceeds a pre-defined temporal cut-off, e.g. 3 months, it is referred to as longstanding 
or chronic pain (Merskey and Bogduk, 1994). Longstanding pain can be an expression of 
ongoing nociceptive signaling as described above, or the consequence of a lesion or a 
disease in the somatosensory nervous system, i.e. neuropathic pain (IASP, 2012). 
However, pain also exists in the absence of a clear pathology and is then classified as e.g. 
idiopathic or non-specific pain, or, as in the case of e.g. fibromyalgia (FM), by specific 
descriptive criteria (Norrbrink and Lundeberg, 2010; Wolfe, 2010). FM is often referred 
to as a pain syndrome including tenderness, widespread pain, fatigue and disturbed sleep. 
The diagnosis is based on descriptive criteria comprising widespread pain and symptoms 
of fatigue, unrefreshed sleep, cognitive problems, and somatic symptoms, of a pre-
specified severity (Wolfe, 2010). The biology involved in acute pain is well studied and 
relatively well understood. In contrast, the biology underlying the development and 
persistence of longstanding pain is less clear, but a number of biological factors have been 
suggested in regard to non-specific longstanding pain and FM. 
2.2 BIOLOGICAL PERSPECTIVES ON LONGSTANDING PAIN 
A few perspectives on the biological processes that are potentially relevant for the 
understanding of longstanding pain are briefly presented below. Importantly, the 
presentation is meant to illustrate the possibility of similar biological processes being 
involved in different descriptive pain classifications, but also in regard to pain-related 
symptoms (e.g. fatigability) and emotions. In addition, these perspectives aim to highlight 
the relation between the biology of pain and motivation. 
2.2.1 Altered sensory processing in the central nervous system 
Central sensitization is characterized by an increase in the neuronal excitability in the 
central nervous system (CNS) that alters certain sensory inputs (Woolf, 2011). According 
to Woolf (2011, p. 14), this change is initially triggered by intense activity in 
nociceptors that in effect strengthen the synaptic connections between the nociceptor 
and the spinal cord neurons. These changes in the synapses result in an amplification of 
inputs in such a way that stimuli that previously have been experienced as innocuous 
now produce pain (Woolf, 2011, p. 4). Under the above circumstances, pain may feel as 
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it comes from peripheral areas of the body, but in actuality it is the product of altered 
and irregular sensory processing in the CNS (Woolf, 2011, p. 4). For example, central 
sensitization may be responsible for the experience of pain following tactile stimulation, 
but also for causing pain and tenderness in areas adjacent to the actual area of tissue 
damage (Woolf, 2011, p. 8). Temporal summation is a phenomena that is related to 
central sensitization, and refers to a progressive buildup of the magnitude of neuron 
activity in the dorsal horn, produced by repeated activation of small diameter pain 
fibers, resulting in a prolonging of pain (Woolf, 2011). 
2.2.1.1 The example of FM 
Altered sensory processing in the CNS of the kind discussed above has been put forth as 
putatively central in FM, based on results from a number of studies (Gracely et al., 2002; 
Kuchinad et al., 2007; Mountz et al., 1995). For example, central pain processing has 
been implied by higher pain intensity and larger areas of referral in persons diagnosed 
with FM (Sorensen et al., 1998), as well as by findings showing greater temporal 
summation of pain in persons suffering from FM-symptoms (Staud et al., 2001). Also, 
previous studies imply dysfunction of endogenous pain inhibitory mechanisms (Kosek 
and Hansson, 1997; Lautenbacher and Rollman, 1997). In addition, based on studies 
showing overlap between for example FM, temporomandibular disorder (TMD) and 
irritable bowel syndrome (IBS) (Plesh, Wolfe, and Lane, 1996) it has been proposed that 
central sensitization possibly represents a unifying pathophysiological mechanism for a 
number of pain syndromes. In line with this, the term central sensitivity syndrome (CSS) 
has been suggested as a way to denote these pain syndromes (Yunus, 2007). 
2.2.2 Pain as part of a sickness response 
However, central sensitization may not sufficiently explain other co-occuring symptoms 
in for example FM, as fatigue, impaired recovery with post-exertional malaise, deficits in 
concentration and memory, sleep-wake cycle disturbances and emotional distress (Van 
Houdenhove and Luyten, 2009). Thus, the role of a severely overburdened (hypo-
functioning) stress system and a pathological neuroimmune sickness response, facilitated 
by e.g. pro-inflammatory cytokines, has been suggested as a possible framework to 
understand these co-occuring symptoms (Fries et al., 2005; Meeus and Nijs, 2007; Van 
Houdenhove and Egle, 2004). This sickness response comprises both physiological and 
behavioral reactions related to immune activation including increased fatigability, loss of 
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concentration, hypersensitivity for sensory stimuli, low-grade fever and a generalized 
increase in pain sensitivity. Importantly, these features of the sickness response may 
increase motivation to withdraw from social and other daily activity (Van Houdenhove 
and Luyten, 2009). 
2.2.3 Pain as a homeostatic emotion 
In summarizing the model of pain as a homeostatic emotion, Craig (2003) describes pain 
as being part of the representation of the body’s physiological interoceptive state. From 
this perspective, pain is cast a feeling and a motivation, a homeostatic emotion, like itch 
temperature and hunger. This system, well developed only in humans, includes an 
interoceptive spino-thalamo-cortical pathway providing a cortical image of the body’s 
condition, “[…] a subjective meta-representation of the feelings from the body that are 
associated with emotion” (Craig, 2003, p. 4). As homeostasis is a dynamic, hierarchic 
process that in an ongoing time-varying manner integrates all aspects of the body’s 
conditions, this model may also shed light on the variability of clinically presented pain 
(Craig, 2003, p. 23). In this view, longstanding pain can be framed as homeostatic 
dysfunction, a physiological imbalance causing a behavioral drive that the homeostatic 
systems cannot rectify automatically. 
2.3 EPIDEMIOLOGY OF LONGSTANDING PAIN 
2.3.1 Demographic data and prevalence 
A large-scale European survey illustrated that the prevalence of longstanding pain in 
adults in 15 European countries ranged from 12% to 30% (Breivik et al., 2006). Results 
from in-depth telephone interviews with persons suffering from pain six months or longer 
(n = 4839) showed that: 56% percent of the participants were women; the mean age was 
50 years; the median pain duration was 7 years; 34% reported severe pain; and that 46% 
suffered from constant pain. Based on interview data from approximately 197.000 
persons, Pleis and Coles (2003) estimated that 28% reported lower back pain, 16% severe 
headache or migraine, 15% reported neck pain, and 4% facial or jaw related pain. 
Results from a systematic review of prevalence studies in Demark and Sweden 
(including 5 studies with low bias and high representativeness for Sweden) illustrated a 
prevalence of longstanding regional pain, musculoskeletal and non-specific spinal pain in 
adults ranging from 23.9% to 56.4% (Harker et al., 2012). In these studies, 53% to 61% 
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percent of the participants were women and the mean age ranged from 46.5 to 50.3 years 
(Arvidsson et al., 2008; Bergman et al., 2001; Demmelmaier et al., 2008). 
As regards FM in particular, Cöster et al. (2008) reported a prevalence of 2.5% in 
Sweden, a figure that falls within the prevalence range of 0.66% to 3.3% reported in five 
population based studies discussed by McBeth (2005), as well as the prevalence range of 
1.3% to 4.8% presented by Wolfe et al. (1995). Similarly, a prevalence of 4.1% (Bergman 
et al., 2001) to 11.4% (Kato et al., 2006) of chronic widespread pain (CWP) has been 
reported in the population. Repeatedly, there is a clear overrepresentation of women 
fulfilling criteria for FM. In a study by Wolfe et al. (1995), 80% of participants were 
women. A study by Bergman et al. (2001) reported a two-fold higher prevalence of CWP 
in women, and in a study by Kato et al. (2006) 81.7% of persons suffering from CWP 
were women. 
2.3.2 Prevalence of anxiety and depression in longstanding pain 
Depression is frequently reported in concurrence with longstanding pain. For example, 
Breivik et al. (2006) illustrated that 21% of the participants reported a diagnosis of 
depression in conjunction with pain. According to Banks and Kerns (1996), 9 out of 14 
prevalence studies that used stringent diagnostic criteria, reported prevalence rates of 
depression between 30% and 54% in adults with longstanding pain. Also, markedly 
higher rates of for example panic disorder, social phobia and posttraumatic stress disorder 
have been reported in the pain population (Tunks, Crook, and Weir, 2008). 
Repeatedly, FM has been related to depressive symptoms and for example Cöster 
et al. (2008) stated that 54% of participants in their study reported mild to severe 
depression in conjunction with FM, and Kato et al. (2006) reported a co-occurrence of 
depressive symptoms in CWP of 40%. 
2.3.3 Impact of pain on daily living and societal costs 
For a substantial number of persons, longstanding pain has a negative impact in several 
life domains. These domains include, ability to: Sleep (65%); exercise (73%); walk 
(47%); do household chores (44%), and drive a car (47%) (Breivik et al., 2006). Pain also 
negatively affects relations and social life and hampers the ability to: Partake in social 
activities (48%); have sexual relations (43%); maintain family relationships (27%) and to 
lead an independent lifestyle (30%) (Breivik et al., 2006). Furthermore, pain is frequently 
associated with reduced concentration and memory functioning (Sjogren et al., 2005). In 
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two Swedish studies (Arvidsson et al., 2008; Cöster et al., 2008), results showed that 
persons with musculoskeletal pain, FM and CWP reported lower scores on factors related 
to HRQL compared with Swedish population data. Notably, Pleis and Coles (2003) 
found that over 32%, despite receiving treatments, reported limitations from pain that 
affected their ability to stand, walk, lift and carry. 
Harker et al. (2012, p. 26) conclude that longstanding pain, apart from having a 
negative impact on functioning and general wellbeing, is also clearly related to 
increased sick leave and uptake of benefits and pension. Consistently, studies imply 
substantial societal costs in relation to longstanding pain. For example, one study 
reported that costs related to longstanding pain in the USA amounted to $560 and $635 
billion annually (Gaskin and Richard, 2012). In Sweden, yearly costs related to chronic 
pain were estimated to SEK 7.5 billion for health-care utilization and medicines and 
SEK 80 billion for sick leave and production losses (SBU, 2006). 
2.4 IMPROVING TREATMENTS OF LONGSTANDING PAIN 
Turk (2003, p. 573) writes that pain remains a substantial problem despite increased 
knowledge of its neurobiological aspects and the development of novel pharmaceutical 
agents, neuroaugmentative procedures (e.g. spinal cord stimulation) and implantable drug 
administration systems. That is, even though the aforementioned treatments have showed 
efficacy, effects are limited. For example, Turk (2002) writes that potent medications 
reduce chronic pain by 30-40% and that spinal cord stimulation reduces pain by an 
average of 65% in selected patients. These figures are largely in line with those presented 
in similar reviews (e.g. SBU, 2006). Also, even when these studies report statistically 
significant reductions in pain, the improvements are often not accompanied by 
comparable improvements in physical or emotional functioning. 
The limited effects of standalone medical treatments on longstanding pain further 
suggests the role of psychological factors (cognitions, emotions and behaviors), and the 
importance of providing patients with strategies that enable them to live with pain that 
remains after otherwise helpful medical interventions (Turk, 2003). However, also 
psychologically oriented treatments that have been found to be efficacious, e.g. behavioral 
medicine and multimodal treatments (SBU, 2010), have a number of issues in regard to 
their efficacy that requires further research. 
In a substantial review of the empirical status of treatments for longstanding pain by 
the Swedish Council on Health Technology Assessment (SBU, 2006, 2010), the authors 
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in regard to these latter treatment approaches specifically mentioned that there is a lack of 
studies evaluating the effects of treatments on costs and HRQL, as well as the cost-
effectiveness of these treatments. In order to evaluate the efficacy of treatments, adequate 
outcome measures are needed. In this regard, the importance of measuring the impact of 
pain on behavior in central life domains, i.e. pain interference has been stressed (Dworkin 
et al., 2005). Furthermore, several authors in the field (Kazdin, 2008; SBU, 2010) have 
highlighted the need for more theoretically based evaluations of how specific treatment 
components, but also situational and patient characteristics, influence the outcome. Below 
I will describe aspects related to: (1) The assessment of pain-interference; (2) the analyses 
of health-related costs and cost-effectiveness; and (3) the analytical models used to 
investigate how specific treatment variables and patient and situational factors influence 
the outcome. These three aspects are directly related to the aims of this thesis. 
2.5 ASSESSMENT OF PAIN INTERFERENCE 
The high prevalence of pain and related disability call for more knowledge regarding the 
impact of pain on behavior, i.e. pain interference, which in turn implies the need for 
reliable and valid questionnaires to assess this construct. The Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials (IMMPACT) has emphasized the 
importance of assessing pain interference in relation to clinical trials. They have also 
stressed a number of issues that should be considered in the development of such 
questionnaires (Dworkin et al., 2005). To start with, the measures feasibility (e.g. the 
understandability of instructions and items) needs to be ensured, which is related to 
response rates and the administrative burden. Second, there is a need for questionnaires 
that can be used in a variety of research settings, for example when brief response times 
are prioritized (e.g. when frequent assessments are required). Third, measures enabling 
investigators to evaluate different groups with unique demographic profiles (e.g. children 
and adults) or disease characteristics are deemed important. 
2.6 COST-EFFECTIVENESS 
A cost-effectiveness analysis (CEA) is used to evaluate the costs and effectiveness of 
interventions aiming to improve health-related outcomes, e.g. HRQL and pain disability 
(Drummond, 2005). These analyses incorporate the assumption that resources, including 
health, are limited and that CEA can aid decision- and policy-making concerning e.g. 
resource allocation. Central to CEA is the incremental cost-effectiveness ratio (ICER), 
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which is calculated by subtracting the changes in average costs in one intervention (A) 
from the changes in average costs in another intervention (B). This figure is then divided 
with the difference resulting from the subtraction of the average effects in intervention 
(A) from the average effects in intervention (B) (Drummond, 2005). 
Costs include all medical and non-medical costs of the participants, for example 
costs related to health care visits and medicines (direct medical costs), costs of other 
health-related services not directly associated with healthcare (direct non-medical costs), 
and costs related to employment status, sick leave, and reduced capacity at work and 
domestically (indirect non-medical costs). In this thesis the effects constitute changes on 
the primary outcome measure, i.e. on continuous data of pain-related disability. However, 
other gauges of the effects of treatment are often also used, e.g. the number of clinically 
significantly changed participants (Ferraz-Nunes, 2007). 
2.7 PROCESSES OF CHANGE IN TREATMENT 
Based on the results from a randomized controlled trial (RCT) utilizing an adequate 
design and statistical analyses we may conclude that a specific treatment caused change in 
the outcome, in a specific sense of the word ‘caused’ (Kazdin, 2007). However, as Kazdin 
(2007, p. 3) points out, “Demonstrating a cause does not say why the intervention led to 
change or how the change came about.” As was done in the present thesis, mediators are 
often assessed and analyzed in order to investigate how treatment-related change occurs. 
A mediator (m) is a variable that has a statistically important role to play between 
the intervention (x) and the outcome variable (y), and provides information of the process 
of change (Kazdin, 2007). When the analyses aim to in greater detail explicate the 
processes of change the term mechanism of change is used. Reasonably, the goal ought to 
be to understand these finer details of change, but the study of mediators constitutes an 
important early step (Kazdin, 2007). Also, highly relevant to the understanding of 
processes of change is the concept of a moderator, a variable (z) that has an influence on 
either the direction or the magnitude of the intervention’s (x) effect on the outcome (y). 
For example, the outcome following treatment may show variation as a function of 
specific patient-characteristics, e.g. high levels of depressive symptoms. 
Kazdin (2007) suggest that a better understanding of mechanisms of change may: 
(1) Lead to better order and parsimony among a number of current interventions, i.e. 
even though treatments differ in certain regards they may target similar processes of 
change; (2) clarify the relation between a specific treatment and its differential 
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outcomes, e.g. how a treatment has an effect on both disability and depressive 
symptoms; (3) facilitate optimization, i.e. the refinement of a treatment so that it more 
efficaciously addresses critical processes; (4) act as a further bridge between research 
and clinical practice, i.e. inform practice on requirements for effective treatment, for 
example what treatment components that should not be diluted; and (5) clarify 
moderators of treatment, which in turn may constitute a basis for selecting suitable 
patients for specific interventions. I will return to these aspects in the discussion section, 
but now I will provide a behavioral perspective on the role of behaviors, cognitions and 
emotions in longstanding pain. 
2.8 A BEHAVIORAL APPROACH TO LONGSTANDING PAIN 
The introduction of the gate control theory (Melzack and Wall, 1965) paved the way for 
the possibility to influence pain via cognitive, emotional, behavioral and motivational 
factors. Melzack and Casey (as cited in Turk, 2003) explicitly stated that: 
 
The surgical and pharmacological attacks on pain might well profit by redirecting 
thinking toward the neglected and almost forgotten contribution of motivational 
and cognitive processes. Pain can be treated not only by trying to cut down sensory 
input by anesthetic blocks, surgical interventions and the like but also by 
influencing the motivational-affective and cognitive factors as well (p. 574). 
 
Likewise, Craig’s (2003) view of pain as a homeostatic emotion and as a motivational 
behavioral drive, directly positions pain within a cognitive, emotive and behavioral 
framework. Motivation and behavior were also mentioned in relation to pain as part of a 
sickness response above (Van Houdenhove and Luyten, 2009). These aspects were further 
implied in the presentation of the epidemiological studies, illustrating that pain co-occurs 
with distress (e.g. depressive symptom and anxiety) and interferes with daily behavior and 
leads to negative consequences in different life domains (Harker et al., 2012). 
In the next section I will give a brief introduction to a limited set of principles that 
have been of immense importance in the development of behavioral and cognitive 
behavioral treatments for longstanding pain, but also for the development of novel 
principles of complex human behavior. This in turn, has served the development of new 
treatment approaches as exemplified by ACT for longstanding pain.  
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2.8.1 Respondent and operant learning 
In its fundamental form, respondent conditioning occurs when a neutral stimulus (NS) in 
close temporal proximity precedes an unconditioned stimulus (UCS) that elicits a reflex, 
an unconditioned response (UCR). Via this temporal pairing, stimulus functions of the 
UCS come to be associated with the NS. The NS is now referred to as a conditioned 
stimulus (CS) and can in turn induce a conditioned response (CR), analogue to the UCR.1 
Ramnerö and Törneke (2008), write that respondent conditioning is a process that gives 
something in the organism’s context “[…] a biological function it did not have up to that 
point. Something that, up to that point, had one function (or none at all) now acquires a 
new one” (p. 64). 
At the core of operant learning are: Situational factors that precede behavior, the 
antecedent (A); the behavior (B) of interest; and the consequence (C) that follows 
directly on the behavior. In this three-term-contingency (the ABC-unit) a specific 
antecedent factor, a discriminative stimulus, has its functions established by a 
previously experienced connection between a behavior and a consequence. In other 
words, based on the historical contiguity between a behavior and the resulting 
consequence, a discriminative stimulus signals the present availability of this 
consequence (Törneke, 2010). For example, based on previous similar experiences, the 
calling out of my surname “Kemani” at the dentist’s office (A), signals the presence of a 
certain consequence (e.g. the dentist). Furthermore, this signal evokes movement 
towards the person calling my name (B), which brings me closer to the dentist (C). 
When analyzing behavior from this perspective, focus is on the functional relationships 
in the three-term-contingency, e.g. the consequential effects of behavior and not its 
descriptive properties. For example, a person raising a hand to alleviate shoulder pain 
behaves in an essentially different manner than a person that raises a hand to great a 
friend, even if the movements descriptively may be identical. 
Consequences comprise two broad functions, behavior increasing (reinforcing) or 
behavior reducing (punishing) functions that in turn add something to the antecedent 
event (positive reinforcement/punishment) or removes something from the antecedent 
event (negative reinforcement/punishment) (Figure 1).  
                                                
1 For an expanded and more critical examination of these relations see e.g. (Rescorla, 1988, p. 151) that 
describes respondent conditioning as the ”learning of relations among events so as to allow the organism 
to represent its environment.” 
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Figure 1. Four types of relations involved in operant learning. 
 
Often, learning takes place via the interaction between both respondent and operant 
principles. For example, respondent conditioning may occur when aspects of a certain 
food (NS) are associated with an inflammatory response (UCS) and abdominal pain 
(UCR), and acquires fear-functions (CR). A later refusal to eat said food (B) when it is 
offered (A), may lead to reduction of fear (C), and thus we are in the operant domain. 
2.8.1.1 An operant view of motivation 
In addition to discriminative functions, Michael (1993) points to antecedents with 
motivational functions that influence both the performance of behaviors and their 
consequences. These antecedent events, motivational operations, have a number of 
defining effects (Laraway et al., 2003). First, they have value-altering effect, in that they 
alter the effectiveness of reinforcers or punishers.2 Second, they have a behavior altering 
effect in that they alter the frequency of behaviors related to these consequences. These 
effects include both an increase in responding (evocative effect) and a decrease in 
responding (abative effect). 
Michael (2000) also makes a distinction between unconditioned motivating 
operations, for example pain, as well as conditioned motivating operations that have their 
functions via learning. As implied from this perspective, pain is conceptualized as a 
motivating operation. That is, when an individual is in pain there is an increase of the 
                                                
2 The value-altering effect comprises four different types of effects. These are: (1) A reinforcer-establishing 
effect; (2) a reinforcer-abolishing effect; (3) a punisher-establishing effect; and (4) a punisher-abolishing 
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reinforcing effectiveness of pain reduction, and the current frequency of behavior (e.g. 
taking pain medication) that has been previously reinforced by pain reduction.3  
Notably, Leigland (2005, p. 137) writes: “Moving into the interpretation and 
analysis of human values naturally involves a considerable increase in complexity, 
because verbal contingencies are involved in any distinctively human behavioral 
phenomenon.” How to understand more complex aspects of Human motivation and 
values, as well as their clinical implications will be presented in more detail in the 
sections dealing with verbal behavior, i.e. Relational frame theory (RFT) and rule-
governed behavior (RGB). First though, some key features of a related well-established 
psychological treatment model for longstanding pain, CBT. 
2.9 COGNITIVE BEHAVIOR THERAPY 
In the 1970’s Fordyce (1976) showed how social and environmental contingencies were 
highly relevant in the shaping of pain behaviors. Contemporary with Fordyce, Aaron 
Beck developed cognitive therapy for depression (Beck, 1979). Over time concepts and 
techniques from cognitive therapy were merged with those of behavioral therapies for 
chronic pain (Turk, Meichenbaum, and Genest, 1983). Among others, procedures from 
cognitive therapy include, cognitive restructuring, behavioral experiments, problem 
solving etc. Contributions from behavior therapy include for example exposure and 
applied relaxation (AR). Also, CBT for longstanding pain includes a number of 
procedures from other traditions, e.g. mindfulness. Typically treatment includes 
homework in form of between-session activities to apply new skills and practice, for 
example relaxation practice. Before describing exposure and AR in more detail, I will 
outline a highly influential CBT-model of how longstanding pain and related disability 
develops and is preserved, the fear-avoidance model. 
2.9.1 Fear, avoidance and catastrophizing 
Lethem et al. (1983) initially introduced the fear-avoidance model, which posits that 
fear of pain leads to avoidance behavior, which is reinforced and in turn leads to 
maintenance and possibly an increase of fear and pain, and in the long run disability 
                                                
3 In order for a stimulus to be conceptualized as a discriminative stimulus (SD), Michael (2000) means that 
the history of learning needs to include a negative discriminative stimulus situation (SΔ). In such a situation 
reinforcement (available in the SD situation) is unavailable and effective, if obtained. In regards to pain, pain 
reduction is a consequence that ought to be unavailable and effective – also in the absence of pain. However, 
when pain is absent it is not clear how pain reduction, if obtained, also would be reinforcing. Thus, Michael 
(2000, p. 406) means that pain should be operationalized as a motivating operation and not as an SD. 
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(Lethem et al., 1983). Over the years the model has been extended and refined. For 
example, catastrophizing has been included as a precursor to fear (Vlaeyen et al., 1995) 
and subsequent avoidance, disability, disuse and depression. Further adjustments to the 
model have illustrated that fear may also activate vigilance and tension (i.e. not solely 
avoidance), which potentially further exacerbates pain (Vlaeyen and Linton, 2000). 
In a recent conceptualization by Flink, Boersma, and Linton (2013), catastro-
phizing is operationalized as the ongoing interrelations between thoughts, emotions and 
overt behavior, i.e. as a process. In this view catastrophizing is conceptualized as 
repetitive negative thinking, similar to worry and rumination, and has the function of 
reducing negative emotions. From this perspective, one possible downside of catastro-
phizing as a dominating strategy is that it obstructs constructive problem solving (Flink, 
Boersma, and Linton, 2013). 
Fear-avoidance and catastrophizing have consistently been found to be associated 
with greater pain as well as pain-related disability (Sullivan et al., 2001; Vlaeyen and 
Linton, 2000). Studies on catastrophizing have focused on the relation between 
catastrophizing, pain and negative outcomes. A finding that has been repeated across 
studies is the relation between catastrophizing and ratings of pain intensity in both acute 
and longstanding pain. Catastrophizing has also been associated with increased disability 
and predicted disability better than pain or disease-related variables (Sullivan et al., 2001). 
Several interventions may be of relevance in interrupting the potential downward spiral 
fueled by catastrophizing, fear and avoidance. Exposure and AR constitute two viable 
candidates. 
2.9.2 Exposure 
Exposure procedures aim to facilitate the gradual increase of activities previously 
avoided due to pain and related distress and are explicitly included in some pain 
treatments (Boersma et al., 2004). The use of exposure as a procedure (for problematic 
anxiety and fear) within CBT is based on a model comprising dysfunctional beliefs and 
respondent and operant conditioning (Abramowitz et al., 2013). Traditionally, the aim of 
exposure has been to achieve extinction of a conditioned response, i.e. a reduction of fear 
or anxiety associated with a specific stimulus. However, research indicates that it might 
be more important in the long term to teach patients how they can act with their anxiety 
and that they can tolerate fear, during and after exposure (Craske et al., 2008). Exposure 
in vivo is a treatment approach within CBT for pain that has been specifically 
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developed for patients with increased pain-related fear. Several studies indicate the 
efficacy of exposure in improving catastrophizing fear, disability and pain (de Jong et 
al., 2008; Leeuw et al., 2008). 
2.9.3 Applied relaxation 
As regards AR, it has been extensively used within CBT (Thyer, 2000; Öst, 1987). The 
intervention is explicitly based on both respondent and operant principles. It was initially 
developed to help persons with anxiety to apply a specific type of relaxation at the first 
signal of discomfort, in order to stop the escalation of anxiety and to better manage 
symptoms. Similarly, AR has been used to help patients cope with longstanding pain and 
pain-related distress more effectively. Its efficacy in the area of pain has been illustrated 
in studies on migraine, tension type headaches, mixed headache, and musculoskeletal pain 
in neck, back, joints, and upper extremities (Gustavsson and von Koch, 2006; Jensen, 
Nygren, and Lundin, 1994; Linton and Götestam, 1984; Linton and Melin, 1983; Linton, 
Melin, and Stjernlöf, 1985; Ström, Pettersson, and Andersson, 2000). 
2.9.4 Empirical support of CBT 
The efficacy of CBT in improving pain, pain-related disability and mood has been 
indicated in systematic reviews and meta-analyses. For example, a Cochrane Review 
(Williams, Eccleston, and Morley, 2012) concluded that (based on 42 included RCTs) 
CBT at post-treatment had significant but small effects on pain and disability, and 
moderate effects on mood and catastrophizing, compared to treatment-as-usual or wait-
list control conditions. However, at 6- to 12-month follow-up, significant effects were 
only found for mood. Also, when compared to active treatments conditions, CBT showed 
significant but small benefits for disability and catastrophizing at post-treatment but was 
not superior for pain or mood outcomes. With the exception of disability, there were no 
benefits at 6- to 12-month follow-up. 
As regards CBT for FM, a review and meta-analysis (including 14 studies) 
indicated the efficacy of CBT in reducing depressed mood and self-efficacy. The effects 
(d) on depression were small at post-treatment, but large on self-efficacy at both post-
treatment and at follow-up (Bernardy et al., 2013). However, CBT did not reduce pain, 
fatigue, sleep disturbances and HRQL at post-treatment and at follow-up. In addition, 
results indicated that operant behavioral therapy may reduce healthcare-seeking behavior 
of patients with FM. 
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Williams, Eccleston, and Morley (2012) state that there is no need for more RCTs of CBT 
for longstanding pain reporting group means. Instead, they recommend the generation of 
better theory to test hypothesis about processes and mechanisms related to specific 
treatment components and outcomes. In regard to this they write that: “[…] different 
types of studies and analyses are needed to identify which components of CBT work for 
which type of patient on which outcome/s, and to try to understand why” (the summary 
of Williams, Eccleston, and Morley, 2012, p. 3). Contextual behavioral science (CBS) 
may be able to contribute in regard to theory-based evaluations as it offers explicit 
scientific assumptions as well as a scientific agenda, and potentially a testable coherent 
theoretical framework of how to achieve behavior change. 
2.10 CONTEXTUAL BEHAVIORAL SCIENCE 
The scientific and theoretical assumptions underlying this thesis are highly overlapping 
with those expressed within CBS (Hayes, Barnes-Holmes, and Wilson, 2012). 
Assumptions in CBS have strong connections to American pragmatism (Bernstein, 2010), 
and its continued development within behavior analysis (Skinner, 1945). Specifically, it 
has been argued that functional contextualism (Pepper, 1942) should constitute the 
philosophy of science underlying CBS (Biglan and Hayes, 1996; Hayes and Long, 2013; 
Hayes, Hayes, and Reese, 1988). In the view of Hayes, Barnes-Holmes and Wilson 
(2012), functional contextualism provides the coherent scientific view and explicit 
assumptions of epistemology and truth needed to ensure that theory, methods and data 
cohere across time and situation. 
From a functional contextual perspective, the basic unit of analysis is the behavior 
of whole organisms interacting in and with a current and historical context in such a way 
that act and context cannot completely be separated (Hayes and Long, 2013). Although 
the basic unit of analysis comprises the act of the whole organism, parts of the whole can 
be examined in a more highly defined manner (Hayes and Long, 2013). In regard to a 
given psychological phenomenon, e.g. the rubbing of a sore knee to alleviate pain, the 
speciﬁc contribution of non-pain-transmitting neurons in the spinal cord dorsal horns can 
be examined. However, from a CBS-perspective, analyses at other levels (e.g. biological) 
do not explain the psychological level, the situated actions of whole organisms, but are 
viewed as thoroughly connected to them (Hayes, Barnes-Holmes, and Wilson, 2012, p. 
3). Importantly, RFT (discussed in the next section) is closely linked to CBS and morphs 
the functional unit of the act-in-context as functions no longer can be analyzed by 
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reference to past experiences, which is generally the case in traditional functional operant 
analyses. 
As regards epistemology and truth Skinner (1976, p. 259) wrote that scientific 
knowledge “[…] is a corpus of rules for effective action, and there is a special sense in 
which it could be ‘true’ if it yields the most effective action possible.” CBS is founded on 
similar tenets. Specifically, knowledge and truth are directly linked to the goals of 
prediction-and-inﬂuence, with precision, scope and depth, of entire organisms that interact 
with a situational and historical context (Hayes, Barnes-Holmes, and Wilson, 2012, p. 3). 
Analyses aim to simultaneously predict and alter acts in context, with a limited set of 
principles that apply to specific events (precision), apply to a wide range of events 
(scope), and cohere across scientific levels of analysis (depth). 
In a number of previous articles several focus areas of CBS have been suggested, a 
few of which are of special relevance for the current thesis (Blackledge, Ciarrochi, and 
Deane, 2009; Hayes, 2008; Hayes et al., 2013; Vilardaga et al., 2009). These include: The 
development of a unified model of psychopathology, intervention and health using 
assessable terms tied to basic principles; the measurement of processes of change; and an 
emphasis on mediation and moderation analyses in applied studies on ACT. I will return 
to these areas in the discussion section. 
2.10.1 Relational frame theory 
In Skinners view, verbal behavior constituted behavior by a speaker that acquired its 
effect through the reinforcing behavior of a listener (Skinner, 1957). Furthermore, this 
type of behavior constitutes an antecedent for the behavior of the listener. For example, 
the statement: “Take these pills two times a day and the pain will be alleviated”, is an 
antecedent (A) for the behavior of taking the pills two times a day (B) in order to achieve 
pain relief (C). According to Skinner, the antecedent functions as a rule in that it specifies 
both a behavior and a consequence (Skinner, 1976). Skinner underscored the contrast 
between behavior that is under the control of these rules and contingency-shaped 
behavior, i.e. behavior that is learned by means of direct experience of consequences. 
However, as described previously, in order for antecedents and consequences to acquire 
their functions and be able to influence behavior they need to be historically and 
situationally contingent on the behavior in question. These cornerstones of respondent and 
operant learning appear to be violated repeatedly when it comes to more complex human 
behavior. For example, this seems to be the case when an individual breaks free from 
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problematic dependency of painkillers based on the admonition: “Stop using these pills, 
or you will severely damage your liver!” In this scenario the avoided consequence, 
“severe liver damage” is a temporally remote and a fairly abstract consequence, 
something never previously encountered. In addition the direct contingencies comprise 
highly aversive consequences (e.g. withdrawal symptoms and increased pain), which 
ought to be highly motivating for continued use of painkillers. 
Relational Frame Theory (RFT) is a set of behavioral principles that aim to 
explain complex human behavior of the sort discussed above, i.e. behavior that is not 
under the control of a history of direct learning and the direct contingencies in the 
present (Hayes, Barnes-Holmes, and Roche, 2001). The behavior of relational respon-
ding, or relational framing, is an ability that humans appear to learn early in life, through 
social reinforcement. This ability is characterized by three phenomena: (1) Mutual 
entailment; (2) combinatorial mutual entailment; and (3) transformation of stimulus 
functions. 
Mutual entailment comprises the relations between two stimuli. For example, if 
you were told that paracetamol (X) is equivalent to acetaminophen (Y), then you will 
easily derive the mutually entailed relation of acetaminophen (Y) also being equivalent 
to “paracetamol” (X). Combinatorial mutual entailment illustrates the relations among 
three or more stimuli. For example, if someone told you that methadone (X) is more 
potent than codeine (Y) and codeine (Y) is more potent than acetaminophen (Z), then 
you, in addition to the mutually entailed relations, can derive that methadone (X) is 
more potent than acetaminophen (Z) and that acetaminophen (Z) is less potent than 
methadone (X). Notably, when the above behavior (relational responding) is 
established, humans do not need to be directly trained that e.g. methadone is more 
potent than acetaminophen, instead in the instance we are given information of how 
certain stimuli are related, we can derive this information based on the relations between 
stimuli (Figure 2).   
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Figure 2. Mutual entailment and combinatorial mutual entailment are illustrated by the 
figure. Stimuli (represented by X, Y, Z in the figure) can be related in a vast number of 
ways. For example, they can be related by means of: Coordination (e.g. X is the same 
as Y and Z); comparison (e.g. X is more than Y, and Y is more than Z); and temporality 
(X comes before Y and Y comes before Z). In all these cases, only two relations need 
to be directly learned, the other four are derived 
 
The third defining feature of relational framing is transformation of functions, which 
aims to capture how a stimulus function, e.g. fear, is “moved” from one stimulus to 
another and is transformed in accord with the specified relations. For example, imagine 
that a friend you view as trustworthy said that your toothache (X) could be a symptom 
of cardiac arrest (Y). This puts toothache (X) in a relation of mutual entailment with 
cardiac arrest (Y). Given other historical and situational contextual factors establishing 
cardiac arrest as related to possible death (Z), which you desperately want to avoid, your 
toothache has instantaneously become related to cardiac arrest and possible death. 
Thereby, the functions of toothache have been transformed in accord with these 
relationships, resulting in that you now feel much more distressed (Dougher et al., 
2007). 
As indicated by the examples so far, the social context determines: (1) Which 
relations that are established; and (2) which functions that are to be transformed via 
these relations. Furthermore, stimuli can be related in a number of different ways, in 
opposition with, in distinction to, hierarchically etc. (Hayes, Barnes-Holmes, and 
Roche, 2001). Given that there are many different ways of relating stimuli, it also 
follows that transformation of functions varies in accordance with these specific 
relations. 
Y X Z 
Directly trained 
Mutual entailment 
Combinatorial mutual entailment 
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Notably, someone is doing the responding. From the above example involving cardiac 
arrest, it is clear that the increased distress is directly related to that something terrible 
could happen, to me. According to RFT, the experience of self is established from three 
different and interdependent relations: I-you; here-there; and now-then (McHugh, 
Stewart, and Hooper, 2012). The first two relations are spatial and the third is temporal. 
As with the other relations discussed above, RFT proposes that these three relations are 
also learned as part of regular language training that takes place via numerous everyday 
questions (e.g. “Can you see what I see?”) and answers (e.g. “I can see!”). Importantly, 
the answers are always given from the perspective of I-here-now and for a verbally 
competent person this establishes an ongoing experience of in a specific sense being me 
(McHugh, Stewart, and Hooper, 2012). When we have become fluent in fitting 
experiences into the relations: I-you, here-there, and now-then, these perspectives can be 
included in relational responding as described previously, including transformation of 
functions (Törneke, 2010). 
When learning to respond relationally, the reinforcement is social and generalized, 
and over time relational responding establishes coherence as a generalized reinforcer (the 
notion that things are logical) (Healy, Barnes-holmes, and Smeets, 2000). RFT posits that 
in principle, anything can be related to anything else. For example something never 
encountered can acquire discriminative functions for a certain behavior, and that which 
was reinforcing can be instantaneously turned into something emotionally punishing, in a 
respondent-like manner. Verbal behavior, according to RFT, is relational responding 
(mutual entailment, combinatorial entailment and transformation of functions), and 
according to this view, thinking is “[…] verbal behavior performed in such a way that 
the only possible observer is the person who is performing it — the person doing the 
thinking” (Törneke, 2010, p. 89). 
2.10.2 Rule-governed behavior 
Antecedents that have acquired their functions via relational responding as described 
above, can now specify behaviors and consequences in a highly flexible manner and 
function as rules or instructions. Rules change behavior via the specific transformations 
of functions resulting from contact with various elements that are included in the rule. 
Rules offer an explanation of our ability as humans to act in accord with consequences 
beyond direct contingencies. This ability enables us to achieve great things in the face 
of adversity, but can also establish rigid patterns of behavior with problematic long term 
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consequences (Törneke, Luciano, and Valdivia Salas, 2008). Three types of RGB have 
been delineated in the literature (Zettle and Hayes, 1982). Two are based on historical 
contingent reinforcement (pliance and tracking), and the third type (augmenting) 
interacts with these other two. 
2.10.2.1 Pliance and tracking 
Pliance is a basic form of RGB that is under the primary control, and corresponds with, 
the speaker mediated consequences specified in a rule (Zettle and Hayes, 1982). For 
example, when someone does what another person asks in order to receive the 
consequences described in the instruction it constitutes pliance. Tracking is RGB 
controlled by the assumed correspondence between the rule and the way the world works 
(Zettle and Hayes, 1982). An instance of tracking would be the behavior in line with the 
instruction: “If you start using your hand normally now, even though it hurts, you will 
regain functioning”, assuming that this is done based on correspondence between the rule 
and the actual consequence of healing and regained functioning. 
2.10.2.2 Augmentals 
The third type of rules, augmentals, occur in combination with pliance or tracking and 
alter (augments) the value of the rules reinforcing or punishing consequences. According 
to RFT, the reinforcing or punishing values of consequences are established by means of 
specific verbal value-altering relational networks that become attached to these 
consequences by means of the social context. If an aspiring classical guitarist hears a 
physical therapist say: “If you start using your hand now, even though it hurts, you will be 
able to play the guitar soon again”, and then starts using the hand again, this person may 
be augmenting. This may be the case as the consequence “to play the guitar soon again” 
has a specific importance and sense of meaning for this person. This also illustrates that 
augmental rule following is directly linked to human motivation (e.g. values) and can 
function as verbally established motivating operations (Plumb et al., 2009). Importantly, 
the types of rules described above are functional units. The topography of the rule is not 
conclusive for our understanding of it. Rather, it is the reinforcing contingencies that 
govern behavior that determine what kind of rule-following is at play. 
2.11 ACCEPTANCE AND COMMITMENT THERAPY 
ACT places a strong emphasis on interventions motivated by RFT, and aims to undermine 
the dominance that problematic verbal behavior has on other human behavior (Hayes, 
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Barnes-Holmes, and Wilson, 2012). ACT can also integrate established behavioral 
interventions like, e.g. exposure (Abramowitz et al., 2013) and behavioral activation 
(Martell, Addis, and Jacobson, 2001). 
As proposed earlier, relational responding underlies (verbal) perspective taking, 
through which we discriminate I-here-now from other perspectives (e.g. “His”, “Her”, 
“The person I used to be”). This ability can be illustrated by the thought: “No one but me 
struggles with pain at work.” Because my private events (events only observable by me), 
for example fear of being perceived as “lesser” by others, are directly related to my sense 
of self, they will likely acquire functions that have high impact on behavior. This can take 
place via rules that are self-generated as: “My colleagues must not find out about my 
struggle with pain.” For a non-verbal organism in distress, avoidance of e.g. a predator is 
often a viable alternative. In contrast, the escape routes from the monsters produced by 
our own verbal activity are highly limited. 
2.11.1 Experiential avoidance 
Verbal monsters, e.g. distressing thoughts, are often not in themselves the real issue 
(Luciano Soriano, Rodriguez Valverde, and Gutierrez Martinez, 2004). Rather, problems 
arise when our efforts to get rid of these aversive experiences do not reap the wanted 
outcomes. This type of behavior constitutes a form of RGB, referred to as experiential 
avoidance, which is operationalized as actions that aim to control or eliminate thoughts, 
emotions and bodily sensations (Hayes et al., 1996, p. 1154). In addition, if rules that 
entail a relation of opposition between the private aversive phenomenon and a meaningful 
life are established, they are likely to function as augmentals (Törneke, 2010, p. 149). In 
this way, experiential avoidance is established. The relational networks that serve as 
augmentals, latch onto and intensify the aversive functions of consequences via abstract 
normative language arranged by the social context. As mentioned previously, a 
fundamental aspect of augmenting is its interaction with pliance and tracking that in turn 
may lead to insensitivity to direct contingencies. 
For example, assume that a person tracks the rule “If I put the trip off, I will be able 
to rest a couple of days instead.” When asked why it is important to rest a couple of days, 
the person might respond that traveling and being social is easier to handle without pain. 
Tracking of this sort may yield benefits in the short term, but it fails to track consequences 
in the longer term. Augmenting could potentially further complicate issues through a self-
generated rule like: “I have to make sure pain doesn’t bother me, since I cannot do the 
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things I want when I’m in pain.” As a result, experiencing pain becomes even more 
aversive, since it is in opposition to “doing the things I like”. This further motivates 
behaviors like “postponing”, “resting” etc., which according to the rule should lead to 
better control over pain. 
A problem with experiential avoidance as an overarching strategy is our limited 
ability to control private phenomena, thoughts, feelings and bodily sensations. Further-
more, it appears that a person may end up more closely in touch with the things aimed at 
avoiding when rules like those discussed here are followed (Abramowitz, Tolin, and 
Street, 2001; Wegner and Gold, 1995). Also, there is a substantial risk that these 
avoidance behaviors become a dominant aspect of life, which may result in the 
abandonment of other possibly valued behaviors. 
Importantly, acting in fusion with these rules appear to play an important part in 
these problematic strategies. In ACT, the term fusion is used to illustrate that certain 
behaviors are completely dominated by, or fused with, functions established via relational 
responding (Blackledge, 2015). Putatively, behavior fused with a certain rule further 
increases the risk of doing things that in the long run have negative and restricting effects 
in a person’s life. 
Repeatedly, empirical data has indicated that experiential avoidance may be central 
to psychopathology (Campbell-Sills et al., 2006; Chapman, Gratz, and Brown, 2006; 
Chawla and Ostafin, 2007). From this perspective, Törneke (2010, p. 177) underlines two 
types of behavior that appear highly relevant to focus on clinically: (1) excessive behavior 
part of a broad functional class constituting experiential avoidance; and (2) alternative 
behavior that does not constitute experiential avoidance and preferably aims at globally 
desirable consequences for the person in question. 
2.11.2 Behavioral flexibility 
In line with the above, the ACT-therapist investigates the relation between the context 
surrounding a narrow and a rigid behavioral repertoire, and during the course of treatment 
aims to facilitate an alternative broader more flexible repertoire. In ACT, this part of a 
functional analysis also serves the purpose of helping the person experience the 
connection between what is done excessively and rigidly to handle the problem, and what 
the long term problematic consequences are. Potentially, the person gets in touch with the 
non-workability of what is done (e.g. “Getting rid of pain”) in relation to what it aims at 
achieving (e.g. “Being able to do the things that matter for me”). Importantly, even 
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though the behavior in question might not be workable in the long run it is coherent. In 
other words, it makes sense from the perspective of the one using these strategies and the 
therapist needs to take this into account when assessing the workability of these 
behaviors. 
As therapy progresses it becomes important to focus on alternative behavior, 
behavior that potentially could increase the meaning and vitality of living. This can be 
accomplished when the therapist gives explicit instructions, but it also occurs indirectly 
when the client generates new rules of living based own conclusions during the course of 
therapy (Törneke, 2010). In this regard, values are of specific importance in ACT. Values 
can be operationalized as a type of motivating augmental rules that include personally 
chosen adaptable patterns of action, which provides a strong sense of importance and 
meaning and reinforces sustainable coordination of behavior over time (Dahl, Lundgren, 
and Plumb, 2009, p. 9). From this perspective, values cannot be completed but instead 
serve to give behavior purpose or direction, as in the case of the value of being present in 
the relations to one’s children and partner – with or without pain. 
As mentioned, fusion entails the dominance of private events that have their 
functions established via relational responding. Importantly, these private events also 
constitute self-evident starting points, which further establish their dominance (Törneke, 
2010). Defusion involves manipulation of the context by the therapist in order to 
undermine the process of problematic transformation of functions and weaken their 
ability to dominate behavior (Dahl, Lundgren, and Plumb, 2009, p. 29). 
Acceptance is related to defusion and comprises behavior lacking verbally based 
avoidance occurring in relation to valued action (Blackledge and Barnes-Holmes, 2009, p. 
54) and constitutes a willingness to experience private events in the moment without 
unnecessary attempts to alter their frequency or form (Levin and Hayes, 2009, p. 15). For 
example, the therapist via different interventions, attempts to establish I-here-now as the 
perspective from which the patient can learn to experience what is happening privately on 
an ongoing basis (the content that is here-now), but also to practice observance of 
thoughts as events occurring there and then (self-as-context) (Foody, Barnes-Holmes, and 
Barnes-Holmes, 2012). According to Törneke (2010, p. 191), all behavior is influenced 
by its context, i.e. the antecedents that precede behavior and the consequences that follow 
on it. The therapist can influence behavior dominated by problematic derived stimulus 
functions and avoidance by targeting these aspects of the context. In so doing a shift may 
occur, from behavior controlled by these problematic experiences, especially behavior 
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based on that these experiences are in opposition to valued action, to more flexible 
behavior that brings along these experiences in the valued direction of the individual 
(Törneke, 2010, p. 236). 
2.11.3 Empirical support for ACT 
In order to broadly present the number and types of studies that have been done on ACT 
in the area of pain we performed systematic database searches with the aim to include all 
empirical studies on ACT and pain (Kanstrup, Kemani et al., in manuscript). Preliminary 
results comprise 153 articles categorized as non-manipulation studies, treatment 
evaluations, laboratory studies and qualitative studies (not presented here). 
2.11.3.1 Non-manipulation studies 
In our search (Kanstrup, Kemani et al., in manuscript) 89 of the studies (58.2%) were 
categorized as non-manipulation studies, of which 83 were cross-sectional and 6 included 
repeated measures. The median number of participants was 160 (Range = 23-686). The 
majority of studies (n = 60) comprised participants reporting non-specific longstanding 
pain. Pain duration ranged from 18-219 months, with a majority of studies (67.1%) 
reporting a mean duration of > 5 years. Out of 100 reported samples 85 comprised 
participants with a mean or median age of 40-60 years. The distribution of females and 
males were reported for 104 samples in the studies, 102 of these (98.0%) had 50-100% 
female participants.  
A general overview of the results illustrated the significant relation between 
acceptance/willingness and related constructs (e.g. avoidance and fusion) on pain-related 
disability. For example Payne-Murphy and Beacham (2014) conducted a cluster analysis 
based on self-reported levels of acceptance in persons suffering from longstanding pain, 
which resulted in three clusters (low, high and medium). Follow-up analyses implied that 
scores on pain-related disability differed across clusters and in accord with the 
hypothesized patterns, i.e. the low-acceptance cluster was associated with poorer 
outcomes and the high-acceptance cluster was related to better functioning. Similarly, in a 
fairly large sample (n = 611) of persons suffering from whiplash associated pain, 
experiential avoidance and fusion, explained a significant amount of variance in pain-
related disability, life satisfaction and depression, also in comparison to pain-related 
fear of movement (Wicksell et al., 2010). 
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2.11.3.2 Laboratory studies 
Eighteen (Kanstrup, Kemani et al., in manuscript) of the studies (11.8%) were classified 
as laboratory studies (see Table 3) and the median number of participants in these studies 
was 67 (Range = 20-219). The majority of studies were conducted with healthy 
participants e.g. students (16 studies), and 2 included participants with chronic pain 
diagnoses. In 15 studies the participants’ mean or median age ranged from 19-29 years. 
Number of males and females were reported for 20 samples, where 16 consisted of 50-
80% females. The cold pressor test was the most commonly used pain inducing strategy 
(10 studies), followed by mild electric shock (5 studies) and other methods (3 studies). An 
acceptance-based experimental manipulation was used in 15 studies, and thirteen of the 
studies used pain tolerance as the primary outcome measure. Three of these 15 studies 
investigated how instructions for higher or lower degree of acceptance were related to 
outcome. In addition, another two evaluated the incremental effect of an added values 
component to the acceptance manipulation; and in 2 an ACT-protocol was used. Control 
conditions consisted of, control-based strategies (10 studies), distraction (6 studies); and 
suppression (2 studies). 
A meta-analytic review of experimental studies on acceptance strategies identified 
30 studies (Kohl, Rief, and Glombiewski, 2012). Results illustrated small to medium 
between-group effects in favor of acceptance strategies in regard to pain tolerance, but 
acceptance was not superior to other emotion regulation strategies in relation to pain 
intensity and negative affect. In conclusion, the authors (Kohl, Rief, and Glombiewski, 
2012, p. 998) write that acceptance strategies do not appear to be more effective than 
other emotion regulation strategies in reducing pain or negative affect, but appear 
significantly better on performance based tasks and pain tolerance. 
Levin et al. (2012) conducted a meta-analysis of 66 laboratory-based component 
studies evaluating treatment elements and processes related to psychological flexibility 
and ACT (e.g. acceptance, defusion and values) These studies did not specifically pertain 
to pain, but included several of the laboratory studies found in our systematic search 
(Kanstrup, Kemani et al. in manuscript). Broadly, results provide support for the utility 
and theoretical coherence of constructs related to psychological flexibility. Significant 
positive effect sizes were observed for e.g. acceptance, defusion and values compared to 
inactive conditions. Greater effect sizes were found on theoretically specified targeted 
outcomes (e.g. pain tolerance). As in the meta-analysis by Kohl, Rief, and Glombiewski 
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(2012), effects were smaller on variables pertaining to the intensity and frequency of 
negative thoughts and feelings. 
2.11.3.3 Treatment studies 
Of the 41 treatment studies (Table 1) found in our systematic search (Kanstrup, Kemani et 
al., in manuscript), the majority of studies (n = 25) consisted of participants with non-
specific chronic pain. Thirty-one of the studies included > 60% females and the majority 
of studies (n = 29) included participants with an age between 40 to 60 years. Pain duration 
(Range = 17.5-420 months) was reported in 30 studies. Eleven of these studies reported a 
mean or median pain duration between 5 to 10 years and 7 studies reported a mean or 
median pain duration of ≥ 10 years. The median sample size was 44 (Range = 1-252). 
Most studies (n = 28) were conducted in an outpatient setting, followed by residential or 
hospital settings (9 studies) and self-help and Internet interventions (3 studies). Twenty-
three studies used the following control conditions: wait-list (7 studies); treatment as usual 
(7 studies); and active interventions (9 studies), including 5 studies comparing ACT to an 
established treatment, e.g. CBT. Three of the studies were case reports; 1 was an 
effectiveness trial; 21 were non-randomized trials with no control condition; 15 were 
RCTs; and 1 study was a randomized trial. Follow-up assessments were administered in 
most studies (n = 33). Of these, 14 reported a single 3-month follow-up, 7 reported a 
single 6-month follow-up, and 10 studies reported 2-3 follow-up assessments between 
0.5-12 months. Two studies performed single long term follow-ups after 1 and 3 years. 
Seven of the studies included a mediation analyses to evaluate processes of change (see 
Table 1). Notably, only one of the studies included an analysis of the treatment’s cost-
effectiveness (Ljotsson et al., 2014).  
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Table 1. Treatment studies (n = 41) 
Nr. Study na Pain typeb Designc 
Control 
cond.d 
1 (Dahl et al., 2004) 19 CS; NSCP RCT MTAU 
2 (McCracken et al., 2005) 108 NSCP NRTNC − 
3 (Wicksell et al., 2005) 1 NSCP CR − 
4 (McCracken et al., 2007) 53; 234 NSCP E-T − 
5 (Vowles et al., 2007) 252 NSCP NRTNC − 
6 (Wicksell et al., 2007) 14 NSCP NRTNC − 
7 (Vowles et al., 2008) 171 NSCP NRTNC − 
8 (Wicksell et al., 2008) 21 WAD RCT TAU 
9 (Lunde et al., 2009) 1 HA CR − 
10 (Vowles et al., 2009) 11; 11 NSCP NRTNC; 
NRTWC 
CBT 
11 (Wicksell et al., 2009) 32 NSCP RCT MDT 
12 (Johnston et al., 2010) 24 NSCP RCT WL 
13 (Vowles et al., 2010) 114 NSCP NRTNC − 
14 (Wicksell et al., 2010) 21 WAD RCT* WL; TAU 
15 (Carbonell-Baeza et al., 
2011) 
75 FM NRTWC TAU 
16 (Ilgen et al., 2011) 13 NSCP; SUD NRTNC − 
17 (Masuda et al., 2011) 1 SCD CR − 
18 (McCracken et al., 2011) 168 NSCP NRTNC − 
19 (Thorsell et al., 2011) 90 NSCP RCT AR 
20 (Vowles et al., 2011) 108 NSCP NRTWC − 
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Table 1. Treatment studies (n = 41). Continued from the previous page. 
Note The full references to the studies listed in the table are found in the Appendix. * 
indicates that the study includes a mediation analysis. 
a Semicolon separated numbers indicate two (separate) samples. 
b CS = Chronic stress; Depr. = Depression; FBS = Failed back surgery; FM = Fibro-
myalgia; HA = Headache; HIV = Human immunodeficiency virus; HrJP = Hemophilia 
related Joint Pain; Migr. = Migraine; NSCP = Non-specific pain; RD= Rheumatic Disease; 
SUD= Substance Use Disorder; WAD = Whiplash Associated Disorder. 
c CR = Case Report; E-T = effectiveness-trial; NRTNC = Non-randomized Trial with No 
Control; NRTWC = Non-randomized Trial With Control, R = Randomized Trial; RCT = 
Randomized Controlled Trial. 
d AR = Applied Relaxation; CBT = Cognitive Behavior Therapy; EW = Expressive Writing; 
Ed = Education; MDT= Multidisciplinary Treatment; MODF= Moderated Online Dis-
cussion Forum; MTAU = Maintenance Treatment as Usual; RPT= Recommended 
Pharmacological Treatment; TAU = Treatment as usual; Trad. = Traditional Therapy; WL 
= Waitlist. 
Nr. Study na Pain typeb Designc 
Control 
cond.d 
21 (Wetherell et al., 2011) 114 NSCP RCT* CBT 
22 (Wicksell et al., 2011) 32 NSCP RCT* MDT 
23 (Dindo et al., 2012) 45 Migr.; Depr. NRTWC WL/TAU 
24 (Huggins et al., 2012) 45 HIV NRTWC* − 
25 (Jensen et al., 2012) 43 FM RCT WL 
26 (McCracken et al., 2012) 40 NSCP NRTNC − 
27 (Mo'tamedi et al., 2012) 30 HA RCT MTAU 
28 (Wicksell et al., 2012) 40 FM RCT* WL 
29 (Alonso et al., 2013) 10 NSCP NRTWC WL 
30 (Baranoff et al., 2013) 186 NSCP NRTNC _ 
31 (Buhrman et al., 2013) 76 NSCP RCT DF 
32 (Elander et al., 2013) 101 HrJP NRTNC _ 
33 (Gauntlett-Gilbert et al., 
2013) 
98 NSCP NRTNC _ 
34 (McCracken et al., 2013) 73 NSCP; FM; 
Depr 
RCT TAU 
35 (Steiner et al., 2013) 28 FM RT Ed 
36 (Vriezekolk et al., 2013) 25 RD NRTNC − 
37 (Baranoff et al., 2014) 120 NSCP NRTNC − 
38 (Ljotsson et al., 2014) 41 FM NRTNC − 
39 (Luciano et al., 2014) 156 FM RCT* RPT; WL 
40 (Vowles et al., 2014) 117 NSCP NRTNC* − 
41 (Trompetter et al., 2014) 238 NSCP RCT EW; WL 
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Veehof et al. (2011) conducted a systematic review and meta-analysis of 22 acceptance-
based interventions (i.e. not specifically ACT) for chronic pain with controlled (waitlist or 
TAU) and non-controlled designs. Primary outcome measures were pain intensity and 
depression. Secondary outcomes were anxiety, physical wellbeing and quality of life. 
The authors (Veehof et al., 2011) reported that that acceptance-based therapies had 
significant small effects on pain intensity and depression and small to medium effects 
on physical and mental health. 
A recent systematic review of RCTs on ACT for longstanding pain reported results 
from ten studies (Hann and McCracken, 2014). Seven of the ten trials had inactive control 
conditions, and one included both inactive and active control conditions (Luciano et al., 
2014). Between-group effects on outcomes related to physical functioning showed 
significant small to large effects in favor of ACT in five of the studies (Buhrman et al., 
2013b; Luciano et al., 2014; McCracken, Sato, and Taylor, 2013; Wicksell et al., 2013; 
Wicksell et al., 2008). Likewise, results from two studies indicated significant medium to 
large effects on pain global disease impact in FM (Luciano et al., 2014; Wicksell et al., 
2013). In three studies, significant medium to large effects were also found on general 
emotional distress, anxiety and depression (Buhrman et al., 2013a; McCracken, Sato, and 
Taylor, 2013; Wicksell et al., 2013; Wicksell et al., 2008). Only one study demonstrated a 
significant large effect on life satisfaction favoring ACT (Wicksell et al., 2008). Also, 
four studies produced significant small to large effects on measures related to 
psychological flexibility in favor of ACT (Buhrman et al., 2013a; McCracken, Sato, and 
Taylor, 2013; Wicksell et al., 2008). 
Active control treatments were used in four studies including CBT, AR, education, 
and recommended medication. Results on most outcome measures indicated that ACT 
was not superior compared to active treatment conditions, but results showed significant 
small to large effects on aspects of psychological flexibility (e.g. pain acceptance) in favor 
of ACT (Steiner, Bogusch, and Bigatti, 2013; Thorsell et al., 2011). 
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2.12 SUMMARY 
Several descriptive pain classifications may share underlying biological mechanisms 
(Plesh, Wolfe, and Lane, 1996; Yunus, 2007). Pain also appears to be biologically meshed 
with a number of other debilitating symptoms, e.g. fatigability (Van Houdenhove and 
Luyten, 2009). In addition, pain and related distress have strong ties to motivation (Craig, 
2003; Michael, 2000; Van Houdenhove and Luyten, 2009). 
Longstanding pain has a negative impact on functioning in a number of life 
domains for large numbers of persons (Breivik et al., 2006). Importantly, there remains a 
need to develop, refine and evaluate treatments aiming to help persons suffering from 
pain to live meaningful vital lives, also in the presence of persisting pain (Turk, 2003). 
From the perspective of RFT and RGB, language and cognition (verbal behavior) 
amplifies the aversive stimulus functions of pain and related distress, and thereby further 
drives motivation characterized by experiential avoidance, fusion and inflexible 
behavioral repertoires (Törneke, Luciano, and Valdivia Salas, 2008).  
CBS and ACT primarily conceptualize pain based on its contextual and functional 
relation to behavior, as illustrated by experiential avoidance. Key features of ACT include 
strategies that aim to undermine experiential avoidance, for example by means of 
strategies facilitating disengagement from and openness towards pain and related distress. 
These strategies aim at creating flexible behavioral repertoires guided by personal values 
and related goals (Törneke, 2010). 
Previous research illustrates that CBT is an efficacious treatment, but that effect-
sizes are moderate. Similarly, accumulating research indicates the efficacy of ACT, but 
also for ACT effect-sizes are small to moderate. In both ACT and CBT there is a 
continued need for: Adequate measures to assess the interference of pain in central life 
domains; evaluations of cost-effectiveness; and of theoretically based investigations of 
processes of change (Kazdin, 2007; SBU, 2006, 2010; Williams, Eccleston, and Morley, 
2012). This brings us to the general and specific aims of this thesis. 
  31 
3 GENERAL AND SPECIFIC AIMS 
The general aims of the thesis were to evaluate the efficacy and processes of change in 
ACT for longstanding pain. Specifically, we wanted to: (1) Evaluate the efficacy of ACT 
delivered in a group setting for FM and non-specific longstanding pain; (2) perform a 
validation of a pain interference questionnaire; (3) evaluate the mediating functions of 
psychological inflexibility in ACT in relation to pain disability and pain interference; (4) 
analyze the cost-effectiveness of ACT. These aims are presented in relation to the 
individual studies below. 
 
• In Study I we aimed to evaluate the efficacy of ACT for FM, and to investigate 
the role of psychological inflexibility as a mediator of improvement in pain 
disability and other outcomes. 
 
• In Study II we aimed evaluate the efficacy and cost-effectiveness of ACT in 
comparison with applied relaxation (AR) for adults with longstanding non-
specific pain. 
 
• In Study III we aimed to evaluate the psychometric properties of a brief 
questionnaire, the pain interference index (PII), developed to assess the inter-
ference of pain on behavior in central life domains. 
 
• In Study IV we aimed to investigate the putatively mediating roles of 
psychological inflexibility, catastrophizing and pain intensity in relation to pain 
interference in ACT and AR, as well as the temporal precedence of the mediator 
in relation to the outcome. 
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4 METHOD 
All studies were conducted at the Karolinska University Hospital in Solna. Study I was 
done in collaboration with another research group at Karolinska Institutet. 
4.1 STUDY I  
4.1.1 Design, participants and procedure 
Study I was an open RCT in which participants were randomized to ACT or to a waitlist 
control condition. The study was based on a superiority hypothesis, i.e. that ACT would 
perform better than the waitlist control condition. Randomization was done based on 
random number sequences generated by computer software. Administrators not involved 
in delivering treatment provided sealed envelopes containing study condition to the 
participants. 
Treatments followed a written protocol and consisted of 12 weekly group sessions 
(5-6 participants in each group). Two psychologists conducted treatment in Study I. In 
ACT, the psychologists conducted ten sessions, and a pain physician with formal therapist 
training in CBT and ACT conducted two sessions (sessions two and eight) as an 
integrated part of treatment. The psychologists were licensed clinical psychologists with 
formal training in CBT, ACT and AR. Furthermore, they had clinical experience of 
behavioral treatments for patients suffering from longstanding pain. Treatment sessions 
were recorded on video and analyzed to formally assess treatment integrity, protocol 
adherence and therapist competence. 
4.1.1.1 Participants and Procedure 
Referrals came from primary care physicians. Eligibility was first assessed in brief 
telephone interviews. A pain physician and clinical psychologists then further assessed 
eligible participants based on inclusion/exclusion criteria. As functional magnetic 
resonance imaging (fMRI) was performed as part of the research project, women between 
18 and 55 years of age, fulfilling the American College of Rheumatology classification 
criteria for FM (Wolfe et al., 1990) were considered eligible for study inclusion. Also, 
inclusion required a weekly average pain intensity of > 40 (visual analogue scale 0–100). 
Left-handed, pregnant and breastfeeding persons, and persons with metal implants or 
claustrophobia, were excluded. Discontinuation of ongoing treatments that risked 
influencing the patients’ pain perceptions (e.g. mood stabilizers and strong opioids) was 
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required, as they were considered incompatible with treatment. However, if discontinued 
48 hours prior to study assessments, small doses of non-steroidal anti-inflammatory drugs 
were allowed as rescue medication. Based on the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (American Psychiatric Association, 2000), a semi-
structured interview was constructed for the present study. Severe psychiatric co-
morbidity resulted in exclusion from the study. Also, ongoing or planned (within 6 
months) treatments based on CBT, or treatments for suicide ideation and intent, psychotic 
and severe depressive symptoms, were incompatible with participation in the current 
study. 
4.1.2 Self-report measures and assessments 
Primary and secondary outcomes, and the process measure, were assessed pre- and post-
treatment as well as at 3-month follow-up. 
4.1.2.1 Primary outcome measure 
The disabling effects of chronic pain on daily activities were assessed using the Pain 
Disability Index (PDI) (Tait et al., 1987). The PDI consists of seven items regarding 
various activities that are rated on a 0-10 scale ranging from “no trouble” to “total 
disability”. Several studies support the reliability and validity of the PDI (Tait, Chibnall, 
and Krause, 1990; Tait et al., 1987). 
4.1.2.2 Secondary outcomes measures 
Average pain intensity the past week was assessed using a single item (“What has your 
average pain level been the past week?”). The item was rated on a numeric rating scale 
from 0 (“No pain at all”) to 6 (“Extremely painful”) (Dworkin et al., 2005). 
We assessed HRQL using the Short Form-36 Health Survey (SF-36) (Ware and 
Sherbourne, 1992). The SF-36 (36-items) provides summary scores for two overarching 
subscales: the physical component scale (SF-36-P) and the mental component scale (SF-
36-M). Higher scores indicate better functioning. Previous research indicated that the 
questionnaire had adequate reliability and validity (McHorney, Ware, and Raczek, 1993; 
Sullivan, Karlsson, and Ware, 1995). 
Depression was measured using the Beck Depression Inventory (BDI), which 
consists of 21 items that are rated on a 4-point scale (Beck et al., 1961). The BDI has been 
used frequently in studies with FM and is recommended as an instrument for detecting 
distress in patients with chronic musculoskeletal pain (Glombiewski et al., 2010). 
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Anxiety was assessed with the Spielberger Trait-State Anxiety Inventory (STAI) 
(Spielberger et al., 1983). The questionnaire consists of two scales comprising 20 items 
each that concern anxiety. Items are rated on a 4-point scale from ‘not at all’ to ‘very 
much so’. Instructions vary regarding the temporal aspect of the two scales in order to 
measure state and trait aspects of anxiety. The questionnaire has been recommended to 
use in the assessment of anxiety in FM (Gowans et al., 2002). 
Self-efficacy, the perceived ability to perform various activities with pain, such as 
visiting friends, was assessed with the Self-Efficacy Scale (SES) (Denison, Asenlof, and 
Lindberg, 2004). The instrument comprises 20 items that are rated on an 11-point scale, 
from ‘not at all confident’ (0) to ‘very confident’ (10). The reliability of a Swedish 
version was illustrated in a study with persons suffering from subacute, chronic or 
recurrent musculoskeletal pain (Denison, Asenlof, and Lindberg, 2004). 
We assessed FM impact on different aspects of health and functioning using the 
Fibromyalgia Impact Questionnaire (FIQ). This questionnaire was developed to assess 
current health status and includes 10 items measuring aspects of physical function, 
psychological distress, pain, sleep, stiffness and well being (Burckhardt, Clark, and 
Bennett, 1991). The instrument has been extensively used in studies on FM and previous 
research has indicated the measure’s reliability, validity and sensitivity to change in 
(medical) treatments targeting symptom reduction (Bennett, 2005). 
4.1.2.3 Process measure 
The Psychological Inflexibility in Pain Scale (PIPS) consists of 12 items rated on a 7-
point scale ranging from ”never true‟ (1) to ”always true‟ (7). Higher scores indicate 
greater psychological inflexibility (range 12–84). The scale consists of two subscales 
measuring experiential avoidance (8 items) and cognitive fusion (4 items). In this study 
the total scale was used. The statistical properties of the questionnaire have been found 
adequate in two previous studies Results from previous studies indicate the adequacy of 
the questionnaires psychometric properties, test–retest stability, sensitivity to change and 
demonstrates its ability to detect indirect effects in ACT (Wicksell et al., 2009; Wicksell 
et al., 2008; Wicksell, Olsson, and Hayes, 2010, 2011). 
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4.1.3 Analytical approach 
4.1.3.1 Treatment outcome 
In Study I outcome data were evaluated using linear mixed models. Time-specific 
residuals were estimated in the model and random coefficients (i.e., random intercept and 
linear slope) and their covariance were retained when they significantly contributed to the 
model. Models were fitted with full information maximum likelihood estimation. 
4.1.3.2 Mediation analysis 
In Study I mediation analyses were conducted with study condition as different levels of 
the independent variable, pre–post change scores in the process variable as mediator, 
and pre- to follow-up changes in the outcome variables as dependent variables. A 
product of coefficients approach with bootstrap resampling (n = 5000) was used to 
evaluate the product of two relations: the treatment’s impact on the process variable (the 
a-path), and the process variable’s effect on the outcome variables, with control for the 
effects of treatment modality (the b-path) (MacKinnon, Fairchild, and Fritz, 2007). The 
mean value for the ab-product across the bootstrapped samples provides a point 
estimate of the mediating effect, and bias-corrected confidence intervals are derived 
from the obtained distribution of ab-scores (Preacher and Hayes, 2004, 2008). If lower 
and upper bounds do not contain zero, the mediating effect is significant at the level 
specified in the analysis. 
4.2 STUDY II 
4.2.1 Design, participants and procedure  
Study II was an open RCT in which participants were randomized to ACT or to AR. The 
study was based on a superiority hypothesis, i.e. that ACT would perform better than AR. 
On the basis of a simulation study of the statistical power of latent growth modeling, 
Study II had sufficient power (0.80) to detect a large effect with a conventional alpha 
level (0.05) given sample size and the 5 assessment occasions (Fan, 2003). Administrators 
not involved in treatment randomized participants in blocks of 12 to ACT or AR using an 
online random numbers service (www.random.org), and provided participants with sealed 
envelopes containing study condition. 
Treatments followed written protocols and consisted of 12 weekly group sessions 
(5-6 participants in each group). Three psychologists delivered ACT (one of the 
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therapists delivered treatment in both ACT and AR). In ACT, the psychologists 
conducted ten sessions and a pain physician with formal therapist training in CBT and 
ACT conducted two sessions (sessions two and eight) as an integrated part of treatment. 
In AR three psychologists conducted all 12 sessions. All psychologists were licensed 
clinical psychologists and had formal training in CBT, ACT and AR, and clinical 
experience of behavioral treatments for patients suffering from longstanding pain. 
Treatment sessions were recorded on video and analyzed to formally assess treatment 
integrity, protocol adherence and therapist competence. 
4.2.1.1 Participants and procedure  
Participants were referred from primary and tertiary care units in Stockholm County, 
Sweden, to the Behavioral Medicine Pain Treatment Services (BMPTS) at the Karolinska 
University Hospital. Psychologists and pain physicians assessed participants for inclusion 
during a 20-month period. Patients were eligible for inclusion if: they were between 18-65 
years of age; they had longstanding pain (≥ 6 months); no further medical assessments 
were required; pain medication had been stable the past 2 months and no changes in pain 
medication were planned. 
Patients were excluded if they participated in a concurrent CBT-based treatment. 
However, if no treatment changes were planned, participation in an ongoing (for ≥ 2 
months) non-medical, non-CBT-based treatment was allowed. Psychiatric co-morbidity 
that may have significantly interfered with treatment and needed to be addressed 
primarily and separately (e.g. high risk of suicide, psychotic symptoms and severe 
depressive episode) resulted in exclusion. The Mini International Neuropsychiatric 
Interview (MINI) was used to screen for psychiatric comorbidity (Sheehan et al., 1997). 
Also, participants were excluded if they were unable to respond to the questionnaires in 
Swedish.  
4.2.2 Self-report measures and assessments 
Primary and secondary outcomes, and the process measure, were assessed pre- and post-
treatment as well as at 3- and 6-month follow-up. 
4.2.2.1 Primary outcome measure 
As in Study I the PDI was used to assess pain disability (see Study I above for more 
information). 
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4.2.2.2 Secondary outcome measures 
Average pain intensity the past week was assessed using the same one-item question as in 
Study I (see Study I above for more information). We used the Short Form-12 (12-items) 
to assess HRQL. SF-12 provides summary scores for two overarching subscales: the 
physical component scale (SF-12-P) and the mental component scale (SF-12-M). Higher 
scores indicate better functioning. The reliability and validity of the questionnaire have 
been found adequate (Luo et al., 2003). 
In this study anxiety and depression were assessed using the Hospital Anxiety and 
Depression Scale (HADS) that consists of 14 items in total. HADS has two subscales, 
Anxiety (HADS-a) and Depression (HADS-d) and items are rated on a 4-point scale. 
Studies indicate that HADS has adequate reliability and validity in assessing anxiety and 
depression in medical settings (Lisspers, Nygren, and Soderman, 1997; Zigmond and 
Snaith, 1983). 
4.2.2.3 Process measure 
The Chronic Pain Acceptance Questionnaire (CPAQ) was used to measure acceptance of 
pain. The Swedish version used here consisted of 19 items rated on a numeric rating scale 
from 0-6, with higher scores indicating higher degree of acceptance. A number of studies 
have supported the reliability and validity of the questionnaire (McCracken and 
Eccleston, 2003, 2006; Vowles et al., 2008; Wicksell, Olsson, and Melin, 2009). 
4.2.3 Analytical approach 
4.2.3.1 Treatment outcome 
In Study II continuous outcomes were analyzed using latent growth curve modeling 
(Bollen and Curran, 2006; Muthén, 1997) A piecewise function was specified to model 
non-linear change across all assessments and to evaluate time and treatment effects during 
distinct time periods of the trial within the same analysis (Raudenbush and Bryk, 2002). A 
two-piece growth model was estimated for each measure. Specific time coefficients were 
provided for the active treatment phase (Piece 1; pre-, mid-, and post-treatment), and for 
the follow-up phase (Piece 2; 3-, and 6-month follow-up). Loadings for linear change 
over time were specified for each piece with an intercept centered at the first assessment 
(pre-treatment). To evaluate the potentially different impact of treatments over the distinct 
time periods of the trial, the linear slope of Piece 1 and Piece 2, were regressed on a fixed 
predictor representing treatment (ACT = 0.5, AR = -0.5). Time-specific residuals were 
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estimated in the model and random coefficients (i.e., random intercept and linear slope) 
and their covariance were retained whenever they significantly contributed to the model. 
Following the principle of intention-to-treat, analyses used all available data from 
randomized participants. The models were fitted with full information maximum 
likelihood estimation. Between-group effect sizes (d) for growth models were calculated 
based on recommendations by Feingold Feingold (2009b) and within-group effect sizes 
were calculated based on recommendations by Morris and DeShon (2002). 
4.2.3.2 Clinical significant change 
Clinically significant change was estimated based on the Jacobson-Truax criteria 
(Jacobson and Truax, 1991). Estimation was done by establishing a cut-off for clinical 
significance and a reliable change index. Based on previous research we adopted a cut-off 
for clinically significant change of an SD = 1 below the participants’ mean pretreatment 
PDI score and utilized a 90% confidence interval (Jacobson et al., 1999; Vowles et al., 
2014). 
4.2.3.3 Cost-effectiveness 
Assessments and analyses of health economic factors included all costs (i.e. had a societal 
perspective). All costs were extrapolated to a 3- month period, primarily because this time 
period better accounted for the costs of ACT and AR during the active treatment phase. 
Intervention costs were calculated by multiplying the time spent by the therapists in 
treatment with the Swedish national tariff for visits to a licensed clinical psychologists/ 
pain physician (ACT: psychologist and physician; AR: psychologist). Costs related to 
healthcare visits (direct medical costs) were calculated by multiplying the reported 
number of visits with the cost for that particular visit (e.g., visit to a general practitioner) 
as specified in Swedish national tariffs. Costs for medicines were obtained by multiplying 
the amount of medicine used with the market price in Sweden. 
Direct non-medical costs were calculated using a mean value of the service (e.g., 
the mean cost of a homeopathic consultation). Productivity losses were based on the 
human capital approach, which means that monetary losses associated with work loss and 
work cutback were based on the average gross earnings in Sweden for the duration of the 
reported sick leave. All costs were converted to US$ for the reference year 2013. 
The incremental cost-effectiveness ratio (ICER) was estimated by subtracting the 
changes in total costs (ie, the change of the sum of all the costs in the aforementioned 
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cost-domains) in AR from the changes in total costs in ACT and dividing this difference 
with the difference resulting from the subtraction of the total effects on pain disability in 
AR from the total effects on pain disability in ACT. This procedure was bootstrapped 
5000 times, which generated probabilistic values of the treatment groups’ incremental 
costs in relation to their incremental treatment benefit. These values (ICERs) were plotted 
in cost-effectiveness planes to evaluate and illustrate the potential cost-effectiveness of 
ACT compared with AR.  
In the cost-effectiveness analyses missing data were imputed using the multiple 
imputation procedure. The Mann-Whitney U test for independent samples was used to 
analyze potential cost-differences between conditions at the different assessment points. 
Also, costs-differences within conditions over time were evaluated using the sign test for 
related samples. Lastly, we evaluated the association between cost reductions, pain 
disability, and pain intensity by using non-imputed bootstrapped regression (5000 
replications) models. More specifically, we included treatment condition as a control 
variable and regressed the changes in costs (pre-assessment to post-assessment) on the 
change scores (pre-assessment to post-assessment) in pain disability and pain intensity. 
4.3 STUDY III 
4.3.1 Design, participants and procedure 
Study III utilized a cross-sectional design comprising a sample of adults with non-specific 
pain, including participants from Study II. The sample size (n = 205) was determined to 
be large enough for the analyses based on recommendations by e.g. Guadagnoli and 
Velicer (1988). 
4.3.1.1 Participants and procedure 
Participants were referred from primary or tertiary care units in Stockholm County, 
Sweden, to the BMPTS at the Karolinska University Hospital. Adult patients between 18 
and 85 years with longstanding (> 3 months) pain were considered eligible for inclusion 
in the study. Patients were excluded if they were unable to respond to the questionnaires 
in Swedish. Patients were included in the study during a period of 4 years. Pain diagnoses 
were coded based on ICD-10 classifications (World Health Organization., 2004).  
4.3.2 Self-report measures and assessment 
Assessments were performed at the first visit at the clinic. 
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4.3.2.1 Independent variable 
The Pain Interference Index (PII) was developed as a brief instrument to assess to what 
degree pain interferes with day-to-day behavior in several central life domains. The items 
in PII were based on the interference scale in the BPI (Cleeland and Ryan, 1994) and the 
MPI (Kerns, Turk, and Rudy, 1985). The PII consists of six items regarding various 
activities that are rated on a 0-6 scale from “no trouble” to “total disability”, with a 
maximum total score of 36 points. The patient is asked to what degree pain has: 1) made 
it difficult to study/work; 2) made it difficult to do leisure activities; 3) made it difficult to 
spend time with friends; 4) affected mood; 5) affected the ability to do physical activities; 
and 6) affected sleep. Two previous studies indicate the measures reliability and validity 
in youths and young adults with longstanding pain (Holmström et al., Accepted 
manuscript; Martin et al., 2015). 
4.3.2.2 Dependent variables 
As dependent variables in this study we used ratings of average pain intensity the past 
week, the PDI, SF-12-M and SF-12-P and HADS-d. See Study II above for more 
information on the respective measures. 
4.3.3 Analytical approach 
4.3.3.1 Psychometric analyses 
First, the frequency distributions were examined to identify items with extremely skewed 
response distribution or low variability. Then we controlled that item inter-correlations 
between variables did neither correlate with too few other variables, nor correlate too 
highly. To ascertain that no items showed low correlations with the overall score of the 
questionnaire (i.e. lower than .25) item-total statistics were analyzed. Also, the adequacy 
of the sample size and the factorability of the correlation matrix were assessed. Next, a 
principal component analysis (PCA) was performed to examine the factor structure 
among the items, i.e. if the items included in the instrument represent one or more factors. 
Also, Cronbach’s alpha was used to evaluate internal consistency, with α ≥ .80 considered 
adequate (Cortina, 1993). 
To characterize relations between sex and age (background variables), average pain 
intensity past week (control variable), pain interference and criteria variables (PDI and 
SF-12-P and SF-12-M), bivariate correlations (Pearson’s r) were calculated. The 
questionnaire’s concurrent criteria validity was further examined using ordinary least 
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squares regression models. Specifically, we examined if the PII explained a significant 
amount of variance in the criteria variables PDI, SF-12-P, SF-12-M and HADS-d. Sex 
and age (background variables) were included as the first and second steps in the models. 
Pain interference was entered as the last step, with and without the prior inclusion of pain 
intensity (control variable). All included predictors were retained in the final model.  
4.4 STUDY IV 
4.4.1 Design, participants and procedure 
See Study II above. 
4.4.2 Self-report measures and assessments 
Data comprised weekly assessments from Study II of the primary outcome and the 
process variables. 
4.4.2.1 Primary outcome measure 
The PII was used as the primary outcome measure in this study (see Study III above for 
more information). 
4.4.2.2 Process measures 
Average pain intensity the past week was assessed using the same one-item question as in 
Study II (see Study II above). The catastrophizing subscale from the Coping Strategies 
Questionnaire (CSQ) (Rosenstiel and Keefe, 1983) was used to assess pain-related 
catastrophizing. The subscale consists of six items reflecting thoughts and feelings that 
might arise when people experience pain. The extents to which these thoughts have been 
present are rated on a seven-point scale from 0 (“never”) to 6 (“always”). The Swedish 
version of the scale has been found to have satisfactory internal consistency and test-retest 
reliability (Jensen and Linton, 1993). The Psychological inflexibility in Pain Scale (PIPS) 
was used to assess psychological inflexibility (see Study II above). 
4.4.3 Analytical approach 
4.4.3.1 Mediation analyses 
In Study IV Longitudinal mediation based on session-to-session changes was modeled 
using a linear mixed-effects regression model for repeated measures. Full information 
maximum likelihood was used to estimate model parameters (and standard errors), and to 
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facilitate model parameter estimation based on all participants who provided at least one 
valid observed data point on the dependent variable. The proposed mediators 
(psychological inflexibility, catastrophizing, and average pain intensity the past week) 
served as lagged time-varying predictors of subsequent changes in the outcome. In other 
words, the hypothesized mediators constituted predictors (week 1 through week 11) of 
subsequent changes in the outcome (week 2 through week 12). Thereby, changes in the 
putative mediators temporally preceded the outcome in these analyses. In this mediation 
model (lower level mediation) the variables time, mediator and outcome were measured 
at Level 1 and variation across individuals was allowed as a function of a Level 2 
predictor (constituting a moderator variable), in this case treatment condition (Kenny, 
Korchmaros, and Bolger, 2003). Thus, we tested moderated mediation, i.e. the moderating 
effect of treatment condition (ACT or AR) on the mediators’ effect on pain interference. 
Independent groups effect sizes (d) for growth models were calculated when applicable, 
using formulas provided by Feingold (2009) and Morris and DeShon (2002). 
4.5 INTEGRITY, ADHERENCE AND COMPETENCE 
4.5.1 Study I and Study II 
In ACT, treatment integrity, protocol adherence, and therapist competency were evaluated 
using a scoring protocol specifically developed for clinical studies on ACT (Plumb and 
Vilardaga, 2010), with minor adjustments for use with pain patients. For AR, an adapted 
version of the protocol was constructed. Fourteen (Study I) and sixteen percent (Study II) 
of the sessions with ACT-specific and AR-specific content were randomly selected. Two 
CBT-trained psychologists with formal training in ACT and AR, not otherwise involved 
in the study performed the ratings following training in how to use the manual. Ratings of 
ACT included both ACT-consistent items (e.g. “Defusion”) and ACT-inconsistent items 
(e.g. “Experiential avoidant change strategies”). Similarly, ratings of AR included AR-
consistent items (e.g. “Applied in-session practice”) and AR-inconsistent items (e.g. 
“Willingess”). To establish the degree of similarity between coders’ ratings of treatment 
consistent items, treatment inconsistent items, overall adherence to treatment manual, and 
overall competency inter-rater reliability was calculated. 
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4.6 TREATMENT DESCRIPTION 
4.6.1 Study I 
4.6.1.1 ACT-protocol 
The ACT-intervention was organized into four phases. During phase 1 (sessions 1 and 2) 
the dysfunctional character of longstanding pain and pain-related behaviors were 
discussed. This was done with the aim to alter the context in which pain symptoms and 
avoidance behaviors occurred and to initiate a shift in perspective from symptom 
reduction to valued living. In phase 2 (sessions 3 and 4) the workability of previous 
strategies to reduce pain and improve functioning were specifically addressed and the 
utility of a more flexible behavioral repertoire in relation to pain and distress was 
emphasized. Also, personal values were formulated and clarified. Phase 3 (sessions 5 and 
6) focused on disengagement from verbal processes, to decrease the negative impact of 
certain thoughts and experiences on behavior (defusion), and to notice and willingly 
experience unpleasant private experiences that could not be directly changed, when doing 
so served valued ends. In phase 4 (sessions 7 to 12) participants defined short and long 
term behavioral goals based on personal values. Also, they practiced the application of 
ACT consistent strategies to manage pain and distress in daily life as part of a gradual 
increase of previously avoided valued activities. In the final session, central aspects of 
treatment as well as relapse prevention strategies were discussed. 
Throughout treatment, defusion and acceptance strategies were practiced by the 
participants in the form of in-session exercises as well as in homework assignments 
carried out between sessions. Illustrations and metaphors were commonly used to clarify 
central concepts, such as defusion and acceptance. Exposure to personally important 
situations and activities previously avoided due to pain were central to treatment and 
aimed at increasing the ability to act in accordance with personally held values, also in the 
presence of interfering pain and distress (i.e. psychological flexibility).  
4.6.2 Study II 
The Act protocol was identical to the one presented for Study I. 
4.6.2.1 AR-protocol 
The AR treatment was based on the original protocol by Öst (1987), adapted for use with 
longstanding pain. Also, the length, number and format of sessions were matched with the 
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ACT protocol. As with the ACT-intervention, the protocol was divided into different 
phases. In the first phase (sessions 1 to 4) the rational of using AR in the context of 
longstanding pain was presented, based on previous research and established relationships 
between fear, anxiety, stress, muscle tension, negative thoughts and pain. Furthermore, 
AR was presented as an alternative behavioral strategy to manage and reduce the negative 
impact of pain on daily life, which would be gradually introduced during the course of 
treatment. Furthermore, it was stressed that successful application of AR required 
thorough in-session as well as between-session practice. Two sessions focused on 
therapist guided in-session practice of the long version of progressive relaxation (i.e. with 
prior tensing of the muscles before relaxing them). One session comprised the brief 
version of progressive relaxation (i.e. without tensing of the muscles). 
Phase two (session 5 to 7) consisted of conditioned and differential relaxation. 
Conditioned relaxation was taught by prompting participants to think “inhale” just prior to 
inhaling and to think “relax” just before exhaling, while being in a relaxed state achieved 
by previous performance of the brief version of progressive relaxation. Differential 
relaxation comprised the prior application of brief progressive relaxation combined with 
conditioned relaxation, after which participants performed certain tasks (e.g. writing, 
standing and walking). 
During the final phase (session 8 to 12), practice of rapid relaxation was done in one 
session and two sessions focused on continued practice and application of rapid relaxation 
in daily life. Participants were encouraged to use rapid relaxation in situations where pain 
and pain-related distress increased. Furthermore, alternative ways of applying rapid 
relaxation were presented, for example by: Performing rapid relaxation prior to initiating 
a pain provoking activity; by repeatedly performing rapid relaxation during the pain 
provoking activity; or by performing scheduled rapid relaxation during the course of the 
day. The final two sessions focused on repetition of central concepts and skills, 
troubleshooting, and relapse prevention strategies. 
4.7 ETHICAL CONSIDERATIONS 
The Ethical Review Board in Stockholm approved all studies and all participants gave 
their written informed consent to participate in the studies. 
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5 RESULTS 
5.1 STUDY I 
In total, 82 women diagnosed with FM were referred to the study and of these 47 
individuals were considered eligible and were further assessed by psychologists and pain 
clinicians. Forty-three of these fulfilled the inclusion criteria, out of which two declined 
participation. Three participants in ACT discontinued treatment and one participant in the 
control condition dropped out of the study between pre- and post-assessments. 
Furthermore, data from one participant were considered unreliable due to lack of 
assessment date and this individual was therefore removed from the analyses. 
5.1.1 Treatment outcome 
The mixed-effects model analyses illustrated significant improvements in pain disability 
in ACT compared to the control condition, as shown by a significant linear time by treat-
ment interaction. Effect size calculations (d) showed medium between-group effects at 
post-assessment (0.75) and at follow-up (0.73). A significant linear time by condition 
interaction was also found in in favor of ACT on the mental aspect of HRQL; FM impact; 
self-efficacy; depression; and state and trait anxiety. For the secondary outcome measures 
significant between-group effect sizes varied between 0.42 and 0.73 at post-assessment. 
At follow-up assessment the between-group effects ranged from 0.39 to 1.05. Also, ACT 
improved significantly in psychological inflexibility compared to the control condition at 
post-treatment assessment (d = 1.05) and follow-up assessment (d = 0.71). 
5.1.2 Mediation analysis 
Mediation analyses were restricted to outcome variables where a significant time by 
condition interaction was found. Also, mediation analyses were only conducted if there 
was a significant relation between pre– and post-assessment changes in psychological 
inflexibility and if there were pre-assessment to follow-up changes in outcome. Results 
illustrated that decreases in psychological inflexibility (pre- to post-treatment assessment) 
significantly mediated the improvements in pain disability (pre-treatment to follow-up 
assessment). Also, psychological inflexibility significantly mediated change in: FM 
impact; self-efficacy; depression; and state and trait anxiety (secondary outcome 
measures). 
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5.2 STUDY II 
Of 109 assessed patients, 60 met inclusion criteria. Those excluded reported higher levels 
of sick leave and catastrophizing compared to those included in the study. 
5.2.1 Treatment outcome 
Average scores and standard deviations from assessments of pain disability, pain 
intensity, mental and physical aspects of HRQL, symptoms of anxiety and depression and 
pain acceptance for the five assessment points are presented in table 2. 
 
Table 2. Means and standard deviations for all outcome measures. 
  Mean (SD)   
Variable Cond. Pre Mid Post 3mfu 6mfu 
PDI ACT 39.1 (14.0) 31.6 (15.6) 28.8 (16.1) 28.5 (16.6) 31.2 (19.0) 
 AR 40.7 (14.1) 42.5 (14.6) 40.3 (13.6) 35.0 (18.8) 34.0 (16.2) 
Pain ACT 4.3 (.79) 3.9 (1.2) 3.7 (1.4) 4.3 (1.0) 4.4 (1.3) 
 AR 4.4 (1.0) 4.2 (1.3) 4.0 (1.5) 4.1 (1.3) 4.1 (1.5) 
SF-12-M ACT 38.8 (8.9) 41.8 (10.0) 40.9 (10.4) 39.9 (12.6) 39.3 (10.8) 
 AR 37.7 (10.0) 36.3 (10.8) 34.9 (10.7) 37.6 (13.7) 38.8 (13.8) 
SF-12-P ACT 29.4 (8.5) 33.3 (10.0) 34.9 (9.1) 36.6 (10.9) 39.3 (10.2) 
 AR 29.4 (7.6) 32.1 (7.6) 32.1 (8.2) 34.3 (10.1) 32.3 (9.8) 
HADS-a ACT 9.0 (3.9) 8.1 (3.5) 7.3 (3.8) 8.1 (5.6) 9.1 (5.1) 
 AR 10.3 (4.9) 9.9 (4.8) 9.0 (4.6) 8.9 (5.1) 9.2 (5.1) 
HADS-d ACT 10.0 (4.1) 9.1 (4.7) 7.1 (4.8) 7.5 (5.0) 8.4 (5.6) 
 AR 9.6 (4.3) 8.9 (3.8) 9.1 (5.3) 8.2 (5.8) 8.4 (5.5) 
CPAQ ACT 43.1 (16.3) 55.7 (15.4) 61.4 (14.5) 64.2 (19.1) 63.4 (21.2) 
 AR 40.6 (15.5) 43.3 (19.3) 43.0 (17.5) 50.0 (19.5) 50.2 (21.9) 
Note Means and standard deviations are based on observed data. CPAQ = Chronic Pain 
Acceptance Questionnaire; HADS-a = Hospital Anxiety and Depression Scale-anxiety; 
HADS-d = Hospital Anxiety and Depression Scale-depression; PDI = Pain Disability 
Index; SF-12-M = Short Form-12 mental subscale; SF-12-P = Short Form-12 physical 
sub-scale. 
 
There were significant reductions across conditions over time (linear) during the treatment 
period (piece 1) on pain disability (d = 0.54), the physical aspect of HRQL (d = 0.79) and 
pain intensity (d = 0.34). Also, there was a significant time by treatment interaction 
(differential treatment effect) in pain disability (d = 0.61) during piece 1, in favor of ACT 
(Figure 3). Reductions in pain disability over time did not reach, statistical significance 
from post-treatment to 6-month follow-up (piece 2). However, there was a significant 
time by treatment interaction on pain disability (d =0.63), in favor of AR (piece 2). There 
were no significant time or differential treatment effects seen in the physical aspect of 
HRQL during piece 2, indicating that improvements during piece 1 were maintained 
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across conditions. During piece 2 pain intensity approached, but did not reach statistical 
significance (p < 0.1) over time and in regard to differential treatment effects, implying 
a slight increase in pain intensity in ACT during piece II. 
There was a significant decrease over time in piece 1 in anxiety (d = 0.33) and 
depression (d = 0.41) across conditions. There were no significant changes over time or in 
regard to differential treatment effects for Piece 2 on anxiety and depression. This 
suggested that the positive treatment-effects found in piece 1 were maintained in piece 2. 
During treatment there was a significant improvement in pain acceptance both over time 
and in regard to the differential treatment effects (d = 0.90). There was a significant 
improvement over time and across groups in acceptance in piece 2, but no significant time 
by treatment interaction, suggesting that the differential effects of treatments in favor of 
ACT during the treatment phase were maintained at 6-month follow-up. 
 
 
Figure 3. The graph is based on average scores in pain disability (Table 2) and 
represents change in ACT and AR, from pre-treatment to post-treatment assessment 
(piece 1), and from post-treatment assessment to 6-month follow-up (piece 2). 
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5.2.2 Clinically significant change 
On the basis of a cut-off for clinical significance (a score < 25.8 on the PDI) in 
combination with a 90% confidence interval, 5 individuals in the ACT condition and none 
in AR met criteria for reliable and clinically significant change at post-assessment. At 3-
month follow-up, 4 individuals in the ACT condition met these criteria, compared with 5 
in AR. Four participants in ACT and 2 in AR met criteria for reliable and clinically 
significant change at 6-month follow-up. There was a marginally significant difference in 
clinically significant change between groups in favor of ACT at post-assessment (p = 
0.056). 
5.2.3 Costs and cost-effectiveness 
There was a statistically significant decrease in work cutback at 3-month follow-up for 
AR and significant reductions in gross total costs at post-assessment and at 3-month 
follow-up for ACT. Furthermore, results illustrated that that pre-treatment to post-
treatment change scores across conditions in pain intensity during the active treatment 
phase were correlated with changes in indirect non-medical costs. Lastly, pre- to post-
treatment changes in pain intensity correlated with changes in total costs (including 
intervention costs) between pre- to post-treatment. 
The cost-effectiveness evaluation was based on plots of simulated ICERs 
(incremental cost-effectiveness ratios) in the quadrants of the ICER plane (Figure 4). At 
post-assessment, 99% of the simulated ICERs were located in the southeast quadrant, 
illustrating that ACT was more cost-effective than AR. At 3-month follow-up, 78% of the 
ICERs were found in the southeast quadrant and 15% in the southwest quadrant, 
illustrating that ACT remained more cost-effective compared with AR, although slightly 
less than at post-assessment. At 6-month follow-up the scatter is more centered, which 
indicates that there are no differences in cost reduction or effectiveness between the two 
conditions.  
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Figure 4. Cost-effectiveness planes comprising 5000 bootstrapped ICERs. The planes 
illustrate comparisons of ACT and AR based on change scores in total costs (including 
the cost of the interventions) and pain disability (assessed with the PDI): At post-
treatment assessment (A); 3-month follow-up (B); and at 6-month follow-up (C). 
 
5.3 STUDY III 
In total 239 patients were eligible for study inclusion and of these 12 failed to fill out the 
requested questionnaires, resulting in an inclusion of 227 participants in the study. Of the 
227 included participants, 22 were excluded from the reliability analyses due to missing 
one or more PII-items, thus the PCA was based on data from 205 individuals.  
5.3.1 Psychometric analysis and concurrent criteria validity 
Initial analyses indicated the factorability of the dataset and that all items could be 
included in the PCA. Following PCA, a one-factor solution was deemed the most 
adequate, based on one component attaining an eigenvalue > 1.0 and the corresponding 
scree plot. Items included in the PII had an adequate internal consistency, as illustrated by 
a Cronbach’s alpha of .85 (Cortina, 1993). Significant bivariate correlations (Pearson’s r) 
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(0.67), physical and mental aspects of HRQL (0.48 and 0.42 respectively) and depression 
(0.45). Results from the hierarchical regression analyses (controlling for, sex, age and 
average pain intensity the past week) illustrated that PII explained an incremental 
significant amount of variance in: pain disability (29%); the physical aspect of HRQL 
(12%); the mental aspect of HRQL (10%); and depressive symptoms (14%). Thus, results 
from the correlation and regression analyses indicated the concurrent criteria validity of 
the measure. 
5.4 STUDY IV 
5.4.1 Mediation analysis 
Means and standard deviations for the weekly assessments of pain interference and 
psychological inflexibility are presented in table 3. 
 
Table 3. Means and SDs for the weekly assessments of the primary outcome (PII) and 
the hypothesized mediator (PIPS) in ACT. 
 PII  PIPS  
 ACT AR ACT AR 
 Mean (SD)  Mean (SD)  
Week 1 26.4 (7.0) 26.7 (7.4) 58.5 (12.5) 58.7 (13.4) 
Week 2 23.3 (8.8) 26.2 (7.3) 53.8 (12.3) 59.0 (13.2) 
Week 3 23.8 (8.1) 27.0 (7.0) 51.8 (12.6) 57.7 (13.2) 
Week 4 23.0 (8.6) 26.9 (7.5) 51.5 (15.0) 61.0 (13.3) 
Week 5 21.9 (9.7) 24.4 (6.6) 52.0 (15.3) 56.3 (12.8) 
Week 6 19.5 (8.9) 25.2 (9.0) 50.2 (16.2) 57.7 (15.2) 
Week 7 22.0 (9.1) 27.7 (4.8) 48.5 (14.3) 63.0 (12.4) 
Week 8 20.9 (9.5) 26.5 (6.6) 48.2 (16.7) 61.3 (12.5) 
Week 9 20.9 (9.4) 24.3 (8.8) 49.1 (16.5) 58.6 (16.1) 
Week 10 22.9 (8.6) 24.2 (6.9) 48.7 (16.8) 57.2 (15.1) 
Week 11 18.8 (8.9) 23.2 (8.1) 44.5 (14.9) 55.7 (16.6) 
Week 12 17.4 (8.9) 26.6 (9.1) 39.6 (15.8) 59.3 (16.8) 
Note Means and standard deviations are based on observed data. PII = Pain Interference 
Index; and PIPS = Psychological Inflexibility in Pain Scale. 
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Results from the outcome analyses using linear mixed models showed a significant 
medium (d = −0.57) main linear effect of time in the ACT-condition on PII (Figure 5), 
which indicated a decrease in pain interference. There was no significant effect of time in 
the AR-condition and no significant differential linear change between treatments from 
first to last session on PII. 
 
 
Figure 5. The graph is based on average scores in pain interference (Table 3) and 
represents session-to-session change in ACT and AR during treatment, from week 2 to 
week 12. 
 
In the model with psychological inflexibility as the mediator, the effect of time (over 
treatment sessions) on the mediator (a-path) as a function of treatment (ACT or AR) was 
significant. This indicated that ACT had a significantly stronger effect (d = 0.92) on 
psychological inflexibility. There was no statistically significant difference on the 
mediator to outcome relation (b-path) as a function of treatment. The asymmetric 
confidence interval test of indirect effects revealed that psychological inflexibility was a 
significant mediator in ACT, but not in AR (Figure 6). In the model with pain intensity as 
the meditator, there were no significant changes over time in a- and b-paths as a function 
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of treatment, resulting in a non-significant indirect effect in both conditions. There was a 
significant difference in a-paths as a function of condition in the model with 
catastrophizing as the mediator, implying that ACT had a significantly stronger effect (d = 
0.38) on catastrophizing compared to AR. However, the test for difference in b-paths by 
treatment was non-significant, and the indirect effect of catastrophizing was non-
significant in both groups. Thus, results imply that changes in psychological inflexibility 
mediated improvements in pain interference for ACT but not AR, and that catastrophizing 
and pain intensity did not mediate improvements in pain interference in either treatment. 
 
 
Figure 6. The graph is based on average scores in psychological inflexibility (Table 3) 
and represents session-to-session change in ACT and AR during treatment, from week 
1 to week 11. 
 
5.5 INTEGRITY, ADHERENCE, AND COMPETENCE  
In both Study I and Study II, ratings showed adequate levels of treatment integrity, 
protocol adherence, and therapist competence. In Study II inter-rater agreement was 
calculated based on the scores of two raters. Except for ratings of AR competency, that 
lacked systematic agreement, there was an acceptable degree of agreement, suggesting 
that items were rated similarly across coders. 
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6 DISCUSSION 
In this doctoral project we evaluated the efficacy of ACT for longstanding pain, a 
contextual behavioral treatment approach aiming to undermine the impact of pain and 
related distress on behavior. More specifically the efficacy of this approach in improving 
pain-related disability, pain interference and HRQL was evaluated. Importantly, we also 
investigated if improvements in psychological inflexibility were functionally related to 
improvements in pain disability and pain interference. In addition, an evaluation of the 
effect of treatment on health-related costs and a cost-effectiveness analysis were 
performed. Lastly, the psychometric properties of a brief pain interference questionnaire 
were analyzed. The questionnaire’s utility as an outcome measure was also explored in 
the aforementioned process analyses. Below I discuss the different studies in relation to 
previous research, aspects of reliability and validity, relevant theory and future directions. 
Before concluding I also touch upon some clinical aspects related to the theoretical and 
clinical approach taken in the thesis. 
6.1 STUDY I AND STUDY II  
During the treatment phase, results from both Study I and Study II indicated significant 
moderate improvements in pain disability in favor of ACT compared to the control 
conditions. In Study I the between-group effect was maintained at three-month follow up. 
During the follow up period in Study II, results indicated significant moderate effects in 
pain disability in favor of AR compared to ACT. However, average scores in pain 
disability (Table 2 and Figure 3) indicated that the improvements during treatment in the 
ACT-group were largely retained during the follow-up phase. The small to moderate 
improvements in pain disability following ACT are in line with previous evaluations of 
ACT for both FM and non-specific pain (e.g. Luciano et al., 2014; Wetherell et al., 2011). 
In addition, the moderate effects of ACT on pain disability directly following treatment 
are similar to those of CBT for longstanding pain (Williams, Eccleston, and Morley, 
2012). 
Notably, the delayed effects on pain disability in AR complicate the interpretation 
of the results, and to my knowledge previous research does not indicate if these patterns 
of results should be expected. There were no significant differences between conditions in 
further treatment seeking (psychological, physiotherapeutic, or complimentary) during the 
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follow-up period. However, other confounding factors that were not assessed could 
explain these postponed effects. 
In Study I there was a significant large between-group effect on the mental aspect of 
HRQL in the ACT-condition that was retained at three-month follow-up. In Study II there 
was a significant moderate effect on HRQL across conditions (ACT and AR) that was 
maintained during the follow-up phase. As regards mood, there were significant small to 
moderate effects on depression and anxiety in favor of ACT in Study I, from pre-
treatment assessment to three-month follow-up. Results from Study II illustrate small 
significant improvements in depression and anxiety across conditions, from pre-treatment 
assessment to six-month follow up. In regard to HRQL, broad comparisons with previous 
studies are difficult to make, as it appears that this outcome has not been widely evaluated 
in ACT and CBT for longstanding non-specific pain (Hann and McCracken, 2014; 
Williams, Eccleston, and Morley, 2012). In regard to FM, results indicate that CBT does 
not improve HRQL at post-treatment assessment or at follow-up (Bernardy et al., 2013). 
The results on depression and anxiety in Study I and Study II largely correspond with 
previous research. Hann and McCracken (2014, p. 223) write that ACT had small to large 
effects on anxiety, depression and general emotional distress in four out of seven studies 
using an inactive control. Results from the meta-analysis by Williams, Eccleston, and 
Morley (2012, p. 12) indicate that CBT, when compared with inactive control 
conditions, had moderate effects on mood at post-treatment assessment and a small 
effect at follow-up. However, no effects on mood were found when compared to active 
treatments. According to Bernardy et al. (2013), there were small effects on mood at 
post-treatment assessment in CBT for FM. 
Results on pain intensity diverged somewhat between studies. In Study I there were 
no significant reductions in pain intensity following ACT, but results from Study II 
showed significant moderate reductions of pain intensity across conditions during the 
treatment phase. Findings from other evaluations of ACT have not shown a consistent 
pattern of pain reduction following treatment (Hann and McCracken, 2014). Results from 
a meta-analysis of laboratory-based studies evaluating components in the ACT-model, 
e.g. acceptance (Levin et al., 2012), illustrated that there were no significant differences 
between more control-oriented strategies (e.g. distraction) and acceptance-based strategies 
in reducing the subjective intensity of e.g. pain during a laboratory-induced stressor. In 
regard to pain, results indicate that CBT may have a small effect on pain intensity at 
post-treatment assessment when compared to inactive control conditions, but not in 
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comparison with active control conditions (Williams, Eccleston, and Morley, 2012). 
Similarly, in the meta-analysis by Bernardy et al. (2013) the authors write that CBT 
does not appear do reduce pain in FM. 
6.1.1 Clinically significant change 
In Study II approximately 20% of the participants in ACT, but none in AR, achieved 
clinically significant improvements in pain disability at post-treatment assessment. 
However, at follow-up assessments proportions were similar across treatments. Clinical 
significant change has been evaluated only in a limited number of studies of ACT for 
longstanding pain, and similarly there is lack of studies investigating clinically relevant 
change in CBT for longstanding pain (Williams, Eccleston, and Morley, 2012). In ACT, 
these evaluations have been done in different pain populations and various methods for 
classifying responders have been used (McCracken, MacKichan, and Eccleston, 2007; 
Trompetter et al., 2015; Vowles et al., 2014). Although small, the proportions of 
participants achieving clinical significant change in regard to disability in Study II are 
comparable with those presented by e.g. McCracken, MacKichan, and Eccleston (2007), 
and Vowles et al. (2014). 
6.1.2 Cost-effectiveness 
Results from Study II also showed that ACT was more cost-effective than AR at post-
assessment and at 3-month follow-up, but that the conditions did not differ at 6-month 
follow-up. Furthermore, results indicated a significant gross total cost reduction at post-
treatment and at 3-month follow-up for ACT, and a significant decrease in work cutback 
at 3-month follow-up for AR. Additionally, results indicated that reductions in pain 
intensity during treatment, across treatment conditions, were related to cost reductions in 
indirect non-medical costs and total costs during this time period.  
The total cost reductions following ACT and the correlation between reductions in 
symptoms and total costs during treatment, correspond with one previous study in which 
we collaborated with another research group in evaluating an internet-delivered ACT-
based treatment for FM (Ljotsson et al., 2014). A few studies have indicated the cost-
effectiveness of CBT for longstanding pain and its effect on health-related costs (Linton 
and Nordin, 2006; Turk, 2002). 
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6.1.3 Future directions 
As regards cost-effectiveness, more studies are needed that evaluate the effects of both 
ACT and CBT (Ehde, Dillworth, and Turner, 2014) on health economic outcomes. In 
addition, health economic analyses in Study II were performed within a ordinary least 
squares regression framework and future studies should evaluate the relationship between 
treatment-related changes in cost-variables and other outcomes, as well as potential 
process-variables, using more appropriate longitudinal designs, assessment methods and 
statistical analyses.  
In regard to clinically significant change, Williams, Morley and Eccleston (2012, p. 
14) mean that researchers should develop measures with high ecological validity that can 
index clinical improvement and enhance, or possibly replace, statistical change. Central 
treatment interventions in ACT aim at establishing behavior guided by values, i.e. 
approach behavior governed by appetitive motivating functions. A few clinical studies 
have investigated the role of valuing as a process of change in ACT for longstanding pain 
(e.g. Vowles et al., 2014) and results indicate its potential as a process of change in ACT. 
This variable also appears relevant to evaluate as an outcome (Wilson et al., 2010), which 
could also be used in analyses of clinical significant change. Notably, potential side 
effects of treatments, resulting in clinically significant deterioration were not evaluated 
within this doctoral project, but should be investigated in future studies. 
In regard to processes of change, researchers have increasingly pointed to the 
limitations in knowledge gained from head to head trials testing two therapies against 
each other based solely on outcome differences (Williams, Eccleston, and Morley, 
2012). Many of these trials have not been able to show clear outcome differences in 
competing psychological treatments. Repeatedly, these studies also fail to provide 
information of which treatment aspects that account for change, also when differences 
are found. Thus, the need to investigate the specific aspects of treatment that influence 
change in the outcome, and situational and participant characteristics that influence 
treatment effects, have been stressed by several researchers (Kazdin, 2007; Williams, 
Eccleston, and Morley, 2012). Potentially, a better understanding of these aspects may 
guide further refinement and development of treatments, and potentially also improve the 
effects of treatment. I will specifically discuss avenues for further process research when 
discussing the results of the mediation analyses. Importantly, we also need to assess 
adequate outcomes, i.e. outcomes that are closely related to what we want to achieve in 
treatment, which brings us to Study III. 
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6.2 STUDY III 
As mentioned in the background, the importance of measuring the impact of pain in 
central life domains has been recommended by IMMPACT (Dworkin et al., 2005). 
Potentially, measures assessing pain interference, i.e. the impact of pain on behavior, may 
be particularly well suited for evaluations of treatments like for example ACT, that 
specifically target variables related to interference, e.g. experiential avoidance. Notably 
the PII was especially developed to be brief and easily understood, which we deemed key 
for use in process evaluations with frequent assessments. 
Results from Study III supported a single factor structure and showed satisfactory 
internal consistency among the items. Furthermore, the PII explained a significant amount 
of incremental variance in pain disability, physical and mental HRQL and depression, 
which indicated adequate concurrent criteria validity. One previous study from our group 
has investigated the reliability and concurrent criteria validity of the questionnaire in a 
sample of adolescents suffering from non-specific pain (Holmström et al., Accepted 
manuscript) and another study (Martin et al., 2015) has performed a validation of an 
English version of the questionnaire in persons, from 6 to 24 years, with neurofibro-
matosis and cancer, but also of a parent version of the questionnaire. Both these studies 
reported internal consistencies and concurrent criteria validity similar to the results in 
Study III. Notably, the questionnaire’s sensitivity to change was implied in Study IV, and 
these results line up with one previous study evaluating ACT for children and adolescents 
in which the questionnaire was also used as an outcome measure (Wicksell, Olsson, and 
Hayes, 2011). 
Apart from early strides (Hayes, Nelson, and Jarrett, 1987), psychometrics have not 
been thoroughly discussed from a contextual viewpoint. However, as presented earlier, 
the CBS-approach to truth is pragmatic and in accord with this assumption it has been 
suggested that self-report questionnaires should display treatment or research utility, 
above and beyond other properties (Hayes, Barnes-Holmes, and Wilson, 2012). 
Treatment utility refers to the measures ability to guide clinical work. For example, it 
should assess outcomes (e.g. pain interference) relevant to central treatment targets (e.g. 
experiential avoidance), and thus also show a relation to these processes, in such way that 
for instance “dosages” can be adjusted and potentially improve outcomes. Similarly, the 
questionnaire’s ability to model change in regard to specific research aims is referred to as 
its research utility (Hayes, Barnes-Holmes, and Wilson, 2012). 
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6.2.1 Future directions 
Hayes, Barnes-Holmes, and Wilson (2012) mean that questionnaire development ought to 
be done in parallel with a more articulated contextual assessment theory and related 
methods. Experience sampling (Bolger, Davis, and Rafaeli, 2003) may be of relevance in 
this regard. This method entails assessment of individuals on several occasions over the 
course of a day, via e.g. a smart phone, in regard to cognitions, emotions, behaviors and 
the context in which they occur. As regards ACT, assessments related to experiential 
avoidance, valued living, pain interference etc. (i.e. outcome and process variables) 
appear specifically relevant. In addition, actigraphy data or frequent sampling of 
biological data appears highly relevant to gather in conjunction with self-reported data. 
6.3 STUDY I AND STUDY IV 
Kazdin (2007) means that inferences and conclusions about mediators demand 
consolidation of several criteria and below I will discuss the results from the mediation 
analyses in relation to: (1) the strength of the relation between treatment and the 
mediator and the mediator and the outcome; (2) the specificity of the proposed mediator 
in relation to other potential mediators; (3) the experimental manipulation of the 
mediator and the timeline between mediator and outcome; and (4) the consistency of the 
mediator across studies and its coherence in relation to the broader scientific field. 
6.3.1 Strong associations between treatment, mediator and outcome  
A strong relation between the intervention (x) and the hypothesized mediator of change 
(m), and an association between the putative mediator (m) and the therapeutic outcome 
(y) is important in building a case for the mediating functions of a variable (Kazdin, 
2007). These requirements also assume an effect of the intervention on the outcome. 
Study I and Study II illustrated that ACT had significant moderate effects on the 
primary outcome, pain disability during treatment in comparison to the control 
conditions. Likewise, results from Study IV showed that ACT had a significant moderate 
effect on pain interference. 
In regard to the effect of treatment on the mediator, the between-group effect-size 
in Study I was large at post-treatment assessment and moderate at three-month follow-
up on psychological inflexibility. In Study II there was a large between-group effect on 
pain acceptance in favor of ACT at post-treatment assessment, an effect that was 
maintained at 6-month follow-up. In Study IV both the within group and the between-
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group effect sizes were large on psychological inflexibility in favor of ACT at post-
treatment assessment. 
As regards the mediator to outcome relationship, results from Study I illustrated a 
significant moderate relation between the mediator and pain disability and Study II 
indicated a significant relationship between psychological inflexibility and pain 
interference in ACT. In Study I results illustrated the mediating role of psychological 
inflexibility for pain disability, but also for a number of secondary outcomes (FM 
impact, self-efficacy, depression and anxiety). The results from the mediation analyses in 
Study IV suggest that reductions in pain interference were mediated by improvements in 
psychological inflexibility, but not by changes in catastrophizing or pain intensity. In 
addition, the results indicated that changes in psychological inflexibility preceded changes 
in pain interference. 
In Study IV change processes in AR were also explored. The anticipation was that 
relaxation would constitute a trained skill, an alternative behavior to previously used 
avoidance strategies that participants could apply in relation to distressing antecedents. 
For example, thinking dominated by thoughts related to catastrophizing (e.g. “I can’t 
handle this pain!”). Results from a study by Smeets et al. (2006) in which catastrophizing 
mediated changes in disability during physical therapy (i.e. an intervention that did not 
include explicit procedures to alter cognitions), indicated the possibility of similar effects 
following AR. However, no such mediating effect was seen in Study IV. AR did not have 
a significant effect on the process or the outcome variable, and most likely this was a 
direct consequence of low power. Thus, the processes of change in AR for chronic pain 
remain unclear and future studies should further explore these aspects, as results from 
both Study II and other previous studies (e.g. Gustavsson and von Koch, 2006) indicates 
the utility of this treatment approach for longstanding pain. 
6.3.2 Specificity of the mediator 
If the specificity of the proposed mediator can be shown in relation to several other 
plausible mediators, the argument for its mediating functions have been substantially 
strengthened (Kazdin, 2007). Study IV included two additional putative mediators, 
catastrophizing and pain intensity. However, these variables were not found to mediate 
change in pain interference and, given that psychological inflexibility exclusively 
mediated change in ACT, these results imply the specificity of this variable in Study IV. 
These results also correspond with results from previous mediation analyses in two RCTs 
  62 
in which we tested the specificity of psychological inflexibility and related constructs as 
mediators in ACT for whiplash-associated disorder (Wicksell, Olsson, and Hayes, 2010), 
and ACT for pediatric non-specific pain (Wicksell, Olsson, and Hayes, 2011). In these 
studies, results showed that changes, specifically in psychological inflexibility and its 
related constructs, compared to several other putative mediators, e.g. pain intensity and 
catastrophizing, mediated changes in pain interference, pain disability and quality of life 
in the ACT-conditions. 
However, findings from other studies illustrate that variables that are typically 
targeted in ACT also appear to mediate changes in outcome in other types of treatments. 
This implies that these treatments may be functionally similar, or that certain processes of 
change are not specific to any one treatment (Arch et al., 2012). Furthermore, processes 
that are not explicitly proposed as processes of change in ACT have been shown to 
mediate outcomes in ACT (Wetherell et al., 2011). Experimental studies that aim to 
provide support for one specific mediator while ruling out several other mediators ought 
to have utility in investigations of specificity. Also, experiments that assign participants to 
different levels of a specific mediator with the aim to show a dose-response relation, i.e. 
that greater provocation of the mediator is linked to larger change in the outcome, would 
be highly useful (Kazdin, 2007; MacKinnon and Luecken, 2008). On a related note, it 
appears highly relevant to investigate how combinations of components affect their 
function (Levin, et al., 2012), for example by systematically comparing combinations of 
components (e.g. defusion and values) with isolated components (e.g. defusion). 
6.3.3 Manipulation of the mediator and establishment of its timeline 
Adequate experimental control and direct manipulation demonstrates cause and reinforces 
the possibility of the suggested mediator being responsible for change in the outcome 
variable (Kazdin, 2007). Pearl (2009, p. 100) states that: “Every claim invoking causal 
concepts must rely on some premises that invoke such concepts […].” Randomization of 
participants to different interventions is such a premise on which we can build causal 
claims of those interventions. The mediation analyses performed in the present thesis 
(Study I and Study IV) were done based on data from RCTs, which provides support to 
causal claims (of the kind presented by Pearl above) of how the intervention influences 
the mediator and the outcome. However, it should be noted that the relation between the 
mediator (m) and the outcome (y), controlling for the treatment condition (x), reflects a 
correlation and not a causal relation (MacKinnon, Fairchild, and Fritz, 2007). This 
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association is a not a result of randomization, i.e., individuals have not been randomized 
to different levels of the mediator. One way to address causality is to provide support of 
the temporal precedence of the mediator in relation to the outcome, i.e. assessment of the 
proposed mediator needs to be done before the outcome. Furthermore, it needs to be 
shown that the mediator actually changes before the outcome (Kazdin, 2007). This was 
the approach taken in Study IV. However, the design and analyses used in Study IV is 
still an oversimplification of how treatment influences trajectories of change across 
variables and individuals. For example, most likely, individuals change at different rates 
in both psychological inflexibility and pain interference during treatment and more 
sophisticated growth models may better address temporality between variables over time 
(e.g. Ljotsson et al., 2013). 
Importantly, from the perspective of the philosophical assumptions of CBS the 
analysis of mechanisms is not done in order to find out how the world “really” works. 
Rather the explicit goal of evaluating mechanisms and processes of change is done in line 
with the other stated aims of prediction and influence. In other words, it is the utility of a 
mechanism, or process, in relation to a specific outcome of interest within a specific 
context that is a gauge of its “truth”. This shifts the focus to investigations of the specific 
circumstances under which a particular strategy works. For example, possibly ACT for 
longstanding pain has stronger effects on persons scoring high on experiential 
avoidance and fusion prior to initiating treatment, in such a way that the mediated effect 
is dependent on baseline levels of the mediator (MacKinnon, Fairchild, and Fritz, 2007).  
While being aware of the potential drawback in regard to external validity, Kazdin 
(2007, p. 20) wrote: “Controlled studies of therapy in research rather than clinical settings 
are more important now than ever before. The careful control afforded by such research is 
precisely what is needed to identify mediators and mechanisms.” Thus, experimental 
studies may facilitate precise manipulation of the mechanisms under investigation and 
careful study of the precedence of the mechanism in relation to the outcome. Also, these 
studies can be done within the population of interest, e.g. specific subgroups of person 
suffering from chronic pain (which in part would address the issue of validity). Likely, 
well-controlled experiments may also serve as an arena to investigate mechanisms of 
change in regard to multiple levels of analysis e.g. both on an observable overt behavioral 
level and in relation to biological levels of analysis. Potentially, single-case studies using 
experimental designs, e.g. multiple baseline studies (Heyvaert and Onghena, 2014), could 
also be of benefit in relation to the exploration of processes of change in clinical settings, 
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and serve as a source of further hypotheses generation. These studies could explore a 
number of questions related to processes of change, e.g. specificity, manipulation and 
timeline, and could also employ varying methods of assessment (e.g. experience 
sampling). 
6.3.4 Coherence of the mediator within a broader scientific context 
Importantly, identification of a process of change in a psychological treatment model is 
not achieved based on the results from a few clinical trials. Rather, it is achieved as results 
from multiple lines of work within the broader scientific community in question 
converges in a coherent manner (Kazdin, 2007). Behavioral inflexibility, characterized by 
experiential avoidance and narrow and rigid behavioral repertoires may, with some 
qualification, live up to these criteria of convergence and coherence. 
Previous research, also without explicit CBS-affiliations, in the area of pain using 
various methodological approaches supports this notion (Hann and McCracken, 2014; 
Kohl, Rief, and Glombiewski, 2012; Levin et al., 2012). Furthermore, results in the 
current thesis converge with results of ACT for related health-issues, for example tinnitus 
(e.g. Hesser, Westin, and Andersson, 2014), as well as with more general trends within 
CBT, as exemplified by the refined views of exposure and the growing utilization of 
acceptance-based interventions (Arch and Craske, 2008; Craske et al., 2008; Veehof et al., 
2011). 
Furthermore, other developments within CBT, including the focus on trans-
diagnostic approaches, unified protocols (Barlow, Allen, and Choate, 2004; Linton, 2013) 
and the suggested relevance of context sensitivity (Linton, 2013) appear to mesh nicely 
with the theoretically and functionally based transdiagnostic approach outlined in the 
current thesis project. Ideally, further discussions should be initiated across specific 
treatment traditions on how to move the field forward in regard to the processes that 
appear central for achieving change in behavioral treatments for longstanding pain. 
Before I move on to a brief discussion of the role of theory in regard to clinical practice I 
will address some methodological considerations. 
6.4 METHODOLOGICAL CONSIDERATIONS 
6.4.1 Limitations 
Reliable treatment credibility data would have provided an opportunity to analyze the 
participants’ perception of treatments, and the potential relation between these perceptions 
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and session attendance, attrition rates and treatment outcome. The sample sizes in the 
outcome studies were small, which may have influenced the stability of parameter esti-
mates and associated standard errors, which suggests that comparisons between 
treatments, including the results pertaining to indirect effects should be interpreted 
cautiously. 
However, the statistical models used to evaluate outcome (Study I and Study II) and 
mediation (Study IV) has several advantages over more commonly used methods. For 
example, it has been shown that latent growth modeling has outperformed traditional 
repeated measures ANOVA in small to moderate sample sizes in terms of statistical 
power in all examined situations (Fan, 2003). Also, these models often provide more 
reliable estimates of treatment effects in the presence of missing data (Lane, 2008). 
Furthermore, we did not calculate an effect-size of the indirect effect, proportion 
mediated or other potential gauges of the mediated effect, which would have enhanced the 
interpretation and discussion of the findings. Notably, in regard to the analyses in Study 
IV the calculations are complicated by the fact that the indirect effect is a product of two 
regression coefficients, and it has been shown that a sample size of n > 500 is required to 
get reliable specific effect size measures for the ab-product (e.g., proportion mediated) 
(MacKinnon and Luecken, 2008). However, as mentioned earlier we did perform effect-
size calculations of significant changes in the mediators over time in ACT. 
All analyses in the current thesis were based on self-reported data. In regard to the 
treatment evaluations, changes of self-report can be a result of the participant’s 
expectations of the particular treatment, and furthermore the covariance between 
measures (e.g. process and outcome measures) may be explained by shared method 
variance. Although these limitations apply to most clinical and psychometric evaluations 
within CBT and ACT, alternative ways of obtaining data in clinical settings (as discussed 
previously) should be explored (Hesser et al., 2009). 
6.4.2 Strengths 
Both Study I and Study II comprised RCTs, which supports the causal relation between 
intervention and the mediators and outcomes. In relation to this, Study II is one of few 
that has compared ACT for longstanding pain with an established behavioral intervention, 
and that has evaluated the cost-effectiveness of these interventions. Furthermore, both 
treatment studies were assessed in regard to treatment fidelity, protocol adherence and 
therapist competence, which to our knowledge has not been done as of yet in studies on 
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ACT for longstanding pain. Furthermore, assessment of treatment in this way is critical to 
ascertain that the proposed processes were in actuality adequately targeted. Finally, in 
Study IV session-to-session data and an appropriate data analytic model was used. This 
enabled an evaluation of the temporal precedence of the mediator in relation to the 
outcome and allowed examination of individual differences in change over time in both 
process and outcome variables. In contrast to studies with pre- and post assessments, this 
approach allowed for a more adequate analyses of mediation (Kazdin and Nock, 2003). 
6.5 CLINICAL ASPECTS 
As discussed above, the results from the outcome and mediation analyses converge with 
results from previous research of ACT (Hann and McCracken, 2014; Levin et al., 2012), 
as well as with more general trends within CBT (Barlow, Allen, and Choate, 2004; 
Craske et al., 2008; Linton, 2013; Veehof et al., 2011). Thus, it appears highly relevant to 
clinically target experiential avoidance and aim at increasing behavioral flexibility. 
The treatments evaluated in the current thesis were delivered by means of protocols 
specifying in fair detail what was to be done during and across sessions. Following 
detailed procedural protocols of this sort is useful under a number of circumstances 
(Waller, 2009). However, as indicated by the moderate effect sizes and limited number of 
participants achieving clinical significant change in the studies in this thesis, as well as 
across studies in CBT and ACT, a number of patients do not improve following treatment 
as delivered using these types of protocols. As has been stressed repeatedly, in the 
background and in the discussion, studies that more thoroughly investigate mediation and 
moderation are highly relevant in this regard. 
In relation to this, potentially, patients may under some circumstances benefit from 
more tailored interventions based on individual conceptualizations and adapted appli-
cations of empirically supported treatment components. In this regard, it has been 
recommended that clinicians should cultivate better working knowledge of the 
theoretical base of CBT, in order to better conceptualize and intervene in relation to 
patients with for example multiple debilitating symptoms and problems (Herbert, 
Gaudiano, and Forman, 2013; McKay, Taylor, and Abramowitz, 2010). This requires a 
choice of an adequate theory, but also a determination of what level of theory that is 
adequate, and with which fluency clinicians should be able to apply this theory. 
Reasonably, the theory should rest on a fairly solid empirical base. A review by 
Dymond et al. (2010) reported a total of 62 empirical and 112 non-empirical publications 
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on RFT from 1991 to 2008. The empirical articles showed overall support of the basic 
tenets of the theory. In the service of precision (and scope and depth) RFT may be found 
lacking in direct accessibility. The ACT-model comprises an effort to link RFT 
terminology with more accessible and applicable mid-level terms, like “fusion”, “values” 
etc. (Hayes, Barnes-Holmes, and Wilson, 2012). Notably, recent efforts have been made 
to yet more directly connect RFT to clinical practice, from a broader cognitive behavioral 
perspective (e.g. Törneke, 2010; Villatte, Villatte, and Hayes, In press). 
Potentially, a more detailed grasp and fluency of a theoretical model, for example 
RFT, may be important in tailoring interventions (Foody et al., 2014), specifically for 
certain sub-groups of patients. Possibly, tailoring treatments in this way could also 
increase the effects of behavioral interventions for chronic pain. Herbert, Gaudiano, and 
Forman (2013) argue this case and conclude that the best way to resolve questions of the 
above sort is through research. For example, they suggest RCTs in which practicing 
clinicians could be randomized to limited theoretically based training and supervision or 
to a condition focused on building theoretical based skills. In addition, evaluations of 
processes of change and cost-benefit analyses could readily be included also in these 
types of studies (Herbert, Gaudiano, and Forman, 2013, p. 587). 
6.6 MAIN CONCLUSIONS 
Results indicate the utility of using a relatively brief ACT intervention in a group format 
for persons suffering from FM and non-specific longstanding pain. Primarily, significant 
effects were seen in disability during treatment. Furthermore, ACT may have utility in 
reducing costs and being a cost-effective treatment. In Study III results indicated that the 
PII is a reliable and valid measure to assess pain interference in adults, and its sensitivity 
to change and utility in evaluations of processes of change was indicated in Study IV. 
Results also suggest the mediating function of psychological inflexibility in regard 
to pain disability and pain interference. Results from Study IV further illustrate the 
mediating function of psychological inflexibility in relation to pain interference in ACT, 
compared to catastrophizing and pain intensity, based on a model in which change over 
time was modeled using session-to-session data to examine temporal relations between 
mediator and outcome. In sum, results add to the growing body of work indicating the 
clinical utility of ACT, and further suggest the role of psychological inflexibility as an 
important treatment target in longstanding pain. 
  68 
7 APPENDIX (TABLE 1) 
1. Dahl, J., Wilson, K. G., & Nilsson, A. (2004). Acceptance and Commitment Therapy 
and the Treatment of Persons at Risk for Long-Term Disability Resulting From 
Stress and Pain Symptoms: A Preliminary Randomized Trial. Behavior Therapy, 
35, 785. 
2. McCracken, L. M., Vowles, K. E., & Eccleston, C. (2005). Acceptance-based treatment 
for persons with complex, long standing chronic pain: a preliminary analysis of 
treatment outcome in comparison to a waiting phase. Behaviour Research and 
Therapy, 43, 1335. 
3. Wicksell, R. K., Dahl, J., Magnusson, B., & Olsson, G. L. (2005). Using acceptance 
and commitment therapy in the rehabilitation of an adolescent female with 
chronic pain: A case example. Cognitive and Behavioral Practice, 12, 415. 
4. McCracken, L. M., MacKichan, F., & Eccleston, C. (2007). Contextual cognitive-
behavioral therapy for severely disabled chronic pain sufferers: effectiveness and 
clinically significant change. European Journal of Pain, 11, 314. 
5. Vowles, K. E., McCracken, L. M., & Eccleston, C. (2007). Processes of change in 
treatment for chronic pain: the contributions of pain, acceptance, and 
catastrophizing. European Journal of Pain, 11, 779. 
6. Wicksell, R. K., Melin, L., & Olsson, G. L. (2007). Exposure and acceptance in the 
rehabilitation of adolescents with idiopathic chronic pain - A pilot study. European 
Journal of Pain, 11, 267. 
7. Vowles, K. E., & McCracken, L. M. (2008). Acceptance and values-based action in 
chronic pain: A study of treatment effectiveness and process. Journal of 
Consulting and Clinical Psychology, 76, 397. 
8. Wicksell, R. K., Ahlqvist, J., Bring, A., Melin, L., & Olsson, L. (2008). Can exposure 
and acceptance strategies improve functioning and life satisfaction in people with 
chronic pain and whiplash-associated disorders (WAD)? A randomized controlled 
trial. Cognitive Behaviour Therapy, 37, 1. 
9. Lunde, L-H, & Nordhus, I. H. (2009). Combining acceptance and commitment therapy 
and cognitive behavioral therapy for the treatment of chronic pain in older adults. 
Clinical Case Studies, 8, 296 
10. Vowles, K. E., Wetherell, J. L., & Sorrell, J. T. (2009). Targeting acceptance, 
mindfulness, and values-based action in chronic pain: Findings of two preliminary 
trials of an outpatient group-based intervention. Cognitive and Behavioral 
Practice, 16, 49. 
11. Wicksell, R. K., Melin, L., Lekander, M., & Olsson, G. L. (2009). Evaluating the 
effectiveness of exposure and acceptance strategies to improve functioning and 
quality of life in longstanding pediatric pain--a randomized controlled trial. Pain, 
141, 248. 
12. Johnston, M., Foster, M, Shennan, J., Starkey, N. J., & Johnson, A. (2010). The 
effectiveness of an acceptance and commitment therapy self-help intervention for 
chronic pain. The Clinical Journal of Pain, 26, 393. 
13. Vowles, K. E., & McCracken, L. M. (2010). Comparing the role of psychological 
flexibility and traditional pain management coping strategies in chronic pain 
treatment outcomes. Behaviour Research and Therapy, 48, 141. 
14. Wicksell, R. K., Olsson, G. L., & Hayes, S. C. (2010). Psychological flexibility as a 
mediator of improvement in Acceptance and Commitment Therapy for patients 
with chronic pain following whiplash. European Journal of Pain, 14, e1. 
15. Carbonell-Baeza, A., Aparicio, V. A., Chillon, P., Femia, P., Delgado-Fernandez, M., 
& Ruiz, J. R. (2011). Effectiveness of multidisciplinary therapy on 
symptomatology and quality of life in women with fibromyalgia. Clinical and 
Experimental Rheumatology, 29, 97. 
  69 
16. Ilgen, M. A., Haas, E., Czyz, E., Webster, L., Sorrell, J. T., & Chermack, S. (2011). 
Treating Chronic Pain in Veterans Presenting to an Addictions Treatment 
Program. Cognitive and Behavioral Practice, 18, 149. 
17. Masuda, A., Cohen, L. L., Wicksell, R. K., Kemani, M. K., & Johnson, A. (2011). A 
case study: Acceptance and Commitment Therapy for pediatric sickle cell 
disease. Journal of Pediatric Psychology, 36, 398. 
18. McCracken, L. M., & Gutierrez-Martinez, O. (2011). Processes of change in 
psychological flexibility in an interdisciplinary group-based treatment for chronic 
pain based on acceptance and commitment therapy. Behaviour Research and 
Therapy, 49, 267. 
19. Thorsell, J., Finnes, A., Dahl, J., Lundgren, T., Gybrant, M., Gordh, T., & Buhrman, 
M. (2011). A comparative study of 2 manual-based self-help interventions, 
acceptance and commitment therapy and applied relaxation, for persons with 
chronic pain. The Clinical Journal of Pain, 27, 716. 
20. Vowles, K. E., McCracken, L. M., & O'Brien, J Zhao. (2011). Acceptance and values-
based action in chronic pain: A three-year follow-up analysis of treatment 
effectiveness and process. Behaviour Research and Therapy, 49, 748. 
21. Wetherell, J. L., Afari, N., Rutledge, T., Sorrell, J. T., Stoddard, J. A., Petkus, A. J., . . 
. Atkinson, J. (2011). A randomized, controlled trial of acceptance and 
commitment therapy and cognitive-behavioral therapy for chronic pain. Pain, 152, 
2098. 
22. Wicksell, R. K., Olsson, G. L., & Hayes, S. C. (2011). Mediators of change in 
Acceptance and Commitment Therapy for pediatric chronic pain. Pain, 152, 2792. 
23. Dindo, L., Recober, A., Marchman, J. N., Turvey, C., & O'Hara, M. W. (2012). One-
day behavioral treatment for patients with comorbid depression and migraine: a 
pilot study. Behaviour Research and Therapy, 50, 537. 
24. Huggins, J. L., Bonn-Miller, M. O., Oser, M. L., Sorrell, J. T., & Trafton, J. A. (2012). 
Pain anxiety, acceptance, and outcomes among individuals with HIV and chronic 
pain: a preliminary investigation. Behaviour Research and Therapy, 50, 72. 
25. Jensen, K. B., Kosek, E., Wicksell, R., Kemani, M., Olsson, G., Merle, J. V., . . . 
Ingvar, M. (2012). Cognitive Behavioral Therapy increases pain-evoked activation 
of the prefrontal cortex in patients with fibromyalgia. Pain, 153, 1495. 
26. McCracken, L. M., & Jones, R. (2012). Treatment for chronic pain for adults in the 
seventh and eighth decades of life: a preliminary study of Acceptance and 
Commitment Therapy (ACT). Pain Med, 13, 860. 
27. Mo'tamedi, H., Rezaiemaram, P., & Tavallaie, A. (2012). The effectiveness of a 
group-based acceptance and commitment additive therapy on rehabilitation of 
female outpatients with chronic headache: preliminary findings reducing 3 
dimensions of headache impact. Headache, 52, 1106. 
28. Wicksell, R. K., Kemani, M., Jensen, K., Kosek, E., Kadetoff, D., Sorjonen, K., . . . 
Olsson, G. L. (2012). Acceptance and commitment therapy for fibromyalgia: A 
randomized controlled trial. European Journal of Pain. 
29. Alonso, M. A., Lopez, A., Losada, A., & Gonzalez, J. L. (2013). Acceptance and 
Commitment Therapy and Selective Optimization with Compensation for Older 
People with Chronic Pain: A Pilot Study. Behavioral Psychology-Psicologia 
Conductual, 21, 59. 
30. Baranoff, J., Hanrahan, S., Kapur, D., & Connor, J. (2013). Acceptance as a process 
variable in relation to catastrophizing in multidisciplinary pain treatment. 
European Journal of Pain, 17, 101. 
31. Buhrman, M., Skoglund, A., Husell, J., Bergstrom, K., Gordh, T., Hursti, T., . . . 
Andersson, G. (2013). Guided internet-delivered acceptance and commitment 
therapy for chronic pain patients: a randomized controlled trial. Behaviour 
Research & Therapy, 51, 307. 
  70 
32. Elander, J., Morris, J., & Robinson, G. (2013). Pain coping and acceptance as 
longitudinal predictors of health-related quality of life among people with 
haemophilia-related joint pain. European Journal of Pain, 17, 929. 
33. Gauntlett-Gilbert, J., Connell, H., Clinch, J., & McCracken, L. M. (2013). Acceptance 
and values-based treatment of adolescents with chronic pain: outcomes and their 
relationship to acceptance. Journal of Pediatric Psychology, 38, 72. 
34. McCracken, L. M., Sato, A., & Taylor, G. J. (2013). A trial of a brief group-based form 
of acceptance and commitment therapy (ACT) for chronic pain in general 
practice: Pilot outcome and process results. Journal of pain, 14(11), 1398.  
35. Steiner, J. L, Bogusch, L., & Bigatti, S. M. (2013). Values-based action in 
fibromyalgia: results from a randomized pilot of acceptance and commitment 
therapy. Health Psychology Research, 1. 
36. Vriezekolk, J. E., Eijsbouts, A. M., van Lankveld, W. G., Beenackers, H., Geenen, R., 
& van den Ende, C. H. (2013). An acceptance-oriented cognitive-behavioral 
therapy in multimodal rehabilitation: a pre-post test evaluation in highly distressed 
patients with rheumatic diseases. Patient Educ Couns, 91, 357. 
37. Baranoff, J., Hanrahan, S. J., Kapur, D., & Connor, J. P. (2014). Six month post-
treatment deterioration in acceptance (CPAQ-8) and cognitions following 
multidisciplinary pain treatment. Journal of Behavioral Medicine, 37, 469. 
38. Ljotsson, B., Atterlof, E., Lagerlof, M., Andersson, E., Jernelov, S., Hedman, E., . . . 
Wicksell, R. K. (2014). Internet-delivered acceptance and values-based exposure 
treatment for fibromyalgia: A pilot study. Cognitive Behaviour Therapy, 43, 93. 
39. Luciano, J. V., Guallar, J. A., Aguado, J., Lopez-Del-Hoyo, Y., Olivan, B., Magallon, 
R., . . . Garcia-Campayo, J. (2014). Effectiveness of group acceptance and 
commitment therapy for fibromyalgia: A 6-month randomized controlled trial 
(EFFIGACT study). Pain, 155(4), 693. 
40. Vowles, K. E., Witkiewitz, K., Sowden, G,, & Ashworth, J.. (2014). Acceptance and 
Commitment Therapy for Chronic Pain: Evidence of Mediation and Clinically 
Significant Change Following an Abbreviated Interdisciplinary Program of 
Rehabilitation. The Journal of Pain, 1, 101. 
41. Trompetter, H. R., Bohlmeijer, E. T., Veehof, M. M., & Schreurs, K. M. (2014). 
Internet-based guided self-help intervention for chronic pain based on 
Acceptance and Commitment Therapy: A randomized controlled trial. Journal of 
Behavioral Medicine, 38, 66. 
 
  71 
8 ACKNOWLEDGEMENTS IN SWEDISH 
Tack Jonas Ramnerö för stringenta och intressanta inlärningsteoretiska föreläsningar på 
psykologprogrammet. Tack Håkan Wisung för pragmatiska tillämpningar av dessa teorier 
i det kliniska momentet. Ni hade en avgörande roll i att väcka mitt intresse för 
inlärningsteori, ACT och RFT. Tack Sandra Bates och Niklas Törneke, för att ni till-
gängliggör inlärningsteori på bred front och för er skarpa tillämpning av dessa principer i 
den kliniska handledningen som löpt parallellt med avhandlingsprojektet. 
Rikard, min nära vän, kollega och huvudhandledare – tack för ditt ihållande, 
närvarande, genomgripande och generösa engagemang under hela avhandlingsarbetet, 
från doktorandplansutkast till disputationsfest. Tack för alla samtal och diskussioner 
under åren, kring inlärningsteori, ACT, psykologisk behandling i stort, nya studier, nya 
samarbeten och projekt, men också för samtal som rört jobbet och livet, i det lilla och i det 
stora. Jag hoppas att du fattar hur mycket jag uppskattar detta Rikard! Tack! 
Tack Gunnar L. Olsson för att du på en mängd sätt möjliggjort detta avhandlings-
arbete i din roll som bihandledare – särskilt i perioder då förutsättningarna inte har varit 
de bästa. Det har varit inspirerande och lärorikt att ta del av din visionära blick, din aptit 
på nya projekt (både på jobbet och privat) och dina enträgna ansträngningar att etablera en 
beteendemedicinsk enhet vid Karolinska Universitetssjukhuset. Tack Mats Lekander för 
att du gick in som bihandledare i projektet och utifrån din gedigna akademiska erfarenhet 
bistått med både vägledande styrning och precisa synpunkter och råd, speciellt i kritiska 
perioder av avhandlingsarbetet. Tack också för att du bidragit med ett neurovetenskapligt 
och psykoneuroimmunologiskt perspektiv på smärta och psykologisk behandling!  
Stort tack Hugo Hesser för att du valde att samarbeta med oss kring de statistiska 
analyserna i studie II och studie IV! Jag uppskattar storligen din tillgänglighet och ditt 
engagemang då jag har tagit mig ned till Linköping med aspirationer att få bättre grepp 
om LGM och HLM, men också då du återkommande via telefon och mejl funnits till 
hands då jag fastnat med analyser, brottats med kniviga synpunkter från reviewers o.s.v. 
Och, vet du vad, jag tror faktiskt jag har bättre förutsättningar nu än någonsin tidigare att 
få grepp om den här statistiken, kanske. Tack Erik Andersson, för att du generöst tog dig 
tid att ge mig förutsättningar att ta mig an, och göra någonting med, den initialt för mig 
obegripliga hög av hälsoekonomiska data som studie II resulterade i. 
Tack Marie Kanstrup för din insats med att bedöma patienter i uppstarten av studie 
II och för en gediget avslappnad behandlingsinsats i denna studie. Tack också för grym 
  72 
återkoppling på bakgrunden i kappan! Tack för alla under åren givande samtal och 
samarbeten kring behandling, ACT och forskning, och för pepp när det har känts trögt! 
Stort tack Linda Holmström, för att du konkret och klarsynt bidragit med din kompetens 
och tid i olika perioder av projektet. Tack för viktig feedback på manuset till studie III och 
för konstruktiva synpunkter som hjälpte mig få styr på kappan. 
Tack, Ingrid Olsson och Milka Dynevik för hjälp med logistiken i början av studie 
II. Tack Maria Gustavsson och Marie-Louise Henning Ottergård för era värdefulla 
behandlingsinsatser i studie II. Tack Valeria Benvestito Mattsson och Rebecca Ringström 
för er hjälp med analyserna av videomaterialet i studie I och II. Tack Camilla Wiwe 
Lipsker, Björn Liliequist, Johan Bogefeldt och Vendela Zetterqvist för era insatser i olika 
delar av projektet! Tack alla härliga vänner och kollegor på beteendemedicinsk 
smärtbehandling, för fin feedback på ett tidigt manusutkast till studie II, för givande 
korridorsnack och lunch-häng, för praktisk hjälp, pepp, goda råd och glada tillrop i 
slutfasen av denna avhandling. Tack Huddingegänget och alla medarbetare på 
Smärtcentrum! 
Tack Bo Melin, Bob Harris, Marianne Youssefi och Eva Holmgaard på Karolinska 
Institutet som på ett flertal sätt möjliggjort detta projekt. Tack Agnetha Julinder och Peter 
Eriksson på Psykologkliniken vid Karolinska Universitetssjukhuset som också bidragit till 
att möjliggöra avhandlingsarbetet. Tack alla vänner som på avstånd följt projektet! Stort 
tack till alla de personer som deltagit i studierna!  
Tack mamma och pappa för att ni gav mig stabila förutsättningar att utforska 
världen. Tack mamma för din ihållande närvaro, ditt engagemang, din raka kommu-
nikation, din generositet – och din omtanke. Tack Mia, Martin och Erika för att ni är 
delaktiga i våra liv och för att ni finns där, i alla livets skeenden. 
Tack älskade Aliisa! Genom allt – från KTH-studier, till gemensam lägenhet, till 
Komvux, till sjuksköterskeutbildning, till nattskift och testutveckling på Ericsson, till 
färdig sjuksköterska, till psykologutbildning, till hus, till Chloe, till färdig psykolog, till 
Leah, till doktorand- och magisterstudier, och allt däremellan – till idag. Jag är så tacksam 
för att vi har fixat den här sista intensiva perioden med inte mer än skrubbsår. Fortsätt 
vara i mitt liv! Tack Leah för att du finns i mitt liv, för att jag får uppleva din fart genom 
dagen och dina synpunkter på världen – pappa är klar med boken nu. Tack Chloe, för att 
du finns i mitt liv och för att du låter mig ta del av din vardag och det som är viktigt för 
dig. Jag har skrivit intensivt under en period och jag har saknat att vara med dig. Nu är jag 
klar. Dags för häng! 
  73 
9 REFERENCES Abramowitz,	  J.	  S.,	  Baucom,	  D.	  H.,	  Wheaton,	  M.	  G.,	  Boeding,	  S.,	  Fabricant,	  L.	  E.,	  Paprocki,	  C.,	  &	  Fischer,	   M.	   S.	   (2013).	   Enhancing	   exposure	   and	   response	   prevention	   for	   OCD:	   a	  couple-­‐based	  approach.	  Behav	  Modif,	  189-­‐210.	  Abramowitz,	   J.	   S.,	   Tolin,	   D.	   F.,	   &	   Street,	   G.	   P.	   (2001).	   Paradoxical	   effects	   of	   thought	  suppression:	  a	  meta-­‐analysis	  of	  controlled	  studies.	  Clin	  Psychol	  Rev,	  683-­‐703.	  Arch,	  J.	  J.,	  Wolitzky-­‐Taylor,	  K.	  B.,	  Eifert,	  G.	  H.,	  &	  Craske,	  M.	  G.	  (2012).	  Longitudinal	  treatment	  mediation	   of	   traditional	   cognitive	   behavioral	   therapy	   and	   acceptance	   and	  commitment	  therapy	  for	  anxiety	  disorders.	  Behav	  Res	  Ther,	  469-­‐478.	  Arch,	   J.	   J.,	   &	   Craske,	   M.	   G.	   (2008).	   Acceptance	   and	   Commitment	   Therapy	   and	   Cognitive	  Behavioral	   Therapy	   for	   Anxiety	   Disorders:	   Different	   Treatments,	   Similar	  Mechanisms?	  Clinical	  Psychology:	  Science	  and	  Practice,	  263-­‐279.	  Arvidsson,	  S.,	  Arvidsson,	  B.,	  Fridlund,	  B.,	  &	  Bergman,	  S.	  (2008).	  Health	  predicting	  factors	  in	  a	  general	  population	  over	  an	  eight-­‐year	  period	   in	  subjects	  with	  and	  without	  chronic	  musculoskeletal	  pain.	  Health	  Qual	  Life	  Outcomes,	  1-­‐9.	  Banks,	   S.	  M.,	  &	  Kerns,	  R.	  D.	   (1996).	  Explaining	  high	   rates	  of	  depression	   in	   chronic	  pain:	  A	  diathesis-­‐stress	  framework.	  Psychol	  Bull,	  95-­‐110.	  Barlow,	  D.	  H.,	  Allen,	  L.	  B.,	  &	  Choate,	  M.	  L.	  (2004).	  Toward	  a	  Unified	  Treatment	  for	  Emotional	  Disorders.	  Behav	  Ther,	  205-­‐230.	  Beck,	   A.	   T.,	   Ward,	   C.	   H.,	   Mendelson,	   M.,	   Mock,	   J.,	   &	   Erbaugh,	   J.	   (1961).	   An	   inventory	   for	  measuring	  depression.	  Archives	  of	  general	  psychiatry,	  561.	  Beck,	  A.	  T.	  (1979).	  Cognitive	  therapy	  of	  depression.	  New	  York:	  Guilford	  Press.	  Bennett,	   R.	   (2005).	   The	   Fibromyalgia	   Impact	   Questionnaire	   (FIQ):	   a	   review	   of	   its	  development,	   current	   version,	   operating	   characteristics	   and	   uses.	   Clin	   Exp	  
Rheumatol,	  154-­‐162.	  Bergman,	   S.,	   Herrstrom,	   P.,	   Hogstrom,	   K.,	   Petersson,	   I.	   F.,	   Svensson,	   B.,	   &	   Jacobsson,	   L.	   T.	  (2001).	   Chronic	   musculoskeletal	   pain,	   prevalence	   rates,	   and	   sociodemographic	  associations	  in	  a	  Swedish	  population	  study.	  J	  Rheumatol,	  1369-­‐1377.	  Bernardy,	  K.,	  Klose,	  P,	  Busch,	  A.	  J.,	  Choy,	  E.	  H.	  S.,	  &	  Häuser,	  W.	  (2013).	  Cognitive	  behavioural	  therapies	  for	  fibromyalgia.	  Cochrane	  Database	  Syst	  Rev,	  CD009796.	  Bernstein,	  R.	  J.	  (2010).	  The	  Pragmatic	  Turn	  (1	  ed.).	  Malden,	  MA:	  Polity	  Press.	  Biglan,	  A.,	  &	  Hayes,	   S.	   C.	   (1996).	   Should	   the	  behavioral	   sciences	  become	  more	  pragmatic?	  The	   case	   for	   functional	   contextualism	   in	   research	   on	   human	   behavior.	   Appl	   Prev	  
Psychol,	  47-­‐57.	  Blackledge,	   J.	   T.	   (2015).	   Cognitive	   Defusion	   in	   Practice:	   A	   clinician's	   Guide	   to	   Assessing,	  
Observing	  and	  Supporting	  Change	  in	  Your	  Client.	  Oakland,	  CA:	  Context	  Press	  Blackledge,	   J.	   T.,	   Ciarrochi,	   J.,	   &	   Deane,	   F.	   P.	   (2009).	   Acceptance	   and	   commitment	   therapy	  
contemporary	   theory	   research	   and	   practice	   (1st	   ed.).	   Bowen	   Hills,	   Qld:	   Australian	  Academic	  Press.	  Blackledge,	  J.T.,	  &	  Barnes-­‐Holmes,	  D.	  (2009).	  Core	  Processes	  in	  Acceptance	  and	  Commitment	  Therapy.	   In	   J.	   T.	   Blackledge,	   J.	   Ciarrochi	   &	   F.	   P.	   Deane	   (Eds.),	   Acceptance	   and	  
commitment	   therapy	   contemporary	   theory	   research	   and	  practice.	   Bowen	   Hills,	   Qld:	  Australian	  Academic	  Press.	  Boersma,	  K.,	  Linton,	  S.,	  Overmeer,	  T.,	  Jansson,	  M.,	  Vlaeyen,	  J.,	  &	  de	  Jong,	  J.	  (2004).	  Lowering	  fear-­‐avoidance	  and	  enhancing	  function	  through	  exposure	  in	  vivo.	  A	  multiple	  baseline	  study	  across	  six	  patients	  with	  back	  pain.	  Pain,	  8-­‐16.	  Bolger,	  N.,	  Davis,	  A.,	  &	  Rafaeli,	  E.	  (2003).	  Diary	  methods:	  capturing	  life	  as	  it	  is	  lived.	  Annu	  Rev	  
Psychol,	  579-­‐616.	  Bollen,	  K.,	  &	  Curran,	  P.	   (2006).	  Latent	  curve	  models:	  A	  structural	  equation	  perspective.	  New	  Jersey:	  John	  Wiley	  &	  Sons,	  Inc.	  Breivik,	  H.,	   Collett,	  B.,	   Ventafridda,	  V.,	   Cohen,	  R.,	  &	  Gallacher,	  D.	   (2006).	   Survey	  of	   chronic	  pain	  in	  Europe:	  prevalence,	  impact	  on	  daily	  life,	  and	  treatment.	  Eur	  J	  Pain,	  287-­‐333.	  
  74 
Buhrman,	  M.,	   Skoglund,	  A.,	  Husell,	   J.,	  Bergstrom,	  K.,	  Gordh,	  T.,	  Hursti,	  T.,	   .	   .	   .	  Andersson,	  G.	  (2013).	  Guided	  internet-­‐delivered	  acceptance	  and	  commitment	  therapy	  for	  chronic	  pain	  patients:	  a	  randomized	  controlled	  trial.	  Behav	  Res	  Ther,	  307-­‐315.	  Burckhardt,	   C.	   S.,	   Clark,	   S.	   R.,	   &	   Bennett,	   R.	   M.	   (1991).	   The	   fibromyalgia	   impact	  questionnaire:	  development	  and	  validation.	  J	  Rheumatol,	  728-­‐733.	  Campbell-­‐Sills,	  L.,	  Barlow,	  D.	  H.,	  Brown,	  T.	  A.,	  &	  Hofmann,	  S.	  G.	  (2006).	  Effects	  of	  suppression	  and	   acceptance	   on	   emotional	   responses	   of	   individuals	   with	   anxiety	   and	   mood	  disorders.	  Behav	  Res	  Ther,	  1251-­‐1263.	  Chapman,	  A.	  L.,	  Gratz,	  K.	  L.,	  &	  Brown,	  M.	  Z.	  (2006).	  Solving	  the	  puzzle	  of	  deliberate	  self-­‐harm:	  the	  experiential	  avoidance	  model.	  Behav	  Res	  Ther,	  371-­‐394.	  Chawla,	   N.,	   &	   Ostafin,	   B.	   (2007).	   Experiential	   avoidance	   as	   a	   functional	   dimensional	  approach	  to	  psychopathology:	  an	  empirical	  review.	  J	  Clin	  Psychol,	  871-­‐890.	  Cleeland,	  C.	  S.,	  &	  Ryan,	  K.	  M.	  (1994).	  Pain	  assessment:	  global	  use	  of	  the	  Brief	  Pain	  Inventory.	  
Ann	  Acad	  Med	  Singapore,	  129-­‐138.	  Cortina,	  J.	  M.	  (1993).	  What	  Is	  Coefficient	  Alpha?	  An	  Examination	  of	  Theory	  and	  Applications.	  
J	  Appl	  Psychol,	  98-­‐104.	  Craig,	  A.	  D.	  (2003).	  A	  new	  view	  of	  pain	  as	  a	  homeostatic	  emotion.	  Trends	  Neurosci,	  303-­‐307.	  Craske,	   M.	   G.,	   Kircanski,	   K.,	   Zelikowsky,	   M.,	   Mystkowski,	   J.,	   Chowdhury,	   N.,	   &	   Baker,	   A.	  (2008).	  Optimizing	  inhibitory	  learning	  during	  exposure	  therapy.	  Behav	  Res	  Ther,	  5-­‐27.	  Cöster,	  L.,	  Kendall,	   S.,	  Gerdle,	  B.,	  Henriksson,	  C.,	  Henriksson,	  K.	  G.,	  &	  Bengtsson,	  A.	   (2008).	  Chronic	  widespread	  musculoskeletal	  pain	  -­‐	  a	  comparison	  of	  those	  who	  meet	  criteria	  for	  fibromyalgia	  and	  those	  who	  do	  not.	  Eur	  J	  Pain,	  600-­‐610.	  Dahl,	   J.,	   Lundgren,	   T.,	  &	  Plumb,	   J.	   (2009).	  The	  Art	  and	  Science	  of	  Valuing	   in	  Psychotherapy:	  
Helping	  Clients	  Discover,	  Explore,	  and	  Commit	  to	  Valued	  Action	  Using	  Acceptance	  and	  
Commitment	  Therapy.	  Oakland:	  New	  Harbinger	  Publications.	  de	  Jong,	  J.	  R.,	  Vangronsveld,	  K.,	  Peters,	  M.	  L.,	  Goossens,	  M.	  E.,	  Onghena,	  P.,	  Bulte,	  I.,	  &	  Vlaeyen,	  J.	   W.	   (2008).	   Reduction	   of	   pain-­‐related	   fear	   and	   disability	   in	   post-­‐traumatic	   neck	  pain:	  a	  replicated	  single-­‐case	  experimental	  study	  of	  exposure	   in	  vivo.	   J	  Pain,	  1123-­‐1134.	  Demmelmaier,	   I.,	   Lindberg,	  P.,	  Asenlof,	  P.,	  &	  Denison,	  E.	   (2008).	  The	  associations	  between	  pain	   intensity,	   psychosocial	   variables,	   and	   pain	   duration/recurrence	   in	   a	   large	  sample	  of	  persons	  with	  nonspecific	  spinal	  pain.	  Clin	  J	  Pain,	  611-­‐619.	  Denison,	  E.,	  Asenlof,	  P.,	  &	  Lindberg,	  P.	  (2004).	  Self-­‐efficacy,	  fear	  avoidance,	  and	  pain	  intensity	  as	  predictors	  of	  disability	  in	  subacute	  and	  chronic	  musculoskeletal	  pain	  patients	  in	  primary	  health	  care.	  Pain,	  245-­‐252.	  Dougher,	  M.	   J.,	   Hamilton,	   D.	   A.,	   Fink,	   B.	   C.,	   &	  Harrington,	   J.	   (2007).	   Transformation	   of	   the	  discriminative	   and	   eliciting	   functions	   of	   generalized	   relational	   stimuli.	   J	   Exp	   Anal	  
Behav,	  179-­‐197.	  Drummond,	  M.	  F.	  (2005).	  Methods	  for	  the	  economic	  evaluation	  of	  health	  care	  programmes	  (3.	  ed.	  ed.).	  Oxford:	  Oxford	  University	  Press.	  Dworkin,	  R.	  H.,	  Turk,	  D.	  C.,	  Farrar,	   J.	  T.,	  Haythornthwaite,	   J.	  A.,	   Jensen,	  M.	  P.,	  Katz,	  N.	  P.,	   .	   .	   .	  Immpact.	  (2005).	  Core	  outcome	  measures	  for	  chronic	  pain	  clinical	  trials:	  IMMPACT	  recommendations.	  Pain,	  9-­‐19.	  Dymond,	  S.,	  May,	  R.	   J.,	  Munnelly,	  A.,	  &	  Hoon,	  A.	  E.	  (2010).	  Evaluating	  the	  evidence	  base	  for	  relational	  frame	  theory:	  a	  citation	  analysis.	  Behav	  Anal,	  97-­‐117.	  Ehde,	   D.	   M.,	   Dillworth,	   T.	   M.,	   &	   Turner,	   J.	   A.	   (2014).	   Cognitive-­‐behavioral	   therapy	   for	  individuals	  with	  chronic	  pain:	  efficacy,	  innovations,	  and	  directions	  for	  research.	  Am	  
Psychol,	  153-­‐166.	  Fan,	   Xitao.	   (2003).	   Power	   of	   Latent	   Growth	   Modeling	   for	   Detecting	   Group	   Differences	   in	  Linear	   Growth	   Trajectory	   Parameters.	   Structural	   Equation	   Modeling:	   A	  
Multidisciplinary	  Journal,	  380-­‐400.	  Feingold,	  A.	  (2009).	  Effect	  sizes	  for	  growth-­‐modeling	  analysis	  for	  controlled	  clinical	  trials	  in	  the	  same	  metric	  as	  for	  classical	  analysis.	  Psychol	  Methods,	  43-­‐53.	  
  75 
Ferraz-­‐Nunes,	   J.	   (2007).	   Hälsoekonomi:	   begrepp	   och	   tillämpningar	   (1	   uppl.).	   Lund:	  Studentlitteratur.	  Flink,	   I.	   L.,	   Boersma,	   K.,	   &	   Linton,	   S.	   J.	   (2013).	   Pain	   catastrophizing	   as	   repetitive	   negative	  thinking:	  a	  development	  of	  the	  conceptualization.	  Cogn	  Behav	  Ther,	  215-­‐223.	  Foody,	  M.,	  Barnes-­‐Holmes,	  Y.,	  &	  Barnes-­‐Holmes,	  D.	   (2012).	  The	  Role	  of	   self	   in	  Acceptance	  and	  Commitment	  Therapy.	  In	  L.	  McHugh	  &	  I.	  Stewart	  (Eds.),	  The	  Self	  and	  Perspective	  
Taking:	   Theory	   and	   Research	   from	   Contextual	   Behavioral	   Science	   and	   Applied	  
Approaches.	  Oakland,	  CA:	  New	  Harbinger	  Publications.	  Foody,	   M.,	   Barnes-­‐Holmes,	   Y.,	   Barnes-­‐Holmes,	   D.,	   Törneke,	   N.,	   Luciano,	   C.,	   Stewart,	   I.,	   &	  McEnteggart,	  C.	  (2014).	  RFT	  for	  clinical	  use:	  The	  example	  of	  metaphor.	  J	  Contextual	  
Behav	  Sci,	  305-­‐313.	  Fordyce,	  W.	  E.	  (1976).	  Behavioral	  methods	  for	  chronic	  pain	  and	  illness.	  Saint	  Louis:	  Mosby.	  Fries,	   E.,	   Hesse,	   J.,	   Hellhammer,	   J.,	   &	   Hellhammer,	   D.	   H.	   (2005).	   A	   new	   view	   on	  hypocortisolism.	  Psychoneuroendocrinology,	  1010-­‐1016.	  Gaskin,	  D.	   J.,	  &	  Richard,	  P.	   (2012).	  The	  economic	   costs	  of	  pain	   in	   the	  United	  States.	   J	  Pain,	  715-­‐724.	  Glombiewski,	  J.	  A.,	  Sawyer,	  A.	  T.,	  Gutermann,	  J.,	  Koenig,	  K.,	  Rief,	  W.,	  &	  Hofmann,	  S.	  G.	  (2010).	  Psychological	  treatments	  for	  fibromyalgia:	  a	  meta-­‐analysis.	  Pain,	  280-­‐295.	  Gracely,	  R.	  H.,	   Petzke,	   F.,	  Wolf,	   J.	  M.,	  &	  Clauw,	  D.	   J.	   (2002).	   Functional	  magnetic	   resonance	  imaging	   evidence	   of	   augmented	   pain	   processing	   in	   fibromyalgia.	   Arthritis	   Rheum,	  1333-­‐1343.	  Guadagnoli,	  E.,	  &	  Velicer,	  W.	  F.	  (1988).	  Relation	  of	  sample	  size	  to	  the	  stability	  of	  component	  patterns.	  Psychol	  Bull,	  265-­‐275.	  Gustavsson,	   C.,	   &	   von	  Koch,	   L.	   (2006).	   Applied	   relaxation	   in	   the	   treatment	   of	   long-­‐lasting	  neck	  pain:	  a	  randomized	  controlled	  pilot	  study.	  J	  Rehabil	  Med,	  100-­‐107.	  Hann,	  K.	  E.	  J.,	  &	  McCracken,	  L.	  M.	  (2014).	  A	  systematic	  review	  of	  randomized	  controlled	  trials	  of	   Acceptance	   and	   Commitment	   Therapy	   for	   adults	   with	   chronic	   pain:	   Outcome	  domains,	  design	  quality,	  and	  efficacy.	  J	  Contextual	  Behav	  Sci,	  217-­‐227.	  Harker,	   J.,	   Reid,	   K.	   J.,	   Bekkering,	   G.	   E.,	   Kellen,	   E.,	   Bala,	  M.	  M.,	   Riemsma,	   R.,	   .	   .	   .	   Kleijnen,	   J.	  (2012).	   Epidemiology	   of	   chronic	   pain	   in	   denmark	   and	   sweden.	   Pain	   Res	   Treat,	  371248.	  Hayes,	   S.	   C.,	   &	   Long,	   D.M.	   (2013).	   Contextual	   Behavioral	   Science,	   Evolution	   and	   Scientific	  Epistemology.	   In	  B.	  Roche	   (Ed.),	  Advances	  in	  relational	  Frame	  Theory.	  Oakland,	  CA:	  New	  Harbinger	  Publications.	  Hayes,	   S.	   C.,	   Nelson,	   R.	   O.,	   &	   Jarrett,	   R.	   B.	   (1987).	   The	   treatment	   utility	   of	   assessment.	   A	  functional	  approach	  to	  evaluating	  assessment	  quality.	  Am	  Psychol,	  963-­‐974.	  Hayes,	  S.	  C.,	  Wilson,	  K.	  G.,	  Gifford,	  E.	  V.,	  Follette,	  V.	  M.,	  &	  Strosahl,	  K.	   (1996).	  Experimental	  avoidance	  and	  behavioral	  disorders:	  a	  functional	  dimensional	  approach	  to	  diagnosis	  and	  treatment.	  J	  Consult	  Clin	  Psychol,	  1152-­‐1168.	  Hayes,	   S.	   C.	   (2008).	   Climbing	   Our	   Hills:	   A	   Beginning	   Conversation	   on	   the	   Comparison	   of	  Acceptance	   and	   Commitment	   Therapy	   and	   Traditional	   Cognitive	   Behavioral	  Therapy.	  Clinical	  Psychology:	  Science	  and	  Practice,	  286-­‐295.	  Hayes,	   S.	   C.,	   Barnes-­‐Holmes,	   D.,	   &	   Roche,	   B.	   (2001).	   Relational	   frame	   theory:	   a	   post-­‐
Skinnerian	  account	  of	  human	  language	  and	  cognition.	  Boston,	  MA:	  Springer.	  Hayes,	   S.	   C.,	   Barnes-­‐Holmes,	   D.,	   &	   Wilson,	   K.	   G.	   (2012).	   Contextual	   Behavioral	   Science:	  Creating	   a	   science	   more	   adequate	   to	   the	   challenge	   of	   the	   human	   condition.	   J	  
Contextual	  Behav	  Sci,	  1-­‐16.	  Hayes,	  S.	  C.,	  Hayes,	  L.	  J.,	  &	  Reese,	  H.	  W.	  (1988).	  Finding	  the	  Philosophical	  Core:	  A	  Review	  of	  Stephen	  Pepper’s	  World	  Hypothesis:	  A	  Study	  in	  Evidence.	  J	  Exp	  Anal	  Behav,	  97-­‐111.	  Hayes,	  S.	  C.,	  Levin,	  M.	  E.,	  Plumb-­‐Vilardaga,	  J.,	  Villatte,	  J.	  L.,	  &	  Pistorello,	  J.	  (2013).	  Acceptance	  and	  commitment	  therapy	  and	  contextual	  behavioral	  science:	  examining	  the	  progress	  of	   a	  distinctive	  model	  of	   behavioral	   and	   cognitive	   therapy.	  Behavior	  Therapy,	  180-­‐198.	  
  76 
Healy,	   O.,	   Barnes-­‐holmes,	   D.,	   &	   Smeets,	   P.	   M.	   (2000).	   Derived	   Relational	   Responding	   as	  generalized	  operant	  behavior.	  J	  Exp	  Anal	  Behav,	  207-­‐227.	  Herbert,	  J.	  D.,	  Gaudiano,	  B.	  A.,	  &	  Forman,	  E.	  M.	  (2013).	  The	  importance	  of	  theory	  in	  cognitive	  behavior	   therapy:	  a	  perspective	  of	   contextual	  behavioral	   science.	  Behav	  Ther,	  580-­‐591.	  Hesser,	  H.,	  Westin,	  V.,	  Hayes,	  S.	  C.,	  &	  Andersson,	  G.	  (2009).	  Clients'	  in-­‐session	  acceptance	  and	  cognitive	   defusion	   behaviors	   in	   acceptance-­‐based	   treatment	   of	   tinnitus	   distress.	  
Behav	  Res	  Ther,	  523-­‐528.	  Hesser,	   H.,	   Westin,	   V.	   Z.,	   &	   Andersson,	   G.	   (2014).	   Acceptance	   as	   a	   mediator	   in	   internet-­‐delivered	  acceptance	  and	  commitment	   therapy	  and	  cognitive	  behavior	   therapy	   for	  tinnitus.	  J	  Behav	  Med,	  756-­‐767.	  Heyvaert,	   M.,	   &	   Onghena,	   P.	   (2014).	   Analysis	   of	   single-­‐case	   data:	   randomisation	   tests	   for	  measures	  of	  effect	  size.	  Neuropsychol	  Rehabil,	  507-­‐527.	  Holmström,	  L.,	  Kemani,	  M.K.,	  Kanstrup,	  M.,	  &	  Wicksell,	  R.	  (Accepted	  manuscript).	  Evaluating	  the	  statistical	  properties	  of	  the	  Pain	  Interference	  Index	  in	  children	  and	  adolescents	  with	  chronic	  pain	  J	  Dev	  Behav	  Pediatr.	  IASP.	   (2012).	   IASP	   Taxonomy.	   Retrieved	   from	   http://www.iasp-­‐pain.org/Taxonomy#Peri	  pheralneuropathicpain	  Jacobson,	  N.	  S.,	  Roberts,	  L.	  J.,	  Berns,	  S.	  B.,	  &	  McGlinchey,	  J.	  B.	  (1999).	  Methods	  for	  defining	  and	  determining	   the	   clinical	   significance	   of	   treatment	   effects:	   description,	   application,	  and	  alternatives.	  J	  Consult	  Clin	  Psychol,	  300-­‐307.	  Jacobson,	   N.	   S.,	   &	   Truax,	   P.	   (1991).	   Clinical	   significance:	   a	   statistical	   approach	   to	   defining	  meaningful	  change	  in	  psychotherapy	  research.	  J	  Consult	  Clin	  Psychol,	  12-­‐19.	  Jensen,	   I.	  B.,	  Nygren,	  A.,	  &	  Lundin,	  A.	   (1994).	  Cognitive-­‐behavioural	   treatment	   for	  workers	  with	  chronic	  spinal	  pain:	  a	  matched	  and	  controlled	  cohort	  study	   in	  Sweden.	  Occup	  
Environ	  Med,	  145-­‐151.	  Kato,	  K.,	  Sullivan,	  P.	  F.,	  Evengard,	  B.,	  &	  Pedersen,	  N.	  L.	  (2006).	  Chronic	  widespread	  pain	  and	  its	  comorbidities:	  a	  population-­‐based	  study.	  Arch	  Intern	  Med,	  1649-­‐1654.	  Kazdin,	  A.	  E.	  (2007).	  Mediators	  and	  mechanisms	  of	  change	  in	  psychotherapy	  research.	  Annu	  
Rev	  Clin	  Psychol,	  1-­‐27.	  Kazdin,	  A.	   E.	   (2008).	   Evidence-­‐based	   treatment	   and	  practice:	   new	  opportunities	   to	  bridge	  clinical	   research	   and	   practice,	   enhance	   the	   knowledge	   base,	   and	   improve	   patient	  care.	  Am	  Psychol,	  146-­‐159.	  Kazdin,	   A.	   E.,	   &	   Nock,	   M.	   K.	   (2003).	   Delineating	   mechanisms	   of	   change	   in	   child	   and	  adolescent	   therapy:	  methodological	   issues	   and	   research	   recommendations.	   J	   Child	  
Psychol	  Psychiatry,	  1116-­‐1129.	  Kenny,	   D.	   A.,	   Korchmaros,	   J.	   D.,	   &	   Bolger,	   N.	   (2003).	   Lower	   level	   mediation	   in	   multilevel	  models.	  Psychol	  Methods,	  115-­‐128.	  Kerns,	  R.	  D.,	  Turk,	  D.	  C.,	  &	  Rudy,	  T.	  E.	  (1985).	  The	  West	  Haven-­‐Yale	  Multidimensional	  Pain	  Inventory	  (WHYMPI).	  Pain,	  345-­‐356.	  Kohl,	   A.,	   Rief,	  W.,	  &	  Glombiewski,	   J.	   A.	   (2012).	  How	   effective	   are	   acceptance	   strategies?	  A	  meta-­‐analytic	  review	  of	  experimental	  results.	  J	  Behav	  Ther	  Exp	  Psychiatry,	  988-­‐1001.	  Kosek,	  E.,	  &	  Hansson,	  P.	   (1997).	  Modulatory	   influence	  on	   somatosensory	  perception	   from	  vibration	  and	  heterotopic	  noxious	  conditioning	  stimulation	  (HNCS)	  in	  fibromyalgia	  patients	  and	  healthy	  subjects.	  Pain,	  41-­‐51.	  Kuchinad,	  A.,	  Schweinhardt,	  P.,	  Seminowicz,	  D.	  A.,	  Wood,	  P.	  B.,	  Chizh,	  B.	  A.,	  &	  Bushnell,	  M.	  C.	  (2007).	  Accelerated	  brain	  gray	  matter	  loss	  in	  fibromyalgia	  patients:	  premature	  aging	  of	  the	  brain?	  J	  Neurosci,	  4004-­‐4007.	  Lane,	  P.	  (2008).	  Handling	  drop-­‐out	  in	  longitudinal	  clinical	  trials:	  a	  comparison	  of	  the	  LOCF	  and	  MMRM	  approaches.	  Pharm	  Stat,	  93-­‐106.	  Laraway,	   S.,	   Snycerski,	   S.,	  Michael,	   J.,	  &	  Poling,	  A.	   (2003).	  Motivating	  operations	  and	   some	  further	   terms	   to	   dscribe	   them:	   some	   further	   refinements.	   J	  Appl	  Behav	  Anal,	  407-­‐414.	  
  77 
Lautenbacher,	   S.,	   &	   Rollman,	   G.	   B.	   (1997).	   Possible	   deficiencies	   of	   pain	   modulation	   in	  fibromyalgia.	  Clin	  J	  Pain,	  189-­‐196.	  Leeuw,	  M.,	  Goossens,	  M.	  E.,	  van	  Breukelen,	  G.	   J.,	  de	   Jong,	   J.	  R.,	  Heuts,	  P.	  H.,	  Smeets,	  R.	   J.,	   .	   .	   .	  Vlaeyen,	  J.	  W.	  (2008).	  Exposure	  in	  vivo	  versus	  operant	  graded	  activity	  in	  chronic	  low	  back	  pain	  patients:	  results	  of	  a	  randomized	  controlled	  trial.	  Pain,	  192-­‐207.	  Leigland,	  S.	  (2005).	  Variables	  of	  which	  values	  are	  a	  function.	  Behav	  Anal,	  133-­‐142.	  Lethem,	  J.,	  Slade,	  P.	  D.,	  Troup,	  J.	  D.,	  &	  Bentley,	  G.	  (1983).	  Outline	  of	  a	  Fear-­‐Avoidance	  Model	  of	  exaggerated	  pain	  perception-­‐-­‐I.	  Behav	  Res	  Ther,	  401-­‐408.	  Levin,	   M.	   E.,	   Hildebrandt,	   M.	   J.,	   Lillis,	   J.,	   &	   Hayes,	   S.	   C.	   (2012).	   The	   impact	   of	   treatment	  components	   suggested	   by	   the	   psychological	   flexibility	   model:	   a	   meta-­‐analysis	   of	  laboratory-­‐based	  component	  studies.	  Behav	  Ther,	  741-­‐756.	  Linton,	  S.	   J.	   (2013).	  A	  Transdiagnostic	  Approach	   to	  Pain	  and	  Emotion.	   J	  Appl	  Biobehav	  Res,	  82-­‐103.	  Linton,	  S.	  J.,	  &	  Götestam,	  K.	  G.	  (1984).	  A	  controlled	  study	  of	  the	  effects	  of	  applied	  relaxation	  and	  applied	  relaxation	  plus	  operant	  procedures	  in	  the	  regulation	  of	  chronic	  pain.	  Br	  J	  
Clin	  Psychol,	  291-­‐299.	  Linton,	  S.	  J.,	  &	  Melin,	  L.	  (1983).	  Applied	  relaxation	  in	  the	  management	  of	  chronic	  pain.	  Behav	  
Cogn	  Psychother,	  formerly	  Behavioural	  Psychotherapy,	  337-­‐350.	  Linton,	   S.	   J.,	  Melin,	   L.,	  &	  Stjernlöf,	  K.	   (1985).	  The	  effects	  of	   applied	   relaxation	  and	  operant	  activity	   training	   on	   chronic	   pain.	   Behav	   Cogn	   Psychother,	   formerly	   Behavioural	  
Psychotherapy,	  87-­‐100.	  Linton,	  S.	  J.,	  &	  Nordin,	  E.	  (2006).	  A	  5-­‐year	  follow-­‐up	  evaluation	  of	  the	  health	  and	  economic	  consequences	   of	   an	   early	   cognitive	   behavioral	   intervention	   for	   back	   pain:	   a	  randomized,	  controlled	  trial.	  Spine,	  853-­‐858.	  Lisspers,	  J.,	  Nygren,	  A.,	  &	  Soderman,	  E.	  (1997).	  Hospital	  Anxiety	  and	  Depression	  Scale	  (HAD):	  some	  psychometric	  data	  for	  a	  Swedish	  sample.	  Acta	  Psychiatr	  Scand,	  281-­‐286.	  Ljotsson,	  B.,	  Hesser,	  H.,	  Andersson,	  E.,	  Lindfors,	  P.,	  Hursti,	  T.,	  Ruck,	  C.,	  .	  .	  .	  Hedman,	  E.	  (2013).	  Mechanisms	   of	   change	   in	   an	   exposure-­‐based	   treatment	   for	   irritable	   bowel	  syndrome.	  J	  Consult	  Clin	  Psychol,	  1113-­‐1126.	  Ljotsson,	  B.,	  Atterlof,	  E.,	  Lagerlof,	  M.,	  Andersson,	  E.,	  Jernelov,	  S.,	  Hedman,	  E.,	  .	  .	  .	  Wicksell,	  R.	  K.	  (2014).	   Internet-­‐delivered	   acceptance	   and	   values-­‐based	   exposure	   treatment	   for	  fibromyalgia:	  A	  pilot	  study.	  Cogn	  Behav	  Ther,	  93-­‐104.	  Luciano,	  J.	  V.,	  Guallar,	  J.	  A.,	  Aguado,	  J.,	  Lopez-­‐Del-­‐Hoyo,	  Y.,	  Olivan,	  B.,	  Magallon,	  R.,	  .	  .	  .	  Garcia-­‐Campayo,	  J.	  (2014).	  Effectiveness	  of	  group	  acceptance	  and	  commitment	  therapy	  for	  fibromyalgia:	  A	  6-­‐month	  randomized	  controlled	   trial	   (EFFIGACT	  study).	  Pain,	  693-­‐702.	  	  Luciano	  Soriano,	  C.,	  Rodriguez	  Valverde,	  M.,	  &	  Gutierrez	  Martinez,	  O.	  (2004).	  A	  proposal	  for	  synthesizing	  verbal	  contexts	  in	  Experiential	  Avoidance	  Disorder	  and	  Acceptance	  and	  Commitment	  Therapy.	  Int	  J	  Psychol	  and	  Psychol	  Ther,	  377-­‐394.	  Luo,	  X.,	  George,	  M.	   L.,	  Kakouras,	   I.,	   Edwards,	   C.	   L.,	   Pietrobon,	  R.,	  Richardson,	  W.,	  &	  Hey,	   L.	  (2003).	   Reliability,	   validity,	   and	   responsiveness	   of	   the	   short	   form	   12-­‐item	   survey	  (SF-­‐12)	  in	  patients	  with	  back	  pain.	  Spine,	  1739-­‐1745.	  MacKinnon,	  D.	  P.,	  Fairchild,	  A.	  J.,	  &	  Fritz,	  M.	  S.	  (2007).	  Mediation	  analysis.	  Annu	  Rev	  Psychol,	  593-­‐614.	  MacKinnon,	  D.	  P.,	  &	  Luecken,	  L.	  J.	  (2008).	  How	  and	  for	  whom?	  Mediation	  and	  moderation	  in	  health	  psychology.	  Health	  Psychol,	  99-­‐100.	  Martell,	   C.R.	   ,	   Addis,	   M.E.	   ,	   &	   Jacobson,	   N.	   S.	   (2001).	  Depression	   in	   Context:	   Strategies	   for	  
Guided	  Action	  (Vol.	  31).	  New	  York:	  Norton.	  Martin,	  S.,	  Nelson	  Schmitt,	  S.,	  Wolters,	  P.	  L.,	  Abel,	  B.,	  Toledo-­‐Tamula,	  M.	  A.,	  Baldwin,	  A.,	   .	   .	   .	  Widemann,	  B.	  (2015).	  Development	  and	  validation	  of	  the	  English	  Pain	  Interference	  Index	  and	  Pain	  Interference	  Index-­‐Parent	  report.	  Pain	  Med,	  367-­‐373.	  McBeth,	   J.	   .	   (2005).	   The	   epidemiology	   of	   chronic	   widespread	   and	   fibromyalgia.	   In	   D.	   J.	  Wallace	  &	  D.	   J.	   Clauw	   (Eds.),	  Fibromyalgia	  and	  other	  pain	   syndromes.	   (pp.	   17–28).	  Philadelphia:	  Lippingcott	  Williams	  &	  Wilkins.	  
  78 
McCracken,	   L.	  M.,	  &	  Eccleston,	   C.	   (2003).	   Coping	  or	   acceptance:	  what	   to	  do	   about	   chronic	  pain?	  Pain,	  197-­‐204.	  McCracken,	  L.	  M.,	  &	  Eccleston,	  C.	  (2006).	  A	  comparison	  of	  the	  relative	  utility	  of	  coping	  and	  acceptance-­‐based	  measures	  in	  a	  sample	  of	  chronic	  pain	  sufferers.	  Eur	  J	  Pain,	  23-­‐29.	  McCracken,	   L.	   M.,	   MacKichan,	   F.,	   &	   Eccleston,	   C.	   (2007).	   Contextual	   cognitive-­‐behavioral	  therapy	   for	   severely	   disabled	   chronic	   pain	   sufferers:	   effectiveness	   and	   clinically	  significant	  change.	  Eur	  J	  Pain,	  314-­‐322.	  McCracken,	   L.	   M.,	   Sato,	   A.,	   &	   Taylor,	   G.	   J.	   (2013).	   A	   trial	   of	   a	   brief	   group-­‐based	   form	   of	  acceptance	   and	   commitment	   therapy	   (ACT)	   for	   chronic	   pain	   in	   general	   practice:	  Pilot	  outcome	  and	  process	  results.	  J	  pain,	  1398-­‐1406.	  	  McHorney,	  C.	  A.,	  Ware,	  J.	  E.,	  Jr.,	  &	  Raczek,	  A.	  E.	  (1993).	  The	  MOS	  36-­‐Item	  Short-­‐Form	  Health	  Survey	  (SF-­‐36):	  II.	  Psychometric	  and	  clinical	  tests	  of	  validity	  in	  measuring	  physical	  and	  mental	  health	  constructs.	  Med	  Care,	  247-­‐263.	  McHugh,	  L.,	  Stewart,	  I.,	  &	  Hooper,	  N.	  (2012).	  A	  Contemporary	  Functional	  Analytic	  Account	  of	  Perspective	  Taking.	  In	  L.	  McHugh	  &	  I.	  Stewart	  (Eds.),	  The	  Self	  and	  Perspective	  Taking:	  
Theory	   and	   Research	   from	   Contextual	   Behavioral	   Science	   and	   Applied	   Approaches.	  Oakland,	  CA:	  New	  Harbinger	  Publications.	  McKay,	  D.,	  Taylor,	  S.,	  &	  Abramowitz,	  J.S.	  (2010).	  Cognitive-­‐behavioral	  therapy	  and	  refractory	  cases:	  What	   factors	   lead	   to	   limited	   treatment	   response?	   In	  A.	   P.	   Association	   (Ed.),	  
Cognitive-­‐behavioral	   therapy	   for	   refractory	   cases:	   turning	   failure	   into	   success.	  Washington,	  DC:	  American	  Psychological	  Association.	  Meeus,	  M.,	  &	  Nijs,	  J.	  (2007).	  Central	  sensitization:	  a	  biopsychosocial	  explanation	  for	  chronic	  widespread	   pain	   in	   patients	  with	   fibromyalgia	   and	   chronic	   fatigue	   syndrome.	  Clin	  
Rheumatol,	  465-­‐473.	  Melzack,	  R.,	  &	  Wall,	  P.	  D.	  (1965).	  Pain	  mechanisms:	  a	  new	  theory.	  Science,	  971-­‐979.	  Merskey,	  H,	  &	  Bogduk,	  N.	   (1994).	  Classification	  of	  chronic	  pain:	  descriptions	  of	  chronic	  pain	  
syndromes	  and	  definitions	  of	  pain	  terms	  (2.	  ed.	  ed.).	  Seattle:	  Seattle	  :	  IASP	  Press.	  Michael,	  J.	  (1993).	  Establishing	  operations.	  The	  Behavior	  Analyst,	  191-­‐206.	  Michael,	  J.	  (2000).	  Implications	  and	  refinements	  of	  the	  establishing	  operation	  concept.	  J	  Appl	  
Beh	  Anal,	  401-­‐410.	  Morris,	  S.	  B.,	  &	  DeShon,	  R.	  P.	  (2002).	  Combining	  effect	  size	  estimates	  in	  meta-­‐analysis	  with	  repeated	  measures	  and	  independent-­‐groups	  designs.	  Psychol	  Methods,	  105-­‐125.	  Mountz,	  J.	  M.,	  Bradley,	  L.	  A.,	  Modell,	  J.	  G.,	  Alexander,	  R.	  W.,	  Triana-­‐Alexander,	  M.,	  Aaron,	  L.	  A.,	  .	  .	   .	  Mountz,	   J.	  D.	  (1995).	  Fibromyalgia	   in	  women.	  Abnormalities	  of	  regional	  cerebral	  blood	   flow	   in	   the	   thalamus	   and	   the	   caudate	   nucleus	   are	   associated	  with	   low	  pain	  threshold	  levels.	  Arthritis	  Rheum,	  926-­‐938.	  Muthén,	  B.	  O.	  &	  Curran,	  P.	  J.	  .	  (1997).	  General	  longitudinal	  modeling	  of	  individual	  differences	  in	   experimental	   designs:	   A	   latent	   variable	   framework	   for	   analysis	   and	   power	  estimation.	  Psychol	  Methods,	  371–402.	  Norrbrink,	  C.,	  &	  Lundeberg,	  T.	  (2010).	  Om	  smärta:	  ett	  fysiologiskt	  perspektiv	  (1	  uppl.).	  Lund:	  Studentlitteratur.	  Payne-­‐Murphy,	   J.	  C.,	  &	  Beacham,	  A.	  O.	  (2014).	  Revisiting	  Chronic	  Pain	  Patient	  Profiling:	  An	  Acceptance-­‐based	  Approach	  in	  an	  Online	  Sample.	  Clin	  Psychol	  Psychother.	  Pearl,	  J.	  (2009).	  Causal	  inference	  in	  statistics:	  An	  overview.	  Statistics	  Surveys,	  96-­‐146.	  Pepper,	  Stephen	  C.	  (1942).	  World	  hypotheses,	  a	  study	  in	  evidence.	  Berkeley	  and	  Los	  Angeles:	  University	  of	  California	  press.	  Pleis,	   J.	   R.,	   &	   Coles,	   R.	   (2003).	   Summary	   health	   statistics	   for	   U.S.	   adults:	   National	   Health	  Interview	  Survey,	  1999.	  Vital	  Health	  Stat,	  212,	  1-­‐137.	  Plesh,	   O.,	   Wolfe,	   F.,	   &	   Lane,	   N.	   (1996).	   The	   relationship	   between	   fibromyalgia	   and	  temporomandibular	   disorders:	   prevalence	   and	   symptom	   severity.	   J	   Rheumatol,	  1948-­‐1952.	  Plumb,	   J.	   C.,	   Stewart,	   I.,	   Dahl,	   J.,	   &	   Lundgren,	   T.	   (2009).	   In	   search	   of	   meaning:	   values	   in	  modern	  clinical	  behavior	  analysis.	  Behav	  Anal,	  85-­‐103.	  
  79 
Plumb,	  Jennifer	  C.,	  &	  Vilardaga,	  Roger.	  (2010).	  Assessing	  Treatment	  Integrity	  in	  Acceptance	  and	  Commitment	  Therapy:	  Strategies	  and	  Suggestions.	  Int	  J	  Beh	  Con	  Ther,	  263-­‐295.	  Preacher,	  K.	  J.,	  &	  Hayes,	  A.	  F.	  (2004).	  SPSS	  and	  SAS	  procedures	  for	  estimating	  indirect	  effects	  in	  simple	  mediation	  models.	  Behav	  Res	  Methods	  Instrum	  Comput,	  717-­‐731.	  Preacher,	  K.	  J.,	  &	  Hayes,	  A.	  F.	  (2008).	  Asymptotic	  and	  resampling	  strategies	  for	  assessing	  and	  comparing	   indirect	   effects	   in	   multiple	   mediator	   models.	   Behav	   Res	  Methods,	  879-­‐891.	  Ramnerö,	  J.,	  &	  Törneke,	  N.	  (2008).	  The	  ABCs	  of	  human	  behavior	  behavioral	  principles	  for	  the	  
practicing	  clinician.	  Oakland,	  Calif.:	  Oakland,	  Calif:	  New	  Harbinger	  Publications.	  Raudenbush,	   S	   W,	   &	   Bryk,	   A	   S.	   (2002).	  Hierarchical	   linear	  models:	   Applications	   and	   data	  
analysis	  methods.	  Newbury	  Park,	  CA:	  Sage.	  Rescorla,	  R.	  A.	  (1988).	  Pavlovian	  conditioning.	  It's	  not	  what	  you	  think	  it	  is.	  Am	  Psychol,	  151-­‐160.	  SBU.	   (2006).	   SBU.	  Metoder	   för	   behandling	   av	   långvarig	   smärta.	   En	   systematisk	   litteratur-­‐översikt.	  Stockholm:	  Statens	  beredning	  för	  medicinsk	  utvärdering.	  SBU.	   (2010).	   Rehabilitation	   of	   Patients	   with	   Chronic	   Pain	   Conditions	   (Summary	   and	  conclusions).	  Stockholm:	  The	  Swedish	  Council	  on	  Health	  Technology	  Assessment.	  Sheehan,	  D.	  V.,	  Lecrubier,	  Y.,	  Sheehan,	  K.	  H.,	  Janavs,	  J.,	  Weiller,	  E.,	  Keskiner,	  A.,	  .	  .	  .	  Dunbar,	  G.	  C.	  (1997).	  The	  validity	  of	  the	  Mini	  International	  Neuropsychiatric	  Interview	  (MINI)	  according	  to	  the	  SCID-­‐P	  and	  its	  reliability.	  European	  Psychiatry,	  232-­‐241.	  Sjogren,	   P.,	   Christrup,	   L.	   L.,	   Petersen,	   M.	   A.,	   &	   Hojsted,	   J.	   (2005).	   Neuropsychological	  assessment	   of	   chronic	   non-­‐malignant	   pain	   patients	   treated	   in	   a	   multidisciplinary	  pain	  centre.	  Eur	  J	  Pain,	  453-­‐462.	  Skinner,	  B.	  F.	  (1945).	  The	  operational	  analysis	  of	  psychological	  terms.	  Psychol	  Rev,	  270-­‐277.	  Skinner,	  B.	  F.	  (1957).	  Verbal	  behavior.	  New	  York:	  Appleton-­‐Century-­‐Crofts.	  Skinner,	  B.	  F.	  (1976).	  About	  behaviorism.	  New	  York:	  Vintage	  Books.	  Smeets,	   Rob	   J.	   E.	   M.,	   Vlaeyen,	   Johan	   W.	   S.,	   Kester,	   Arnold	   D.	   M.,	   &	   Knottnerus,	   J.	   André.	  (2006).	   Reduction	   of	   Pain	  Catastrophizing	  Mediates	   the	  Outcome	  of	  Both	  Physical	  and	  Cognitive-­‐Behavioral	  Treatment	  in	  Chronic	  Low	  Back	  Pain.	  J	  Pain,	  261-­‐271.	  Sorensen,	  J.,	  Graven-­‐Nielsen,	  T.,	  Henriksson,	  K.	  G.,	  Bengtsson,	  M.,	  &	  Arendt-­‐Nielsen,	  L.	  (1998).	  Hyperexcitability	  in	  fibromyalgia.	  J	  Rheumatol,	  152-­‐155.	  Spielberger,	  C.	  D.,	  Gorsuch,	  R.	  L.,	  Lushene,	  R.,	  Vagg,	  P.	  R.,	  &	  Jacobs,	  G.	  A.	  (1983).	  Manual	  for	  
the	  State-­‐Trait	  Anxiety	   Inventory	   (Form	  Y)	   :	   self-­‐evaluation	  questionnaire.	   Palo	   Alto,	  Calif.:	  Consulting	  Psychologists	  Press.	  Staud,	   R.,	   Vierck,	   C.	   J.,	   Cannon,	   R.	   L.,	   Mauderli,	   A.	   P.,	   &	   Price,	   D.	   D.	   (2001).	   Abnormal	  sensitization	   and	   temporal	   summation	   of	   second	   pain	   (wind-­‐up)	   in	   patients	   with	  fibromyalgia	  syndrome.	  Pain,	  165-­‐175.	  Steiner,	   J.L.,	   Bogusch,	   L.,	   &	   Bigatti,	   S.	   (2013).	   Values-­‐based	   action	   in	   fibromyalgia:	   results	  from	  a	  randomized	  pilot	  of	  acceptance	  and	  commitment	  therapy.	  Heal	  Psychol	  Res.	  Ström,	  L.,	  Pettersson,	  R.,	  &	  Andersson,	  G.	  (2000).	  A	  controlled	  trial	  of	  self-­‐help	  treatment	  of	  recurrent	  headache	  conducted	  via	  the	  Internet.	  J	  Consult	  Clin	  Psychol,	  722-­‐727.	  Sullivan,	   M.	   J.,	   Thorn,	   B.,	   Haythornthwaite,	   J.	   A.,	   Keefe,	   F.,	   Martin,	   M.,	   Bradley,	   L.	   A.,	   &	  Lefebvre,	   J.	   C.	   (2001).	   Theoretical	   perspectives	   on	   the	   relation	   between	  catastrophizing	  and	  pain.	  Clin	  J	  Pain,	  52-­‐64.	  Sullivan,	   M.,	   Karlsson,	   J.,	   &	   Ware,	   J.	   E.,	   Jr.	   (1995).	   The	   Swedish	   SF-­‐36	   Health	   Survey-­‐-­‐I.	  Evaluation	   of	   data	   quality,	   scaling	   assumptions,	   reliability	   and	   construct	   validity	  across	  general	  populations	  in	  Sweden.	  Soc	  Sci	  Med,	  1349-­‐1358.	  Tait,	   R.	   C.,	   Chibnall,	   J.	   T.,	   &	   Krause,	   S.	   (1990).	   The	   Pain	   Disability	   Index:	   psychometric	  properties.	  Pain,	  171-­‐182.	  Tait,	   R.	   C.,	   Pollard,	   C.	   A.,	   Margolis,	   R.	   B.,	   Duckro,	   P.	   N.,	   &	   Krause,	   S.	   J.	   (1987).	   The	   Pain	  Disability	  Index:	  psychometric	  and	  validity	  data.	  Arch	  Phys	  Med	  Rehabil,	  438-­‐441.	  Thorsell,	  J.,	  Finnes,	  A.,	  Dahl,	  J.,	  Lundgren,	  T.,	  Gybrant,	  M.,	  Gordh,	  T.,	  &	  Buhrman,	  M.	  (2011).	  A	  comparative	   study	   of	   2	   manual-­‐based	   self-­‐help	   interventions,	   acceptance	   and	  
  80 
commitment	   therapy	   and	   applied	   relaxation,	   for	   persons	  with	   chronic	   pain.	  Clin	   J	  
Pain,	  716-­‐723.	  Thyer,	  B.	  A.	  (2000).	  Review:	  individual	  applied	  relaxation	  and	  cognitive	  behavioural	  therapy	  are	   effective	  psychological	   treatments	   for	   generalised	  anxiety	  disorder.	  Evid-­‐Based	  
Ment	  Heal,	  76-­‐76.	  Trompetter,	  H.	  R.,	  Bohlmeijer,	  E.	  T.,	  Veehof,	  M.	  M.,	  &	  Schreurs,	  K.	  M.	  (2015).	  Internet-­‐based	  guided	   self-­‐help	   intervention	   for	   chronic	   pain	   based	   on	   Acceptance	   and	  Commitment	  Therapy:	  a	  randomized	  controlled	  trial.	  J	  Behav	  Med,	  66-­‐80.	  Tunks,	  E.	  R.,	  Crook,	   J.,	  &	  Weir,	  R.	   (2008).	  Epidemiology	  of	   chronic	  pain	  with	  psychological	  comorbidity:	  prevalence,	  risk,	  course,	  and	  prognosis.	  Can	  J	  Psychiatry,	  224-­‐234.	  Turk,	   D.	   C.	   (2002).	   Clinical	   effectiveness	   and	   cost-­‐effectiveness	   of	   treatments	   for	   patients	  with	  chronic	  pain.	  Clin	  J	  Pain,	  355-­‐365.	  Turk,	  D.	  C.	  (2003).	  Cognitive-­‐behavioral	  approach	  to	  the	  treatment	  of	  chronic	  pain	  patients.	  
Reg	  Anesth	  Pain	  Med,	  573-­‐579.	  Turk,	  D.C.,	  Meichenbaum,	  D.,	  &	  Genest,	  M.	  (1983).	  Pain	  and	  behavioral	  medicine:	  A	  cognitive	  behavioral	  perspective:	  (Vol.	  22).	  New	  York:	  Guilford	  Press.	  Turk,	  D.C.,	  &	  Melzack,	  R.	   (2011).	  Handbook	  of	  pain	  assessment	   (3.	   ed.).	  New	  York:	  Guilford	  Press.	  Törneke,	   N.,	   Luciano,	   C.,	   &	   Valdivia	   Salas,	   S.	   (2008).	   Rule-­‐Governed	   Behavior	   and	  Psychological	  Problem.	  Int	  J	  Psych	  Psychol	  Ther,	  141-­‐156.	  Törneke,	  Niklas.	   (2010).	  Learning	  RFT	  :	  An	  Introduction	  to	  Relational	  Frame	  Theory	  and	  Its	  
Clinical	  Applications.	  Oakland,	  CA:	  New	  Harbinger	  Publications.	  Van	   Houdenhove,	   B.,	   &	   Egle,	   U.	   T.	   (2004).	   Fibromyalgia:	   a	   stress	   disorder?	   Piecing	   the	  biopsychosocial	  puzzle	  together.	  Psychother	  Psychosom,	  267-­‐275.	  Van	   Houdenhove,	   B.,	   &	   Luyten,	   P.	   (2009).	   Central	   sensitivity	   syndromes:	   stress	   system	  failure	  may	  explain	  the	  whole	  picture.	  Semin	  Arthritis	  Rheum,	  218-­‐219;	  author	  reply	  220-­‐211.	  Veehof,	  M.	  M.,	   Oskam,	  M.	   J.,	   Schreurs,	   K.	  M.,	  &	  Bohlmeijer,	   E.	   T.	   (2011).	   Acceptance-­‐based	  interventions	   for	   the	   treatment	   of	   chronic	   pain:	   a	   systematic	   review	   and	   meta-­‐analysis.	  Pain,	  533-­‐542.	  Vilardaga,	   Roger,	   Hayes,	   Steven	   C.,	   Levin,	  Michael	   E.,	   &	  Muto,	   Takashi.	   (2009).	   Creating	   a	  strategy	   for	   progress:	   a	   contextual	   behavioral	   science	   approach.	  Behav	  Anal,	   105-­‐133.	  Villatte,	   M.,	   Villatte,	   J.	   ,	   &	   Hayes,	   S.	   C.	   (In	   press).	   The	   Language	   of	   Psychotherapy:	  
Strengthening	  Clinical	  Practice	  with	  Relational	  Frame	  Theory.	  Guilford	  Press.	  Vlaeyen,	   J.	   W.,	   Kole-­‐Snijders,	   A.	   M.,	   Boeren,	   R.	   G.,	   &	   van	   Eek,	   H.	   (1995).	   Fear	   of	  movement/(re)injury	   in	   chronic	   low	   back	   pain	   and	   its	   relation	   to	   behavioral	  performance.	  Pain,	  363-­‐372.	  Vlaeyen,	   Johan	  W.	   S.,	   &	   Linton,	   Steven	   J.	   (2000).	   Fear-­‐avoidance	   and	   its	   consequences	   in	  chronic	  musculoskeletal	  pain:	  a	  state	  of	  the	  art.	  Pain,	  317-­‐332.	  Vowles,	   K.	   E.,	   McCracken,	   L.	   M.,	   McLeod,	   C.,	   &	   Eccleston,	   C.	   (2008).	   The	   Chronic	   Pain	  Acceptance	  Questionnaire:	  Confirmatory	  factor	  analysis	  and	  identification	  of	  patient	  subgroups.	  Pain,	  284-­‐291.	  Vowles,	  Kevin	  E.,	  Witkiewitz,	  Katie,	  Sowden,	  Gail,	  &	  Ashworth,	  Julie.	  (2014).	  Acceptance	  and	  Commitment	   Therapy	   for	   Chronic	   Pain:	   Evidence	   of	   Mediation	   and	   Clinically	  Significant	   Change	   Following	   an	   Abbreviated	   Interdisciplinary	   Program	   of	  Rehabilitation.	  J	  Pain,	  101-­‐113.	  Waller,	  Glenn.	   (2009).	   Evidence-­‐based	   treatment	   and	   therapist	   drift.	  Behav	  Res	  Ther,	  119-­‐127.	  Ware,	  J.	  E.,	   Jr.,	  &	  Sherbourne,	  C.	  D.	  (1992).	  The	  MOS	  36-­‐item	  short-­‐form	  health	  survey	  (SF-­‐36).	  I.	  Conceptual	  framework	  and	  item	  selection.	  Medical	  Care,	  473-­‐483.	  Wegner,	  D.	  M.,	  &	  Gold,	  D.	  B.	  (1995).	  Fanning	  old	  flames:	  emotional	  and	  cognitive	  effects	  of	  suppressing	  thoughts	  of	  a	  past	  relationship.	  J	  Pers	  Soc	  Psychol,	  782-­‐792.	  
  81 
Wetherell,	  J.	  L.,	  Afari,	  N.,	  Rutledge,	  T.,	  Sorrell,	  J.	  T.,	  Stoddard,	  J.	  A.,	  Petkus,	  A.	  J.,	  .	  .	  .	  Atkinson,	  J.	  (2011).	  A	  randomized,	  controlled	  trial	  of	  acceptance	  and	  commitment	  therapy	  and	  cognitive-­‐behavioral	  therapy	  for	  chronic	  pain.	  Pain,	  2098-­‐2107.	  Wicksell,	  R.	  K.,	  Kemani,	  M.,	   Jensen,	  K.,	  Kosek,	  E.,	  Kadetoff,	  D.,	   Sorjonen,	  K.,	   .	   .	   .	  Olsson,	  G.	  L.	  (2013).	   Acceptance	   and	   commitment	   therapy	   for	   fibromyalgia:	   a	   randomized	  controlled	  trial.	  Eur	  J	  Pain,	  599-­‐611.	  Wicksell,	   R.	   K.,	   Lekander,	   M.,	   Sorjonen,	   K.,	   &	   Olsson,	   G.	   L.	   (2010).	   The	   Psychological	  Inflexibility	   in	   Pain	   Scale	   (PIPS)	   –	   statistical	   properties	   and	   model	   fit	   of	   an	  instrument	  to	  assess	  change	  processes	  in	  pain	  related	  disability.	  Eur	  J	  Pain,	  771.e1-­‐771.e14.	  Wicksell,	  R.	  K.,	  Melin,	  L.,	  Lekander,	  M.,	  &	  Olsson,	  G.	  L.	  (2009).	  Evaluating	  the	  effectiveness	  of	  exposure	   and	   acceptance	   strategies	   to	   improve	   functioning	   and	   quality	   of	   life	   in	  longstanding	  pediatric	  pain-­‐-­‐a	  randomized	  controlled	  trial.	  Pain,	  248-­‐257.	  Wicksell,	  R.	  K.,	  Olsson,	  G.	  L.,	  &	  Melin,	  L.	  (2009).	  The	  Chronic	  Pain	  Acceptance	  Questionnaire	  (CPAQ)-­‐further	  validation	  including	  a	  confirmatory	  factor	  analysis	  and	  a	  comparison	  with	  the	  Tampa	  Scale	  of	  Kinesiophobia.	  Eur	  J	  Pain,	  760-­‐768.	  Wicksell,	  R.	  K.,	  Ahlqvist,	  J.,	  Bring,	  A.,	  Melin,	  L.,	  &	  Olsson,	  Gunnar	  L.	  (2008).	  Can	  exposure	  and	  acceptance	   strategies	   improve	   functioning	   and	   life	   satisfaction	   in	   people	   with	  chronic	   pain	   and	  whiplash-­‐associated	   disorders	   (WAD)?	   A	   randomized	   controlled	  trial.	  Cogn	  Behav	  Ther,	  1-­‐14.	  Wicksell,	  R.	  K.,	  Olsson,	  G.	  L.,	  &	  Hayes,	  S.	  C.	  (2010).	  Psychological	  flexibility	  as	  a	  mediator	  of	  improvement	   in	   Acceptance	   and	   Commitment	   Therapy	   for	   patients	   with	   chronic	  pain	  following	  whiplash.	  Eur	  J	  Pain,	  1-­‐11.	  Wicksell,	  R.	  K.,	  Olsson,	  G.	  L.,	  &	  Hayes,	  S.	  C.	   (2011).	  Mediators	  of	  change	   in	  Acceptance	  and	  Commitment	  Therapy	  for	  pediatric	  chronic	  pain.	  Pain,	  2792-­‐2801.	  Williams,	   A.	   C.,	   Eccleston,	   C.,	   &	   Morley,	   S.	   (2012).	   Psychological	   therapies	   for	   the	  management	  of	  chronic	  pain	  (excluding	  headache)	  in	  adults.	  Cochrane	  Database	  Syst	  
Rev,	  CD007407.	  Willis,	   W.	   D.,	   &	   Westlund,	   K.	   N.	   (1997).	   Neuroanatomy	   of	   the	   pain	   system	   and	   of	   the	  pathways	  that	  modulate	  pain.	  J	  Clin	  Neurophysiol,	  2-­‐31.	  Wilson,	   K.	   G.,	   Sandoz,	   E.,	   Kitchens,	   J.,	   &	   Roberts,	   M.E.	   (2010).	   The	   Valued	   Living	  Questionnaire:	   Defining	   and	   Measuring	   Valued	   Action	   Within	   a	   Behavioral	  Framework.	  Psychol	  Rec,	  249-­‐272.	  Wolfe,	   F.,	   Ross,	   K.,	   Anderson,	   J.,	   Russell,	   I.	   J.,	   &	   Hebert,	   L.	   (1995).	   The	   prevalence	   and	  characteristics	  of	  fibromyalgia	  in	  the	  general	  population.	  Arthritis	  Rheum,	  19-­‐28.	  Wolfe,	   F.	   (2010).	   New	   American	   College	   of	   Rheumatology	   Criteria	   for	   Fibromyalgia:	   A	  Twenty-­‐Year	  Journey.	  Arthritis	  Care	  &	  Research,	  583-­‐584.	  Woolf,	   C.	   J.	   (2011).	   Central	   sensitization:	   implications	   for	   the	   diagnosis	   and	   treatment	   of	  pain.	  Pain,	  2-­‐15.	  World	   Health	   Organization.	   (2004).	   International	   statistical	   classification	   of	   diseases	   and	  
related	   health	   problems	   (10th	   revision,	   2nd	   edition.	   ed.).	   Geneva:	   World	   Health	  Organization.	  Yunus,	  M.	  B.	  (2007).	  Fibromyalgia	  and	  overlapping	  disorders:	  the	  unifying	  concept	  of	  central	  sensitivity	  syndromes.	  Semin	  Arthritis	  Rheum,	  339-­‐356.	  Zettle,	   R.	   D.,	   &	   Hayes,	   S.	   C.	   (1982).	   Rule-­‐Governed	   Behavior:	   A	   Potential	   Theoretical	  
Framework	  for	  Cognitive–Behavioral	  Therapy:	  Elsevier	  Inc.	  Zigmond,	   A.	   S.,	   &	   Snaith,	   R.	   P.	   (1983).	   The	   hospital	   anxiety	   and	   depression	   scale.	   Acta	  
Psychiatr	  Scand,	  361-­‐370.	  Öst,	   L.	   G.	   (1987).	   Applied	   relaxation:	   Description	   of	   a	   coping	   technique	   and	   review	   of	  controlled	  studies.	  Behav	  Res	  Ther,	  397-­‐409.	  
